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ABSTRACT
MHC class I molecules are heterotrimeric complexes of a polymorphic MHC class I 
heavy chain, beta-2 microglobulin (p2 M) and a short peptide. These complexes 
present self and foreign peptides to host effector cells. This allows for monitoring of 
the internal milieu of cells through representation of the protein breakdown products 
(peptides) within MHC class I complexes at the cell surface.
This thesis examines the role of the endoplasmic reticulum resident MHC class I 
chaperone tapasin in this process. The initial characterisation was undertaken at a 
genetic level, identifying polymorphic variants of human tapasin. A search for linkage 
with MHC class I and II genes was carried out, with linkage only identified for the 
nearest MHC class II loci. The limited genomic variation was further analysed in 
primate tapasin and 15 amino acid differences from human tapasin were identified. 
Further work was directed at developing a functional test for the role of tapasin in 
MHC class I presentation, so that such differences could be analysed.
A model system was set up that examined the role of tapasin upon previously 
identified tapasin dependent and independent alleles (B*4402 and B*2705 
respectively). A thermostability assay was developed that assessed the peptide cargo 
of BM402 and B*2705 within cells that were competent or deficient for tapasin. This 
work identified that tapasin was important for the optimal assembly of both B*4402 
and B*2705. Tapasin was shown to improve both the rate and extent of optimal 
peptide acquisition. More detailed studies showed that the improvement in the 
thermostability of such complexes could occur independently of tapasin for B*2705, 
although to a lesser extent to that seen in the presence of tapasin. B*4402 was 
unable to load optimal peptides in the absence of tapasin, although it was shown that 
these B*4402 complexes were unlikely to be peptide empty as their thermostability fell 
further upon TAP blockade. When the loading of these alleles was assessed in the 
presence of a soluble tapasin construct that did not abridge the MHC class I 
complexes to TAP, peptide loading was achieved but the thermostability of such 
complexes was reduced when compared to full length tapasin. This suggested that 
the association of nascent MHC class I molecules with the TAP complex is necessary 
for maximal optimisation of the MHC class I complex peptide cargo. Finally, a single 
point mutation was identified that permitted tapasin independent loading of B*4402. 
This single change at position 116 was identical to that seen in the allele B*4405. 
B*4402 was shown to achieve a greater thermostability than B*4405 in the presence 
of tapasin. B*4405 was able to load optimal peptides in the absence of tapasin, with a 
further improvement in the presence of tapasin. Both B*2705 and B*4405 were less 
thermostable than B*4402 in the presence of tapasin.
These experimental observations have led to a reassessment of the multiple functions 
of tapasin in facilitating peptide loading and a consideration of the molecular 
mechanisms that may permit such allele specific interactions.
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CHAPTER 1 INTRODUCTION
1.1 AN OVERVIEW OF THE IMMUNE SYSTEM.
The immune system of man is an evolutionary masterpiece of engineering, 
designed to protect the host from a panoply of invading micro-organisms. It 
exists to provide an immediate response to an enormous variety and number of 
pathogenic viruses, bacteria, fungi and parasites. Critically, it is able to build 
upon this initial encounter to protect the host (and its offspring) from similar or 
recurrent life-threatening infections. Such immune responses require the host to 
recognise the foreign molecules of pathogens and thereby effect a counter 
response to eliminate the pathogen with negligible harm to the host. The foreign 
molecules that generate the anti-paihogen response are termed antigens. The 
immune recognition of such antigens is carried out by lymphocytes and their 
accessory cells. The requirement to both identify all potential foreign molecules 
and distinguish these from self molecules has been achieved in a variety of 
ways. Certain ‘signature’ molecules are expressed by foreign micro-organisms 
and these provide the immune system with a predictable, fixed and discriminating 
signal in which to identify potential invasion (Underhill, 2003). The Toll receptors 
represent the best appreciated recognition receptors for this category of antigen 
and these are principally expressed on the surface of accessory antigen 
presenting cells. These antigens include bacterial DNA (CpG), viral RNA
(dsRNA) and parasitic proteins (flagellin). Ttiis ‘hard wired’ recognition system 
(often termed Pattern Recognition) is considered part of the innate immune 
system as it has little ability to adapt to change or mutation within the pathogen, 
is activated early within host defence and has no capacity to improve upon 
subsequent exposure (Medzhitov and Janeway, 2000).
Immune responses that are directed against unique antigen patterns of a 
pathogen are usually referred to as adaptive immune responses (often termed 
Specific Recognition). This type of response has two key attributes, namely 
specificity and memory. This latter property allows for an enhanced response to 
that antigen upon a secondary exposure. This type of adaptive immune 
response is mediated by lymphocytes. These cells have evolved in concert with 
the innate systems of phagocytic and plasma enzyme based host defence, to 
provide an integrated immune recognition and response unit. Indeed, there 
exists mutual dependence upon these sub-systems in affording the optimum 
response to micro-organisms (Fearon and Locksley, 1996).
Lymphocytes are derived from a lymphoid stem cell within the mammalian bone 
marrow. This precursor cell gives rise to two principal lymphocyte subsets, 
namely the B and T cells. B cells are generated in the bone marrow and display 
cell surface immunoglobulin molecules that are capable of recognising foreign 
proteins. This immunoglobulin can be secreted to provide a soluble immune 
recognition defence and this can be an important component of the adaptive
immune response to certain invading micro-organisms. The T cells are 
generated in the thymus gland following export from the bone marrow. They can 
subsequently be identified in peripheral blood, lymphoid organs and tissue sites 
where they are divided into 2 subsets based upon the expression of certain cell 
surface co-receptors. The co-receptors are the CD4 or CD8 molecules which 
assist in the identification of their respective immune recognition molecules. The 
adaptive responses mediated by both T and B cells are achieved through the 
rearrangement of germ line genes that produce an almost infinite repertoire of 
anticipatory B and T cell receptors. The B cell immunoglobulin receptor consist 
of a heavy and light chain that contribute towards antigen recognition. Each 
chain has a constant region and a variable region which defines its uniqueness 
and specificity. The T cell receptor is similar in concept, having 2 paired chains 
each with a constant and variable region. Both receptors have a similar 
configuration of germ line genes that encode for their respective configuration of 
B and T cell receptors (BCR and TOR). Their receptor loci have a variable and 
constant block of genes. The variable block is made from variable (V), joining (J) 
and diversity (D) gene segments. For the BCR, 250-1000 V, 10 D and 4 J 
segments exist for the heavy chain with over 250 segments for the 2 possible 
light chains. The T cell receptor exists in 2 forms, either utilising a and ^  gene 
loci (majority of peripheral T cells) or y and 6  gene segments. The a locus 
contains approximately 100 variable and 50 joining regions, whilst the ^  region 
has 50 V, 2 D and 12 J regions. These germline segments assemble to form a 
VDJA/J variable region. This combinatorial association and joining greatly
diversifies the potential repertoire. This is further broadened by the processes of 
N-region diversity and junction flexibility in both BCR and TCR’s and a unique 
process of somatic hypermutation for the BCR. The end result of this genetic 
flexibility is a receptor repertoire estimated at This anticipatory
capacity exceeds the total number of lymphocytes with a host but permits an 
extremely broad repertoire of receptors upon B and T cells for subsequent 
recognition of invading micro-organisms (Paul, 1993).
The antigen presentation molecules that are recognised by the receptors of the 
adaptive immune system are specific for each form of antigen and often its 
cellular location. B cells recognise intact protein through their cell surface B cell 
receptors or secreted immunoglobulin. The recognition is determined by the 
shape and fit congruity between the antigen and the BCR heavy and light chains. 
T cells recognise antigens in a fundamentally different manner. CD8 positive T 
cells recognise small protein fragments (peptides) presented by cell surface 
molecules termed Major Histocompatibility Class I (MHC I) complexes 
(Townsend and Bodmer, 1989). Typically these are the classical and non 
classical MHC class I complexes termed HLA-A, B and C and HLA -E, F, G 
respectively (see section 1.2). CD4 T cells recognise protein fragments 
presented by cell surface molecules termed Major Histocompatibility Class II 
complexes (Cresswell, 1994). Both antigen presentation molecules are encoded 
on a region of chromosome 6 that is dense for genes involved in immunological 
processes. MHC class I molecules principally present peptides from the
intracellular environment of the antigen presenting cell whilst MHC class II 
complexes present peptides derived from the extracellular environment. These 
MHC molecules are polymorphic at a population level and polygenic at an 
individual level (Parham and Ohta, 1996). Such diversity is believed to permit 
presentation of a multitude of antigens from the infinite number of micro­
organisms a species may encounter. This immune response at a population 
level is an important concept in understanding the influences that have shaped 
the immune system. Finally, it has become recently appreciated that a third 
family of antigen presentation receptors are important in host protection by T 
cells. This family of CD1 molecules presents lipid antigens to the adaptive 
immune system, increasing further the breadth of micro-organism targeting 
(Dutronc and Porcelli, 2002) (Figure 1.1).
Once a pathogen has been recognised by the immune system, two processes 
occur. The first is a period of proliferation (originally termed clonal selection) 
where the T and B cells having receptors specific for the invading organism 
receive a positive signal to expand their number from its low precursor frequency. 
For B cells this is accompanied by a genetic program that permits improvements 
to be made in the affinity of the BCR for the stimulating antigen. For T cells this 
is not possible, but an improved avidity for the antigen is thought to occur through 
the redistribution and aggregation of the TOR within certain domains of the 
plasma membrane (Farmery et al., 2000; Slifka and Whitton, 2001). The second 
stage is that of an effector response directed at clearing the inciting pathogen.
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Figure 1.1 - Antigen Presentation
Multiple presentation strategies are available to present 
antigens to T cells through polymorphic and 
non polymorphic receptors.
For B cells this may be capture and removal of a harmful toxin following secretion 
of the BCR, fixation to a micro-organism and engagement of plasma enzyme 
systems (complement) or uptake of the organism through membrane bound BCR 
for presentation to T cells. The T cell response may involve the secretion of 
molecules to aid B cell development, attract accessory cells or promote cell 
killing. In the case of CD8 T cells, direct cytotoxicity of the infected cell may be 
undertaken through the release of lytic granules and enzymes (Catalfamo and 
Henkart, 2003). Alternatively cell surface Fas ligand may mediate cellular 
cytotoxicity through ligation of the target cell's Fas receptor (CD95) (Berke,
1995). Following control and/or clearance of the pathogen, a state of adaptive 
memory is maintained. For B cells this is demonstrated by the continued 
production of high affinity antibody that is specific for the prior organism. T cells 
specific for a previously seen pathogen maintain themselves at a higher 
precursor frequency and acquire the capacity to exert an effector response at an 
earlier time point upon subsequent exposure.
The importance of each component of this integrated system is apparent when 
natural deficiencies of certain components are described in man. The selective 
absence of B cells, CD4, CD8 T cells, complement, phagocytes or MHC class I/ll 
molecules all have characteristic phenotypes that highlight their particular niche 
in eliminating certain pathogens (Fischer, 2002). The role of tapasin in the cell 
biology of MHC class I presentation to CD8 T cells is considered with this broad 
canvas in mind.
1.2 THE MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) 
GENES
The major Histocompatibility complex genes encode for molecules that are 
fundamental to self/non self discrimination. Their initial description and 
terminology relates to their identification through allogenic transplantation studies 
in mice. This work initially involved the study of tumour transplant rejection by 
Snell and Gorer (Gorer et al., 1948) and later skin transplantation by Medawar 
(Billingham et al., 1953). It was appreciated that graft refection was 
immunologically mediated and a series of experimental rabbit, guinea pig and 
mouse systems were set up to identify the mechanisms involved (Levine et al., 
1963; McDevitt and Sela, 1965). Immunogenetic studies using highly inbred 
strains of mice defined a region called the major Histocompatibility complex on 
chromosome 17 in mice and chromosome 6 in humans (Klein, 2001). This 
genetic region dictated the compatibility between different strains of mice for 
transplant acceptance or rejection. At the same time McDevitt and others were 
investigating immune response (IR) genes that determined whether a strain 
would respond to polypeptide antigens. These IR genes were localised to the 
same MHC region (McDevitt and Chinitz, 1969). It is now appreciated that both 
immune responses to foreign polypeptides (i.e. viral, bacterial), non-self 
transplants and self antigens are directed through the MHC class I and II proteins 
of the MHC.
The human MHC is located on the short arm of chromosome 6 and is divided into 
3 areas. The MHC class I region contains the MHC class I genes, MHC class II 
area the MHC Class II genes and the MHC class III area other immunologically 
relevant (and non relevant) genes (Kumanovics et al., 2003). The human MHC 
region extends over 4 Mb with the MHC class I region centromeric, the extended 
MHC class II region telomeric and the MHC class III region between the two.
The MHC class III region is about 700kb in length and contains immune genes 
relating to the complement system and tumour necrosis family (Beck and 
Trowsdale, 2000) (Figure 1.2). The MHC class I and II region will be discussed 
separately.
1.2.1 MHC CLASS I REGION
The MHC class I region extends from the HLA-F locus at the telomeric end of the 
short arm of chromosome 6 to the HLA-B locus, a distance of approximately 
1.4MB. There are six functional genes: HLA-A, B, C, E, G, and F within this 
region (Kumanovics et al., 2003). The HLA A, B and C genes are highly 
polymorphic and termed classical MHC as they were responsible for the original 
histoincompatibility observations (termed major Histocompatibility antigens) 
(Klein, 1986; Klein, 2001). Recently a new taxonomy of mammalian MHC class I 
molecules has been proposed (Hughes et al., 1999). Previously the classical 
MHC class I molecules have been termed class la  whilst the non-classical have
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Figure 1.2 -  Schematic representation of the human 
MHC complex on the short arm of 
chromosome 6
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been termed class 1b. Due to the discovery of gene families within the MHC 
possessing a greater divergence from class la than previous class lb genes (i.e. 
MIC), and the recognition of other class I related genes outside of the MHO 
region, a new nomenclature has been proposed for human and mouse MHO 
class I molecules ( Table 1.2.1). This extends the previous class la  and class 1b 
categories with a class 1c group including MICA, MICB and the 
haemachromatosis gene (HFE) which are on chromosome 6 and a class Id  
which are not (i.e. CDIand the neonatal Fc receptor [FCRn]).
The MHC class la  genes encode for the MHC class I heavy chain which non- 
covalently associates with yff2-nnicroglobulin (^2M) to form the MHC class I 
complex. The genes encoding the HLA-A, B and C heavy chain have very a 
similar exon-intron organisation in which separate exons encode the signal 
peptide, the three extracellular domains (ai, 0^2 and 0 3 ), the transmembrane 
region and cytoplasmic tail. Exons 2 and 3 encode for the ai and az regions of 
the mature protein, providing the peptide binding site. Exon 4 encodes the 0 3  
region of the mature protein which interacts with This association is 
recognised by the CD8 co-receptor of MHC class I restricted T cells. The 
polymorphism between the various HLA-A, B and C alleles is primarily located in 
exons 2 and 3 and contributes to the specificity of the peptide binding groove 
(Marsh et al., 2000). The a^  and <72 domains consist of two or-helices that rest 
upon a sheet of eight yff-strands, thereby forming the peptide binding groove.
The main purpose of the MHC Class I complex is to present peptides of 8-9
CLASS
1A
CLASS
IB
CLASS
1C
CLASS
ID
Human HLA-A HLA-E MICA FcRn
HLA-B HLA-F MICB CD1
HLA-C HLA-G HFE
Mouse H-2K H-2Q HFE FcRn
H-2D H-2T CD1
H-2L H-2M
TABLE 1.2.1 -  A new taxonomy of MHC class I molecules
The abbreviations used are FcRn for the Fc receptor gene 
for HFE for the haemachromatosis gene.
amino acids in length within this groove to CD8 positive T cells (Bjorkman et al., 
1987a; Bjorkman et al., 1987b; Townsend et al., 1985; Zinkernagel and Doherty, 
1974). In addition to this function such MHC class I peptide complexes are 
targets for NK cells which possess receptors that identify polymorphic resides in 
the a  ^ region (Sawicki et al., 2001). This is particularly evident for HLA C 
complexes at amino acid (aa) residues 77-80 and HLA A and B at positions 77- 
83 (Boyington et al., 2001). The non-classical MHC class I loci encode for less 
polymorphic heavy chains that all have a similar structure and requirement for 
yff2 M association. These proteins have a limited tissue distribution in comparison 
to classical MHC which is expressed on virtually all nucleated cells. HLA-E 
presents peptides derived from the signal sequence of other MHC class I 
proteins to natural killer cells (NK cells) expressing CD94/NKG2 receptors (Braud 
et al., 1998a). More recently HLA-E has also been shown to present foreign 
antigen to ap T cells (Heinzel et al., 2002). HLA-G is able to bind a wider variety 
of peptides but has a limited tissue expression confined to the extravillous 
cytotrophoblast of the placenta (Le Bouteiller and Blaschitz, 1999). Very little is 
known about HLA-F. Its expression is mainly restricted to B cells, being retained 
in the ER as a TAP bound complex (Wainwright et al., 2000). More recently 
HLA-F has been identified on the cell surface of extravillous trophoblasts that 
have invaded the maternal deciduas (Ishitani et al., 2003). In addition to the 
classical and non-classical genes, the MHC class I region also contain two MIC 
genes (MHC class I chain related, MICA and MICB). These are polymorphic; do 
not require an association with y^ 2 M and their cell surface expression is restricted
1 0
to intestinal epithelium under normal conditions (Stephens, 2001). They are 
recognised by an activating receptor complex (NKG2D/DAP10) that is present on 
NK cells and some T cells.
Non-class I genes outnumber the MHC class I genes within the MHC class I 
region. In the 600Kb segment between HLA-C and HLA-E there are at least 20 
functional non-MHC class I genes (Consortium, 1999). These include 
transcription factors, a tyrosine kinase, helicase and a group of genes potentially 
involved in the pathogenesis of psoriasis (Oka et al., 1999). Unlike the class I 
genes, the non-class I genes in this region are orthologous among different 
species from different mammalian orders (Figure 1.2.1a). The class I genes 
occupy the same intergenic regions but are not necessarily related across 
species. The framework hypothesis suggests that the non-class I genes 
represent a framework that was filled by the expanding MHC class I genes. Both 
human and mouse class I regions have a class I family that is missing in the 
other MHC. There are no MIC genes in the mouse and no H2/10 like genes 
humans. It is interesting to note that there are no other MHC Class I specific 
genes in the MHC class I region; with tapasin, TAP and the proteasome subunits 
encoded elsewhere within the MHC. This is in contrast to the chicken MHC 
where the MHC class I region includes both TAP genes between the 2 class I 
genes, extending over a small region of less than 15Kb (Kaufman et al., 1999) 
(Figure 1.2.1b). These intergenic distances are important in determining the 
probability of co-inheritance of certain gene families. The apparent linkage
11
H u m a n  Cfî v v#M / /  4# €  1 0 ia # # W  € < " "# $§## €—^ W##%
■ B /C  F ■ t  A / G / F
Mouse
K 0  ' T " ' M   ^ M  M
3* 2 0  45 8  3 3Rat imsif— -
 " A ” c / t  C/E W M ' "Nï
E x te nd e d  Cfas5 II CIass i ré g i o n  Ex t e nd e d
c l a s s  H c l a s s  IH c l a s s  I
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Figure 1.2.1b - Organization of human, mouse rat and
chicken MHC regions.
The human HLA complex extends over almost 4 Mb of DNA 
between the TAP genes and classical Class I genes. The 
H-2 complex and RT1 regions extend over 2Mb and 300Kb 
distances respectively. The chicken B locus has the 
classical Class I genes flanking the TAP genes and 
separated by a distance of only 30 nucleotides.
between 2  genes is occasionally in excess of what would be expected by chance 
and such linkage disequilibria are thought to represent a beneficial interaction 
between such genes. This area of linkage has proven to be important within the 
MHC class I, II and II regions where particular haplotypes have been recognised 
(Price et al., 1999). The relevance of such co inheritance has been detailed in 
the rat MHC where a particular MHC class I allele is co-inherited with a peptide 
transporter that is able to correctly furnish the co-inherited class I complex with 
appropriate peptides (Powis et al., 1992). Such clear examples have not 
emerged in the study of human MHC class I complexes.
1.2.2 MHC CLASS II REGION
The MHC class II region extends from HLA-DR through to DP (Figure 1.2.2a).
The MHC class II molecules that present peptides to CD4 positive T cells are 
encoded by 3 loci within this region. These are HLA-DP, DQ and DR, each 
encoding separate a and p  genes. The DR genes encode one DR a gene and 
up to 4 DR yff genes. DP and DQ encode a single functional a and p  gene. The a 
chains of each loci associate with the p  chains of their own family. A high degree 
of polymorphism is seen in class II molecules. This is mostly in the genes of 
each p  loci. These polymorphisms are not random but occur in regions of the 
molecule around the peptide binding groove.
1 2
The products of the MHC class II genes are heterodimers of heavy (a) and light 
(J3) glycoproteins. Each chain has 5 domains: 2 extracellular globular domains, a 
connecting peptide, a transmembrane domain, and a cytoplasmic domain. The 
&2 and p 2 extracellular domains have the structural characteristics of an 
immunoglobulin domain. The a^,p^ and ^^ 2 domains are disulphide linked whilst 
the a^  domain is not. X ray crystallography has shown that the class II molecule 
has a peptide backbone composed of 8  strands of anti-parallel p  sheets, forming 
a floor, and 2 anti-parallel helical regions as the sides (Stern and Wiley, 1994). 
The structure of the MHC class II peptide binding groove is remarkably similar to 
that of the MHC class I structure despite being conformed by 2 separate chains. 
One key difference between the class I and class II structures is the relatively 
open end of the groove which allows the class II molecule to except larger 
peptides than that of MHC class I molecules (Fremont et al., 1998; Fremont et 
al., 1996).
Other MHC class II molecules encoded in the MHC class II region include HLA- 
DM (DM) and DO. These are relatively non polymorphic molecules that do not 
bind peptide. These contain sorting signals in their cytoplasmic, tails directing 
the molecules to the endosomal compartments where they promote antigenic 
peptide loading (Alfonso and Karlsson, 2000).
The MHC class II region also contains genes involved in MHC class I antigen 
presentation. These are the TAP 1, TAP 2, LMP2 and LMP7 genes. The first 2
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genes encode for a heterodimeric ATP dependent peptide transporter that 
transfers peptides from the cytoplasm into the ER for MHC class I assembly 
(Uebel and Tampe, 1999). The latter 2 genes are inducible catalytically active 
subunits of the proteasome (Van den Eynde and Morel, 2001). These form part 
of the ‘immunoproteasome’ that generates antigenic peptides from polypeptide 
precursors in the cytoplasm.
The extended MHC class II region describes a region from KNSL2 to C0L11A2 
at the centromeric end of the MHC, approximately SOOkb from DP (Beck and 
Trowsdale, 1999; Herberg et al., 1998a). This region contains the tapasin gene 
and is syntenic with the extended MHC class II region in mice (Figure 1.2.2b).
1.3 ANTIGEN PRESENTATION
1.3.1 MHC CLASS I PRESENTATION
MHC class I A, B and C complexes are expressed on the surface of virtually all 
nucleated cells. They exist as a heterotrimeric complex of MHC class I heavy 
chain (HC), ;^2 M and peptide. This trimeric structure is the ligand recognised by 
MHC class I restricted CD8  T cells and MHC class I reactive NK cells (Pamer 
and Cresswell, 1998). In the absence of peptide oryff2 M no partial complexes are 
able to exit the endoplasmic reticulum (ER) (Arce-Gomez et al., 1978; Baas et 
al., 1992; Cerundolo et al., 1990).
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The region from KNSL2 to C0L11A2 at the centromeric 
end of the MHC is conserved between human and mouse 
It contains 15 orthologous genes, including the tapasin 
gene.
Each HC is initially translated into the ER as a nascent glycoprotein. Within the 
ER it undergoes assisted folding and disulphide linkage of its cysteine residues 
within the 0 2  and az regions. This folding is assisted by the glycoprotein 
chaperone calnexin and thioreducatase ERp57 (Bergeron et al., 1994; Farmery 
et al., 2000; Nossner and Parham, 1995; Sugita and Brenner, 1994). Once 
correctly folded, the HC may interact with P2^  (Smith et al., 1995). This peptide 
receptive complex is then able to acquire a peptide within the ER. The binding of 
peptide stabilises the non-covalent interaction between HC and P2^  permitting 
egress from the ER (Elliott, 1991; Elliott et al., 1991). Each MHC class I 
molecule has a peptide binding site which consists of two anti-parallel (/-helices 
overlying a platform of yff-strands. The peptide lies in the groove with its N and C 
termini amino acid side chains interacting with the groove to form a stable, high 
affinity interaction. The extensive polymorphism that characterises MHC class I 
gene complex is directed at residues that contribute to the peptide binding 
groove (Elliott et al., 1993). This amino acid changes alter the pockets within the 
binding groove or potential hydrogen bond networks that may be set up with 
certain peptides. These limitations set up particular binding motifs for each allele 
that are unique to the individual peptide binding grooves. The bound peptide has 
its anchor residues fill various pockets within the peptide binding groove whilst 
other amino acid side chains point out of the groove to T cells (Madden, 1995).
In the MHC class I peptide binding groove 6  pockets have been identified, 
namely A, B, C, D, E and F. The A and F pockets interact with the N and C
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termini of the bound peptide setting up important hydrogen bonds and salt 
bridges with the residues in these pockets. The other pockets have similar 
interaction with the peptide side chains. For human MHC class I alleles a 
hydrophobic or basic residue is preferred at the C-terminus (Engelhard et al., 
2002). The T cell recognises the exposed residues of the peptide and elements 
of the (7-helix (Gao et al., 1997; Garboczi et al., 1996). The peptides are 
predominantly generated in the cytosol though the action of a protease known as 
the proteasome (Rock and Goldberg, 1999; Rock et al., 1994). These peptides 
are then transported into the ER through a heterodimeric, transmembrane ABC 
transporter known as TAP (transporter associated with antigen processing) 
(Elliott, 1997; Townsend et al., 1989). This is a constitutive process that can be 
further increased through the action of interferon gamma (IFN-y) (Elliott, 1997). 
The peptide is then loaded onto the awaiting peptide receptive MHC class I 
molecule. This peptide loading is undertaken through the co-operative actions of 
at least three MHC class I assembly chaperones that co-associate on TAP 
(Bouvier, 2003; Momburg and Tan, 2002). These proteins are tapasin, 
calreticulin and ERp57. When associated with TAP they form an assembly 
complex which is termed the peptide loading complex (PLC) (Cresswell et al., 
1999; Ortmann et al., 1997). Exceptions to this pathway do exist with some MHC 
class I alleles able to load transported peptides without an interaction with this 
complex and others able to load peptides in the absence of TAP (Neisig et al., 
1996; Wei and Cresswell, 1992). The transported peptides are typically 9-15 
amino acids in length with an optimal requirement for MHC class I association of
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8-9 amino acids (Shastri et al., 2002). The C terminus of the transported 
peptides is determined through the action of the proteasome whilst the N 
terminus may undergo further trimming within the ER (Craiu et al., 1997; Mo et 
al., 2000). One such ER aminopeptidase has recently been identified (ERAAP) 
and has been shown to be important in generating the optimal peptide for certain 
alleles (Saric et al., 2002; York et al., 2002). Once the MHO class I complex is 
stably loaded with peptide it is able to exit the ER. Its arrival at the cell surface 
permits T cells to sample the protein content of the cell, identifying ‘foreign 
contamination’ amongst the self repertoire of MHO class I peptides. This 
sampling of endogenous protein is in contrast to the MHC Class II system where 
sampling of exogenous proteins that access a different peptide loading 
environment is undertaken (Figure 1.3.1).
In addition to this classical pathway of MHC class I presentation other alternate 
pathways appear to exist (Reimann and Schirmbeck, 1999). These pathways 
have similarities to the MHC class II system as they can sample exogenous 
antigens and present such peptides to CD8  positive T cells. These processes 
have been termed cross-presentation when referenced to the antigen presenting 
dendritic cell (Yewdell et al., 1999). There are at least 4 ways in which this non 
classical presentation may allow MHC class I complexes to acquire peptide. The 
first appears to involve a phagosome to cytosol pathway which then intersects 
with the conventional presentation route (Rodriguez et al., 1999). This pathway 
may utilise a specific transporter from the phagosome to cytosol or follow from a
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Figure 1.3.1- Endogenous and exogenous MHC class I
antigen presentation pathways.
The classical pathway processes endogenous antigen and directs peptide 
loaded complexes form the ER to the cell surface. The exogenous pathway 
operates in professional antigen presenting cells through a variety of possible 
mechanisms, (i) Phagosome to cytosol transfer of exogenous antigen 
(ii) Regurgitation of endosomally processed antigen to peptide receptive cell 
surface complexes (iii) Recycling and loading of cell surface complexes within 
endosomal compartments and (iv) direct trafficking of complexes from the ER 
to endosomal compartments or through fusion of the ER with a phagosome.
loss of phagosomal membrane integrity. The second manner involves 
exogenous antigens that have been processed within an endolysomal 
compartment and then regurgitated into the extracellular space to be bound by 
peptide receptive cell surface complexes (Pfeifer et al., 1993). The third route 
relates to the cell surface recycling of MHC class I complexes through 
endosomal compartments. Such recycling through acid compartments may 
liberate certain acid sensitive peptides and permit exchange for other peptides 
within these compartments (Gromme et al., 1999; Schirmbeck et al., 1995; 
Schirmbeck and Reimann, 1996). Lastly, MHC class I complexes may traffic 
directly to such endosomal compartments, perhaps through the co-association 
with invariant chain (Cerundolo et al., 1992; Vigna et al., 1996). Most recently it 
has been shown that the ER may fuse with a phagosome within dendritic cells 
and macrophages to generate a new ER-phagosome compartment that is 
competent for MHC class I assembly and presentation (Ackerman et al., 2003; 
Guermonprez et al., 2003; Houde et al., 2003). It is believed that these alternate 
pathways of MHC class I presentation are of fundamental importance in initiating 
responses through dendritic cells (Heath and Carbone, 2001). Dendritic cell 
mediated CDS T cell priming against an intracellular bacteria or virus is thought 
to require such cross presentation, if such organisms do not have tropism for 
dendritic cells. Furthermore for some pathogens that interfere with classical 
antigen presentation systems such alternate pathways provide another approach 
to CTL (cytotoxic T lymphocyte) generation (Hewitt, 2003).
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1.3.2 MHC CLASS II PRESENTATION
MHC class II antigen presentation is analogous to MHC class I presentation in 
that its primary purpose is to present peptide antigens to I  cells. The MHC class 
II genes are encoded 1Kb centromeric of the MHC class I genes and have 
comparable polymorphic variation. The MHC class II genes are divided into 3 
families DP, DQ, and DP, which in contrast to MHC class I products are only 
expressed on specialised antigen presenting cells (Beck and Trowsdale, 1999). 
These are namely dendritic cells, B cells and cells of the monocyte/macrophage 
lineage. The protein structure of MHC class II molecules is similar to MHC class 
I molecules with a non covalent association of an a and p  chain to provide the 
antigen binding cleft (Figure 1.3.2). The MHC class Ikpeptide complex is then 
expressed at the cell surface for recognition by CD4 positive T cells. These CD4 
T cells may then mediate a diverse array of effector or helper functions for both 
CD8  T cells and B cells.
The MHC class II heterodimer is composed of the transmembrane o and p  
subunits from the DR, DQ or DP loci. The loci are highly polymorphic with 
polymorphisms largely confined to the antigen binding pocket of these molecules. 
(The DR a gene is the exception being essentially monomorphic). The peptide 
binding cleft is an extended groove with an eight stranded yff-pleated sheet 
forming the floor and 2 (/-helical regions forming the walls. The antigenic 
peptides that are loaded into this groove are derived from foreign and self
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A schematic representation of the MHC class II 
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promotes the exchange of CLIP for peptide within the 
MHC class II loading compartment (MIIC).
proteins. These are typically longer than MHC class I peptides, typically being 
10-15 amino acids in length (Rammensee et al., 1995). Their suitability for 
occupation of the MHC class II groove is dependent upon the hydrogen bond 
network that is established between the peptide backbone and the floor of the 
peptide binding groove. Within the peptide binding groove distinct pockets have 
been identified which accept the peptide side chains of the antigenic peptides. 
The polymorphisms in the class II structure are located within these pockets and 
this dictates the allele specificity of peptide binding (Engelhard, 1994).
The MHC class II proteins are initially assembled in the ER. This initially folding 
and assembly is supported by the glycoprotein chaperones calnexin and BiP 
(Anderson and Cresswell, 1994; Schaiff et al., 1992). A specific class II 
accessory molecule termed invariant chain (Ii) also associates with nascent class 
II within the ER (Roche and Cresswell, 1990). The Ii has a number of important 
properties and functions. It is a transmembrane glycoprotein with 2 flexible 
domains. The first domain contains a 21 amino acid sequence (position 80-101) 
that is known as CLIP (Class II associated Invariant chain peptide). The 
cytosolic tail contains both an endosomal sorting and ER export signal. These 2 
structural features are paramount to the successful loading of MHC class II 
molecules as the nascent class II molecules all bind to the CLIP region of 
invariant chain, permitting egress to their respective antigenic peptide loading 
compartments (Cresswell, 1992). This initial MHC class II apw complex co­
associates as trimers which are subsequently liberated from calnexin and traffic 
from the ER. The apW nonamers transverse to the golgi where they are sorted
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towards the endocytic route and out of the default secretory pathway to the cell 
surface. This is accomplished through the recognition of a dileucine motif in the 
cytoplasmic tail of Ii (Lotteau et al., 1990). The entry of the nascent MH class II 
complexes in the endosomal system is critical as their peptide repertoire is 
sampled from internalised proteins that have been modified within the endosomal 
compartments (Bakke and Dobberstein, 1990; Pieters et al., 1993). This 
intersection of two trafficking pathways is characteristic of antigen presentation 
pathways
Thus, the fundamental difference between MHC class II and I peptide processing 
presentation is therefore the source of peptides and the site of peptide loading. 
MHC class II presentation presents exogenous foreign (or self) peptides that 
have been internalised and delivered to the MHC class II loading compartment. 
Antigens may reach these intracellular compartments following a variety of 
antigen uptake mechanisms such as phagocytosis, pinocytosis or receptor 
mediated endocytosis (Watts, 1997). The early endosomes are the first 
compartment encountered and these have little proteolytic activity in generating 
peptide antigens for MHC class II loading. The late endosomes and lysosomes 
provide an acidic pH which permits proteolysis and disulphide bond reduction of 
polypeptides (Watts, 2001). Acidification is an important factor in protein 
unfolding and in the activation of proteases. Disulphide bond reduction has more 
recently been shown to have an important role in the liberation of antigenic 
peptides (Marie et al., 2001). The endosomal proteases that generate peptides
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are classified into families according to the residue that they use to cleave the 
peptide bond. Most of the lysosomal proteases are known as cathepsins 
followed by a letter (A, B, C). Studies have shown a great complexity in the 
activity of many of these proteases in liberating antigenic peptides from precursor 
polypeptides (Riese and Chapman, 2000).
The co-association of newly synthesised MHC class ll-li complexes and peptide 
in the same endocytic vesicle requires a process of Ii chain removal and peptide 
loading (Denzin and Cresswell, 1995; Sherman et al., 1995). Firstly the Ii chain 
is cleaved by a variety of cysteine proteases and cathepsins until only the CLIP 
peptide occupies the binding site (Villadangos et al., 1999). Once the endosomal 
localisation signal of the invariant chain in removed the MHC class ll-CLIP 
complex can traffic to the cell surface (Bakke and Dobberstein, 1990). This is 
not normally seen, implying a substitution of CLIP for antigenic peptide shortly 
after Ii chain proteolysis. The principle factor that contributes to CLIP removal is 
the activity of the MHC class II chaperone HLA DM. This heterodimer, which is 
encoded within the MHC class II region, is non-polymorphic and does not bind 
MHC class II peptides. It is believed to act upon the CLIP occupied but ‘flexible’ 
MHC class II peptide binding groove, to open the groove, and permit CLIP loss. 
Furthermore, it stabilises the open peptide binding groove providing an 
opportunity for antigenic peptide binding. This action may take place on other 
MHC class II loaded complexes whose binding groove is occupied but flexible. 
This process has been termed kinetic proofreading to convey the functional
2 2
context of peptide distinction between optimal and suboptimal peptides (Brooke 
et al., 2002; Kropshofer et al., 1996). Another MHC lass II chaperone is 
encountered within the endosomal route. This molecule is HLA-DO and is 
encoded within the MHC class II region. Like DM it does not bind peptides and 
has limited polymorphism. It is principally expressed in B cells and its function is 
not clear. It is thought to promote high affinity peptide binding in late endosomal 
compartments and support the stabilisation of open MHC class II molecules by 
HLA-DM (Kropshofer et al., 1999). Once antigenic peptide has bound, the MHC 
class II molecule is thought to adopt a more rigid conformation which is 
unsuitable for DM association, permitting egress to the cell surface. Once at the 
cell surface the MHC class II complexes are internalised for lysosomal 
destruction or interchange of peptides within the endosomal compartments.
MHC class II presentation ensures that exogenous/internalised proteins are 
presented to the immune system. This presentation of antigenic ligand and 
receptor is seen by CD4 T cells. This is undertaken in professional antigen 
presenting cells for the subsequent activation, proliferation, cytokine liberation 
and co-stimulatory help that CD4 cells provide to B and CDS T cells in mediating 
control of an invading micro-organism.
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1.3.3 CD1 ANTIGEN PRESENTATION
Following the advances in understanding the processing and presentation of 
protein antigens in the late 1980 and early 1990's, a new pathway of T cell 
antigen recognition was described in 1992 (Porcelli et al., 1992). This pathway 
was restricted to the presentation of lipid antigens to T cells through a group of 
molecules encoded outside of the MHC region. This initial description concerned 
the molecule CDIb which is one of 5 CD1 proteins (CDIa, CDIb, CDIc, CDId, 
CDIe) encoded on chromosome 1. The polypeptides that are encoded by the 
CD1 genes have homology to MHC class I heavy chains containing 3 
extracellular domains (au c/2 and c/3). They are also non-covalently associated 
with yff2-microglobulin Off2 in) (Porcelli and Modlin, 1999). X-ray crystallographic 
studies of CDIb and CDId have shown that they have large antigen binding 
grooves that are lined by hydrophobic amino acids (Gadola et al., 2002; Zeng et 
al., 1997). These structures show the alkyl chains of the amphipathic lipids 
interacting with the hydrophobic pocket allowing the hydrophilic component of the 
antigen to protrude from the groove. Several types of lipid antigen are known to 
be presented by CD1 molecules including mycobacterial mycolic acids, bacterial 
glycolipids such as lipoarabinomannan, phosphatidylinositols, sphingolipids, 
polyisoprenoid lipids and their glycosylated derivatives.
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CD1 molecules require an association with the protein folding chaperones 
calreticulin and calnexin shortly after translation. This ER assisted folding of the 
glycosylated heavy chain of the CD1 proteins is believed to promote subsequent 
P2^  and self lipid association. Although the self ligand association has not been 
conclusively demonstrated, various lines of experimental evidence have 
supported this concept. In an analogous manner to the role of class II invariant 
chain (Ii) and peptide (CLIP) in binding to MHC class II molecules (and 
suboptimal peptide binding to MHC class I molecules), this self ligand association 
is believed to protect/block the groove until the appropriate ligand is identified 
(Moody and Porcelli, 2003). Following release from the ER all CD1 molecules 
are believed to transit to the cell surface before they diversify in their intracellular 
distribution (Figure 1.3.3).
CDIa molecules are unusual as their cytoplasmic tails lack a recognised 
internalisation sorting motif. CDIa is therefore found predominantly at the cell 
surface with a small fraction in sorting endosomes. CDIa has been shown to 
present glycolipids from mycobacteria and self lipids to aP T cells.
CDIb has a cytosolic tail with a tyrosine internalisation sorting motif. This YXXZ 
(where Z is a hydrophobic residue and X any amino acid) permits an association 
with adaptor proteins that mediate intracellular sorting. The YQNIP cytoplasmic 
tail of CDIb permits penetration through to the late endosomes , lysosomes and 
MHC class II compartments. As CDIb is able to present at least 3 classes of
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CD1 antigen presentation pathway
CD1B
CD1C
CD1A
Figure 1.3.3 -  CD1 antigen presentation pathway
A schematic representation of the GDI antigen 
presentation pathway. The CD1 isoforms traffic through 
different intracellular compartment from the cell surface. 
These include the sorting endosome (SE), early and late 
endosomes (EE/LE) and the MHC class II loading 
compartment (MIIC). This intracellular trafficking is 
controlled by cytoplasmic tail interactions with adaptor 
proteins and the invariant chain association with CDId.
lipid antigen (mycolates, diacylglycerols and sphingolipids) there may be differing 
requirements for loading of such lipids within different environments. This has 
been recently shown for the sphingolipid, ganglioside GM2 , where the length of 
the alkyl chain of the lipid antigen determined whether it bound to the CD1b 
molecule within an endosomal ( > 6 4 0  long) or non-endosomal pathway (<C4o short) 
(Joyce and Van Kaer, 2003).
CD1c has a YQDI cytosolic motif which permits internalisation through an 
interaction with the AP-2 adaptor complex but not with the APS complex. CD1c 
is therefore only able to traffic to the early and late endosomal compartments. 
This surveillance of the endocytic pathway permits loading of CD1 c with 
microbial isoprenoids ligands (Briken et al., 2000).
CD1d is a peculiar CD1 molecule, as it presents an unknown self lipid, has 
multiple intracellular localisations and selects/activates a particular T cell subset 
with an invariant <724)^11 gene usage. Its cytoplasmic tail (YQGVL) permits 
localisation to the early and late endosomes (like CD1c) and a dileucine motif 
enables sorting to lysosomes (like GD1b). In addition it has been shown to 
associate with Ii and traffic to the MHC class II compartments (MIIC).
The emergence of the CD1 antigen presentation pathways for the selection and 
activation of lipid specific T cells complements and extends our understanding of 
the MHC class I and II pathways for protein antigens. Similarities can be drawn
2 6
between the need to initially load a self ligand for correct folding, selective 
trafficking and the avoidance of degradation. Secondly the capacity of antigen 
presenting molecules to change their cargo, sample antigens in different cellular 
compartments and signal to selected effector cells underscores the importance of 
understanding the molecular nature of these pathways.
1.4 CELL BIOLOGY OF MHO CLASS I ANTIGEN 
PRESENTATION
1.4.1 PROTEASOME AND ITS SUBSTRATES
The generation of peptides is fundamental to the process of MHC class I 
presentation. This activity is principally undertaken by the constitutively active 
peptide producing machinery of the cytosolic proteasome (Kloetzel, 2001). The 
substrates of the proteasome are usually:
1 ) Damaged/oxidised proteins at the end of their life
2) Displaced, deglycosylated ER proteins
3) DRiPS (Defective Ribosomal Products)
Such waste disposal of host proteins is required to maintain a homeostasis of 
new protein synthesis and senescent protein removal. It is this essential 
housekeeping service that serves as the platform for peptide ligand generation 
and is necessary to eventually complete MHC class I complex assembly. The 
constant availability of proteosome/cytsolic peptidase substrate in all cells
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provides a continuous source of host peptide to be presented on MHC class I 
molecules in all nucleated cells. In the presence of foreign proteins, such as 
those from an invading virus, it would not be acceptable to the host immune 
system to wait for protein senescence before the foreign proteins can be made 
into peptides for presentation to the host immune system (Yewdell et al., 1996; 
Yewdell et al., 2001). This dilemma has been recently addressed by the 
introducing the concept of protein biosynthesis as an imperfect system with its 
defective ribosomal products (DRiPs) being channelled through the host peptide 
producing machinery to yield antigenic peptides. This DRiP hypothesis thus 
allows the immune system to monitor protein synthesis rates in cells and not 
protein concentration or degradation. This process of protein substrate 
generation allows the immune system to sample foreign peptide from the 
background of self proteins, permitting a rapid detection of infected cells 
(Yewdell, 2002).
1.4.2 PROTEASOME
The proteasome is a large multicatalytic proteinase that is present in both the 
nucleus and cytosol of all eukaryotic cells. It is composed of 4 heptameric 
subunit (ajpTpjaj) rings which form a hollow barrel with a central chamber in 
which substrates are degraded (Kloetzel, 2001). This central chamber has the 
catalytically active faces of the p  subunits directed into the central chamber. This 
catalytic core of the proteasome is known as the 208 proteasome. The other
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structural features of proteasome are the regulatory subunits that attach to each 
end of the 20S proteasome. The major regulatory subunit is the 19S regulator 
which is able to recognise polyubiquitin chains of protein substrates and direct 
them into the barrel of the 20s proteasome. The 26S proteasome complex is 
made from a 19S regulator subunit sited at either end of the 20S core. The base 
of each regulator subunit is composed of 6 ATPases of the AAA family. This 
family has an ATP binding site with conserved motifs known as Walker A and 
Walker B. These are in contact with the 20S catalytic unit resulting in the ATP 
dependent opening of the a rings, permitting polypeptides access to the 
proteolytic core. Of the seven p  subunits only 3 are catalytically active, p \ , p2 
and p5, providing 6 active sites within the core. Two cut preferably after 
hydrophobic residues (/ff5-‘chymotrypsin like’), two cleave after basic residues (p2 
- ‘trypsin like’) and the two remaining sites preferentially act after acidic residues 
(P  ^ -  ‘caspase like’). These catalytically active subunits all contain a threonine at 
their amino termini characterising the proteasome as a member of the amino- 
terminal nucleophile hydrolase family. In certain tissues these catalytically active 
subunits may be replaced with interferon y (IFN- y) inducible subunits. These 
inducible subunits are LMP2, LMP 7 and MECL-1. Collectively they are refereed 
to as the immunosubunits and their incorporation into a new 20S proteasome is 
identified as the ‘immunoproteasome’. A further IFN- y inducible component of 
the proteasome is the proteasome activator PA28 (11S regulator). It is 
composed of 2 IFN inducible subunits PA28a and PA28yff. This attaches to the a 
rings of the 20S proteasome to form a 19S-20S-11S complex. The constitutive
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26S proteasome (19S-20S-19S) and immunproteasome 19S-20S 
(LMP2/LMP7/MECL-1 )-11S are believed to maximise the diversity of peptides 
from precursor polypeptides (Emmerich et al., 2000; Toes et al., 2001). This has 
been shown at the level of individual peptides where either of these variants may 
destroy or enhance the index peptide. At the ‘population’ level of liberated 
peptides a different repertoire has been identified between constitutive or 
immunoproteasomal proteolysis (Van den Eynde and Morel, 2001).
The targeting of misfolded, damaged or incomplete proteins to the proteasome is 
mediated through the ubiquitin pathway. The targeting for degradation is 
mediated by the attachment of multiple molecules of ubiquitin to the substrate. 
This small protein covalently attaches to a free amino group on the substrate.
The lysine of the preceeding ubiquitin is then targeted by subsequent ubiquitin 
molecules to generate a polyubuiquinated substrate. This process is undertaken 
by 3 important enzymes. E l initiates the cascade through an ATP dependent 
activation of ubiquitin. This occurs through a thioester bond between the C- 
terminal carboxyl group of ubiquitin and a cysteine side chain of E l This is then 
suitable for transfer to the E2 carrier protein via a trans-esterification reaction to 
the cysteine residue in the active site of E2. E2 is sufficient to transfer the 
ubiquitin to the substrate but the third enzyme is usually required to catalyse 
polyubiquitination. This final enzyme (E3) is ubiquitin protein ligase (E3) and this 
brings E2 into the vicinity of the substrate in addition to directly catalysing 
ubiquitin conjugation to the substrate. The polyubiquinated substrate is
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recognised by the 19S regulator subunit and fed into the 20 S catalytic core for 
proteolysis (Kisselev and Goldberg, 2001; Kornitzer and Giechanover, 2000).
1.4.3 CYTOSOLIC PEPTIDASES
The ubiquitin proteasome pathway is considered to be the major contributor of 
antigenic peptides for MHC class I assembly. However, the use of selective 
proteasomal inhibitors has implicated other cytosolic proteases as having a role 
in antigenic peptide production for MHC class I assembly. Over the last few 
years a number of these proteases have been identified and studied.
- Tripeptidylpeptidase II (TPII) was described in 1999 as a giant protease that 
may substitute for some of the proteolytic actions of the proteaosome (Geier 
et al., 1999). TPII is a ubiquitous serine peptidase that can exist as a 
cytosolic and membrane bound form. It cleaves aminoterminus tripeptides in 
a chymotrypsin/trypsin like manner. Additional endopeptidase activity after 
lysine and arginine residues has also been seen but this is thought to only 
account for 0.2% of its exopeptidase activity. TPII therefore probably acts to 
degrade oligopeptides which may be circumvented for MHC class I usage 
(Wang et al., 2000). Recently this has been identified for the HLA-A3 Nef 73- 
82 peptide which is reduced when TPII activity is inhibited pharmacologically 
(AAF-CMK) or by RNA interference (RNAi) (Seifert et al., 2003).
- Bleomycin hydrolase (BH) and Puromycin sensitive aminopeptidase (PSA) 
were identified in 2000 as having N terminal trimming activities (Stoltze et al..
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2000). BH is a cysteine peptidase (inhibited by E64) that was identified as a 
cytosolic trimmase of a VSV epitope, whilst PSA is a metalloprotease 
identified under similar circumstances. Their individual contributions to MHC 
class I assembly have not been clearly addressed and similar to the 
proteasome and TPII, both have general housekeeping functions in most 
cells.
- Leucine aminopeptidase was shown in 1998 to undertake N terminal 
trimming of an extended peptide to a final MHC class I epitope (Beninga et 
al., 1998). Furthermore this enzyme was inducible upon IFN-y treatment, a 
stimulus for many MHC class I assembly chaperones. Upon inhibition by 
bestatin this N terminal trimming was lost.
- TOP (thiol-sensitive metallopeptidase) has been most recently shown to 
behave as a cytosolic endopeptidase. It has been shown to cleave peptides 
of 6-17 amino acid residues and importantly upon over expression to destroy 
antigenic peptides (Sane et al., 2001). Manipulation by RNAi showed an 
improved presentation of antigenic peptides (York et al., 2003). It can 
therefore be seen as a limiting factor in the transformation of proteosome 
derived peptides to MHC class I ligands.
The role of each of these cytosolic peptidases in the preparation of peptides for 
TAP transport and eventual MHC class I assembly will become clearer over the 
following years through the selective use of ‘knockdowns’ and global and 
selective epitope analysis.
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1.4.4 TRANSPORTER ASSOCIATED WITH ANTIGEN PRESENTATION 
(TAP)
TAP is a member of the ATP binding cassette transporter family (ABC 
transporters). It is a heterodimer of TAPI and TAP 2 whose genes are encoded 
in the MHC class II region of chromosome 6 (Elliott, 1997). The TAP proteins are 
composed of a hydrophobic domain, comprising of multiple transmembrane 
segments and a hydrophilic nucleotide binding domain (NBD). The NBD has a 
highly conserved sequence motif (Walker A and B) that permits ATP binding and 
hydrolysis. The TAP heterodimer transports peptides from the cytosol to the ER 
in an ATP-dependent manner (Neefjes et al., 1993b). TAP exhibits some degree 
of size and sequence specificity for substrate peptides: transported peptides are 
optimally 9-12 amino acids in size although longer peptides may be transported 
(Androlewicz and Cresswell, 1996). Recent work using GPP tagged TAP chains, 
which allows for the calculation of TAP mobility within the ER membrane, has 
shed new light on the function of TAP. The lateral mobility of TAP in the ER of 
living cells increases when TAP is inactive and decreases when it translocates 
peptides (Reits et al., 2000). Using this approach it has been suggested that in 
‘normal’ cells only a third of TAP molecules are actively transporting peptides. 
However TAP activity is seen to become fully operational following viral infection. 
The source of extra substrate in these experiments was shown to be defective 
ribosomal products (DRiP’s). The enhanced TAP activity was reduced when the
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production of viral DRiP’s was impeded. An additional observation was that 
peptides that could bind to TAP but were not transported could decrease the 
mobility of TAP. This suggested that a peptide induced conformational change in 
TAP may occur independently of peptide translocation. This notion has been 
subsequently supported by experiments showing that peptides or nucleotides 
can promote different TAP conformations (Karttunen et al., 1999). Using TAP 
mutants that were unable to bind ATP, Knittler and colleagues found that (Alberts 
et al., 2001 ; Knittler et al., 1999);
(i) peptide transport required nucleotide binding to both TAP subunits
(ii) peptide mediated release of MHC class complexes from TAP required 
nucleotide binding but not hydrolysis (when peptide was exogenously added)
(ill) nucleotide binding was necessary for peptide binding to TAP.
These observations were novel as peptide binding to TAP had previously been 
considered as a nucleotide independent event and class I release from TAP had 
not been linked to conformational changes in TAP. They concluded that peptide 
mediated release of MHC class \IP2^  from TAP is driven by a nucleotide 
dependent conformational change in TAP. Subsequent work using TAP mutants 
that would allow ATP binding but not ATP hydrolysis indicated that:
(i) TAP subunits have asymmetrical properties
(ii) TAPI has a high affinity ATP binding site
(iii) peptide binding and transport requires nucleotide binding of both NBDs
(iv) peptide mediated disassembly depended mainly on nucleotide binding by 
TAPI
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(v) mutations in TAP 2 (but not TAP 1 ) that permit nucleotide binding but 
interfere with ATP hydrolysis prevent peptide transport and MHC class I cell 
surface expression.
Together these studies suggest that the TAP subunits have distinct roles in
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peptide transport, such that ATP hydrolysis at one chain induces ATP binding at 
the other and that peptide mediated dissociation of MHC class I from TAP is 
linked to conformational signals arising from ATP occupation of TAP1.
Karttunen and colleagues provided additional evidence for the asymmetrical 
functions of the TAP heterodimer (Karttunen et al., 2001). They analysed human 
TAPI and TAP2 constructs with a point mutation in the Walker binding motif that 
allows ATP binding but prevents ATP hydrolysis (different mutation to that of 
Knittler et al). They also identified an enhancement of ATP binding to TAP 1 
following nucleotide or peptide binding to binding to TAP2. Furthermore, mutant 
TAPI/wild type TAP2 permitted peptide binding and transport to support B5 
expression but no peptide binding or transport was observed when mutant TAP 
2/wild type TAPI was expressed in TAP mutant T2 cells. It will now be 
interesting to see how the assembly of TAP associated MHC class \lp2^  
complexes with peptide is coupled to this transport cycle and whether this 
orchestration can improve either the kinetics of peptide acquisition, or the 
qualitative nature of the loaded peptides.
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1.4.5 TAPASIN
In 1994 Greenwood et al described a mutant cell line (721.220) in which TAP 
was necessary but not sufficient for the stable assembly of MHO class I 
complexes (Greenwood et al., 1994). A spectrum of allelic differences in the 
assembly and cell surface expression of differing classical MHC class I 
complexes was shown to be a post translational event and to follow H d p 2^  
assembly. Subsequent work showed that this cell line was defective in a 48kDa 
protein, previously seen in co-immunoprecipitates of TAP and class I (Ortmann et 
al., 1994), that bridged MHC class \lp2^  complexes to TAP (Sadasivan et al.,
1996). This protein, coined tapasin (TAP -associated glycoprotein), was cloned 
in 1997 (Ortmann et al., 1997), and shown to reconstitute normal MHC class I 
assembly in 721.220. Tapasin is an ER resident type I transmembrane protein 
that is encoded by a gene within the extended MHC class II region of 
chromosome 6 in humans. The genomic structure of tapasin is seen in Figure 
1.4.5.1. The coding sequence of the gene spans 12 357 bp of DNA situated 200 
KB centromeric of the DP locus. It contains 8 exons, a promoter with an IFN-y 
response element and 2 very large introns situated between exons 3/4 and 7/8. 
Exon 1 (52 bp) and exon 2(171 bp) contain the leader sequence and N terminus 
of the mature protein. Exon 3 (261 bp) encodes a region that has sequence 
homology to a partial immunoglobulin superfamily (Ig) domain. Exon 4 (399 bp) 
has no homology to other sequences (Exon 4 of chicken tapasin does have 
homology to to other sequences) and contains a dimorphism, whilst exon 5 (342
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Exon 1 2 3 4 5 6 7 8
Bp 53 171 261 399 342 90 35 72
%
Intron 1 2 3 4 5 6 7
Bp 142 217 7830 351 79 138 2183
12357 bp gene (Accession Z97184)
Figure 1.4.5.1 -Tapasin gene structure
The human tapasin gene is approximately 13,000bp with 8 
exons. Exons 2, 3 and 4 encode 75% of the mature protein 
There are 2 large introns (>2000bp) and a 5’ sequence that 
possess a IFN-y response element. The mouse tapasin 
shares a similar genomic structure within the murine 
H-2 locus.
bp) contains a domain with homology to a complete Ig domain. .Exon 6 (90 bp) 
contains the connecting peptide and part of the transmembrane region whilst 
exon 7 (35 bp) and exon 8 (72 bp) form the remainder of the transmembrane 
region and the cytoplasmic tail. Klein recently suggested, using sequence 
structure predictive algorithm programming that tapasin had the greatest 
structural association with the Ig C1 domain of the MHC class I heavy chain 
(Mayer and Klein, 2001 ). Furthermore this matching was greatest for amino acid 
residues encoded in exon 5. Other strong matches were found for the first two p  
strands of the class I a domain and exon3 and the homologous part of the a2 
domain and exon 4. No profile could be identified for exon 2 and the first half of 
exon 3. A schematic of the human tapasin and MHC class I gene organisation is 
seen in Figure 1.4.5.2. The mature tapasin protein is 428 amino acids and 
migrates as a 48 kDa band by SDS-PAGE electrophoresis. It has a single 
glycosylation site and an ER retention/retrieval sequence (Herberg et al., 1998b). 
Subsequent investigations have suggested that tapasin is involved in many 
aspects of MHC class I assembly (Momburg and Tan, 2002). In addition to 
bridging MHC/^2m heterodimers to TAP, it increase TAP levels, promotes 
peptide binding by TAP and facilitates the incorporation of other chaperones in to 
a multi-molecular peptide loading complex (PLC) at the TAP interface. The 
molecular mechanisms mediating these multiple functions are poorly understood 
at present and are investigated within this thesis.
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Ex 1 Ex 2
Tapasin
Ex 3 Ex 4 Ex 5 Ex 6 7 8
LP
Ex 1 Ex 2
a1-like a2-like lgC1 CP,TM,Cy
MHC class I
Ex 3 Ex 4 Ex 5 Ex 6 7 8
CP,TM,Cya1 a2 a3LP
Figure 1.4.5.2- Comparison of the gene organisation
between tapasin and the MHC class I HC
The protein domains are LP (leader peptide), a1 and o2 
peptide binding domains. lgC1 is the immunoglobulin 01 
domain and CP (connecting peptide), TM (transmembrane), 
Gy cytoplasmic domain.
1.4.6 CALRETICULIN
Calnexin and calreticulin are glycoprotein specific chaperones that assist in the 
folding of newly synthesized glycoproteins in the ER (Parodi, 2000). Calnexin 
was first described as glycoprotein-specific ER protein in 1993, possessing an 
ER localisation sequence at its 0  terminus (Bergeron et al., 1994). Calreticulin is 
a glycoprotein specific chaperone that assists in the folding of newly synthesised 
glycoproteins in the ER (Johnson et al., 2001). It is a soluble protein possessing 
a KDEL ER retrieval sequence at its C terminus, a proline rich central P domain 
and both low affinity and high affinity calcium binding sites. Its principal 
interactions are with newly synthesised glycoproteins that bear high mannose 
glycans with a single terminal glucose residue arising from either trimming of the 
tri-glucose extension by the action of ER glucosidase 1 and 2 or through the 
reglucosylation of the man® core via the action of UGGT (Helenius and Aebi, 
2001). Calreticulin (together with calnexin) undertakes a process of ER 
glycoprotein quality control that ensures that only correctly folded and assembled 
glycoproteins leave the ER. This calnexin/calreticulin quality control mechanism, 
in association with ERp57, acts upon monoglucosylated glycoproteins to promote 
their folding and disulphide bond formation (High et al., 2000). Dissociation of a 
glycoprotein from calreticulin exposes the terminal glucose to trimming by ER 
glucosidase 2, and the option to enter the secretory pathway. However, if is the 
glycoprotein is incompletely folded, it is rapidly reglucosylated by UDP-glucose
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glucosyltransferase (UGGT) allowing the protein to undergo another cycle of 
glycoprotein chaperone association (Ellgaard and Helenius, 2003). Proteins that 
are persistently misfolded are retained in the ER prior to degradation. This 
degradation process is termed ERAD (ER associated degradation) and promoted 
by mannose trimming of the oligosaccharide unit by ER mannosidases I and II 
(Tsai et al., 2002). The individual contributions of calnexin and calreticulin to 
MHC class I assembly have been facilitated through studies on knock out cell 
lines. A mouse calreticulin KO cell line study has shown an important 
contribution of calreticulin in MHC class I assembly (Gao et al., 2002). The 
absence of calreticulin leading to an 80% reduction in total cell surface MHC 
class I, a failure to generate specific MHC class I peptide complexes and a 
change in the trafficking rate of MHC class I molecules. The exact molecular 
mechanisms mediating this altered function are currently unclear and similar 
studies are awaited for human calreticulin
1.4.7 CALNEXIN
Calnexin is an ER transmembrane bound lectin that has specificity for newly 
synthesised glycoproteins with a single glucose residue. It is the first 
glycoprotein to associate with MHC class I heavy chain (Degen and Williams, 
1991; Jackson et al., 1994; Paulsson et al., 2001a). However, studies of a 
human calnexin deficient cell line have shown no obvious reduction in class I 
presentation at the cell surface (Scott and Dawson, 1995). Nevertheless, upon
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correct folding and ^ 2^  association human HC complexes normally dissociate 
from calnexin whilst mouse complexes remain associated until peptide is 
acquired in the PLC (Harris et al., 1998). Calnexin has been shown to be 
associated with TAP and tapasin in human cell lines and this complex has been 
termed the pre PLC (Diedrich et al., 2001). Following HCiyffaM incorporation, 
calnexin is thought to dissociate from such a complex. The purpose of such a 
pre-PLC is not understood at present. Calnexin has an important role in the 
removal of glycoproteins from the ER if they have failed to fold correctly. This 
process involves calreticulin within a calnexin/calreticulin quality control pathway 
(Chevet et al., 2001). Upon correct folding of protein the terminal glucose is 
trimmed by ER glucosidase II leading to a failure to re-associate with calnexin. 
The glycoprotein may than leave the ER or if identified as incompletely folded by 
the glycoprotein ‘sensor’ UGGT it may undergo a further reglucosylation for 
another round of calnexin associated folding. Recently another pathway that is 
competing with this pathway has been identified (Molinari et al., 2003; Oda et al., 
2003). The trimming of the Mang backbone to Mans by ER mannosidase I lowers 
the affinity of the glycoprotein for UGGT mediated reglucosylation. Additionally 
this oligosaccharide becomes a ligand for a recently described ER receptor 
termed EDEM (ER degradation-enhancing 1, 2 mannosidase-like-protein). This 
glycan signal recognition factor is associated with calnexin but requires release 
of substrates from calnexin (through deglucosylation) to mediate enhanced 
glycoprotein degradation. Finally it appears that retrotranslocation to the cytosol 
for proteasomal mediated removal of such misfolded glycoproteins is required to
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complete the degradative process. How the calnexin/EDEM complex co­
operates with the Sec 61 translocon is currently not known.
1.4.8 ERP-57
This protein is the most recent component to have been identified as being 
important in MHC class I assembly. In 1998, 3 groups identified ERp57as a 
component of the PLC (Hughes and Cresswell, 1998; Lindquist et al., 1998; 
Morrice and Powis, 1998). In contrast to TAP and tapasin an ERp57 knockout 
cell line does not exist and therefore information regarding its function is currently 
inferred from consideration of other mutant cell lines. ERp57 is a thiol dependent 
oxido reductase (containing 2 thioredoxin motifs) that has been shown to mediate 
disulphide bond formation in monoglucosylated glycoproteins, often in 
association with the lectin binding chaperones calnexin/calreticulin. The 
association of ERp57 with a target glycoprotein is dramatically reduced if the 
glycan trimming to a monoglucosylated form is prevented (Elliott et al., 1997; 
Farmery et al., 2000; Oliver et al., 1997). ERp57 may also function as a more 
general chaperone as it has been found to associate with non-cysteine 
containing glycoproteins and is glucose regulated like the classical molecular 
chaperones BiP and GRP94. Thus ERp57 may operate as a ‘general 
chaperone’ as well as having a more specific role in disulphide bond formation. 
Within the PLC the function of ERP57 is not known. The peptide/HC/yff2m 
complex has a glycosylation site in the alpha 1 region and cysteines at position
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101 and 164 in the alpha 2 domain and 203 and 259 in the alpha 3 domain of the 
HC. These are fully oxidised when the peptide/HC/yff2 m complex reaches the 
PLC (Dick et al., 2002). In studies of the tapasin deficient cell line 721.220, 
ERp57 does not associate with the TAP complex. Experiments in the ^ 2^  
negative Daudi cell where no HC/yff2m complex is seen within the PLC could 
identify ERp57 in association with TAP/tapasin and calnexin (Diedrich et al., 
2001). ERp57 has been identified in the PLC of calreticulin deficient cell lines 
(Gao et al., 2002). Furthermore in TAP deficient cells, ERp57 has been identified 
in a tapasin/CRT/ HC/yff2 m subcomplex (Hughes and Cresswell, 1998).
Therefore it appears that the incorporation of ERp57 into the PLC is only critically 
dependent upon tapasin and independent of the HC%m complex or calreticulin. 
Studies of cells transfected with N terminal deletion tapasin constructs, that do 
not bridge HC/^2m complexes to TAP, fail to associate ERp57 with TAP. This 
was observed when only the N terminal 50 amino acids were absent from the 
428 amino acid tapasin protein suggesting that this region is important for an 
interaction with tapasin or that deletion of this region disrupts the structure of 
tapasin and accordingly the ERp57 association (Bangia et al., 1999). We await 
further studies on the role of ERp57 within the PLC and additional techniques to 
delineate the function of ERp57 within the both early and late phases of MHC 
class I assembly.
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1.4.9 ENDOPLASMIC RETICULUM (ER) PEPTIDASES
The ability of N terminally extended peptides to be delivered into the ER and be 
correctly presented suggested that aminopeptidase activity within the ER could 
occur (Elliott et al., 1995; Snyder et al., 1994). The identity of such a ER 
aminopeptidase remained elusive until 2002 when two groups identified such an 
aminopeptidase (Saric et al., 2002; York et al., 2002). Goldberg and colleagues 
identified ER-aminopeptidase I (ERAP1) as an interferon inducible 
aminopeptidase that was inhibited by the drugs leucinethiol and 1,10- 
phenanthraline. Overexpression of this aminopeptidase increased the cell 
surface expression of an N terminally extended model peptide, suggesting that in 
vivo trimming is rate limiting for antigen presentation. Further studies suggested 
that ERAP1 could also destroy peptides in the ER, limiting antigen presentation 
at a bulk level. Shastri and colleagues showed that ERAP (termed ER 
aminopeptidase associated with antigen presentation [ERAAP]) failed to cleave 
the X-Pro bond which they had previously established as classical for this 
leucinethiol inhibited ER aminopeptidase. Furthermore they showed that ERAP's 
proteolytic activity is controlled by the length of the peptides substrate becoming 
less active on 8-mer and 9-mer peptides which are optimal for MHC class I 
loading.
In contrast to the aminopeptidase activity that has been established within the 
ER, there appears to be little evidence for carboxypeptidase activity (Lobigs et 
al., 2000; Snyder et al., 1997). The other recognised peptidase activity that has
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been shown to influence MHC class I assembly within the ER relates to signal 
peptidase (SP) and signal sequence peptidase (SPP) (Martoglio and 
Dobberstein, 1998). The first of these is known to trim the signal sequence from 
ER translocated proteins and was initially shown to be important in providing 
hydrophobic peptides in a TAP independent manner from alleles such as HLA A2 
(Henderson et al., 1992). It has also be shown to be important from providing 
peptides from the signal sequences of MHC class I alleles for subsequent 
loading upon the non classical allele HLA-E (Lemberg et al., 2001). Lastly SPP 
has recently been shown to undertake an important intramembrane cleavage 
step in liberating signal peptides for subsequent HLA-E binding (Bland et al., 
2003).
The ER mediated trimming of peptides completes the proteolytic cascade which 
begins with cytosolic multiunit proteases such as the proteasome and TPII, 
through specific cytosolic peptidases, TAP transport and final N terminal trimming 
by ERAP and perhaps other ER resident trimmases.
1.4.10 MHC CLASS I
1.4.10.1 Structure and function
MHC class I complexes are a trimeric association of MHC class I heavy chain, 
and peptide. The MHC class I heavy chain associates with the A2 M subunit 
to a form a peptide receptive heterodimeric complex. The structure of this
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peptide receptive heterodimeric protein has proved difficult to analyse as it is 
believed to be of a molten globular form and thus resists crystalisation 
approaches. Important biochemical observations about its structure were initially 
made by Bouvier and Wiley (Bouvier and Wiley, 1998). Thermolytic digestion of 
peptide vacant and occupied complexes revealed cleavage sites in the 0 2  and a^ , 
helices identified at temperatures between 15-37°C for the unoccupied complex 
and above 60°C for peptide occupied complexes. Utilising the hydrophobic 
binding dye ANS which is used to probe proteins in a molten globule state, they 
demonstrated increased binding to the complexes in the peptide unoccupied 
state. Studies by Schneck and colleagues utilised fluorescence energy transfer 
(FRET) to examine the structure of peptide occupied and vacant complexes 
(Catipovic et al., 1994). A fluorescently labelled antibody to the 0 2  domain of the 
MHC class I HC and one to were used for FRET analysis. In the peptide 
vacant state no FRET was observed, however upon peptide binding FRET was 
detected suggesting a change in conformation from that of an extended 
configuration to a more compact form. Furthermore the degree of FRET was 
influenced by the bound peptide suggesting further conformer variation within the 
peptide occupied form. Functional analyses of peptide receptive murine 
complexes by Springer et al extended these observations and demonstrated, 
through tryptophan fluorescence studies, real time binding of peptide to peptide 
receptive complexes (PR) (Springer et al., 1998). Furthermore the calculations 
of association rates exceeded those predicted by equilibrium constants and 
dissociation rates, suggesting that peptide binding to PR MHC class I complexes
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is not a single step association/dissociation. It is suggested that part of the 
binding energy is used to allow a conformation change to occur in the molecule. 
This extended previous data on in cell lysates of peptide deficient cells, where 
conformational changes in the complexes were monitored by conformational 
dependent antibodies upon peptide and ^ 2^  addition (Townsend et al., 1990). 
The crystal structure of a peptide occupied complex showed that 
approximately three quarters of the peptide was buried within the binding groove, 
suggesting that this assembly must initially take place within a MHC class I 
complex bearing an ‘open groove ‘ around which a conformational change may 
take place (Fremont et al., 1992).
The peptide occupied complex has a cooperative stability contributed by both 
peptide and IS2U (Elliott, 1991). Among different MHC class I heavy chains 
notable differences exist in the affinity of the HC ior P2U, with the mouse allele 
have a well documented low affinity which may contribute some of its unique 
presentation functions (Hansen et al., 2000). Within a single allele the 
cooperative stability is influenced by the bound peptide leading to the concept of 
high affinity, high stability long lived complexes and lowered affinity, less stable 
peptide occupied complexes. This is best demonstrated for the mouse allele 
expressed in the peptide transporter incompetent cell line RMA-S. Originally this 
allele was thought to be devoid of peptide as indicated by its thermo-instability as 
compared to expressed in the normal cell line RMA (Ljunggren et al., 1990). 
Recently, peptide elution analysis at reduced temperatures has enabled the 
isolation of peptides from expressed in RMA-S cells (De Silva et al., 1999).
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Figure 1.4.10.1a- Structure of a peptide occupied MHC
class I complex and with a T cell 
receptor
The human A6 TOR is seen associated with HLA A2 
complexed with the HTLV-1 TAX peptide P6a.
The MHC class I heavy chain is coloured cyan, the |32M is 
magenta and the TCR a and (3 chains blue and pink. The 
image was generated through the Protein Explorer Front 
door program via accession number 1QRN
Figure 1.4.10.1b -  Structure of a peptide occupied
MHC class I complex and with a 
NK ceii receptor
The co-crystal structure of the NK cell receptor KIR2DL2 
and the MHC ligand MHC-Cw3 with the peptide 
GAVDPLLAL. The MHC class I heavy chain is cyan, 
the (32M magenta and the KIR2DL2 blue. The image was 
generated through the Protein Explorer Front door 
program via accession number 1EFX .
This suggests that low affinity peptides normally occupy these complexes in 
comparison to high affinity peptides within thermostable complexes in competent 
cell lines. The choice of peptide not only determines the stability of a complex 
but also provides the unique ligand for TCR recognition. Within every MHC class 
I bound peptide complex a signature is created of the peptide side chains that 
extend out of the groove within the context of the ai and 0 2  helices of the MHC 
class I HC. These form the contact points for the TCR and direct the specificity 
of the MHC class I ligand TCR interaction (Figure 1.4.10.1a). With regard to NK 
cell receptor recognition, seminal studies on KIR and HLA-C allele association 
have shown a distinct but overlapping footprint to that of the TCR (Figure 
1.4.10.1b). The KIR (KIR 2DL2) appear to contact the as helix and have a 
peptide contribution restricted to residues P7 and P8.
The purpose of such presentation in the context of T cells is the transmission of a 
message from the cell with regard to its internal protein array. In the setting of an 
infection, the novel peptide MHC class I complexes may activate the T cell to 
divide and differentiate in to a cytotoxic CD8 T cell. For NK cells the self peptide 
MHC class I complexes are believed to present a signal of cellular ‘well being’ 
transmitted as a negative signal for the NK cell’s default killing program.
Finally it should be remembered that the peptide selection of host proteins early 
in the ontogeny of the immune system allows for the T cell selection of self. This 
critical role of the self peptide MHC class I complex for CD8 T cell development 
is elegantly seen in human and mouse models of TAP deficiency, where CD8 
cells are absent ((Gadola et al., 2000; Van Kaer et al., 1992).
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1.4.10.2 Peptide occupancy and vacancy
The conventional view of MHC class I complex occupancy is one of two forms, 
peptide occupied and peptide vacant. In contrast, MHC class II molecules are 
considered as empty, low affinity ligand and high affinity ligand bound complexes 
(Sadegh-Nasseri et al., 1994; Zarutskie et al., 2001). Furthermore the empty 
MHO class II complex has been considered as existing in at least 2 forms 
(Rabinowitz et al., 1998). The first of these isomers is believed to be peptide 
receptive and have a short half life prior to conversion to isomer 2 which resistant 
to peptide binding. The low affinity ligand bound complex is the CLIP MHC class 
II complex that forms in the ER. The suggested roles of CLIP are diverse 
including directing secretory traffic to the endosomes, preventing empty MHC 
class II complex aggregation and promoting isomer 1 formation following CLIP 
removal. The high affinity ligand complex is also believed to exist in more than 
one conformation as suggested by kinetic studies on single peptide species class 
II complexes (Sadegh-Nasseri and Gerrnain, 1991). It is believed that high 
affinity peptide occupied complexes convert to a long lived high affinity peptide 
complex over time. This may involve reconfiguration of the peptide within the 
binding groove until the optimal side chain interactions and hydrogen bound 
networks have been established (Belmares et al., 2003; Schmitt et al., 1999). In 
biochemical analyses the distinction between empty/low affinity complexes and 
high affinity complexes has been their susceptibility to SDS mediated subunit
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MHC class II occupancy and vacancy
iJ
iU
Aggregation/
degradation
IÜ
2 I
SDS Unstable
iU
4___ I
SDS Stable
Figure 1.4.10.2 - Schematic representation of MHC
class II isoforms
Complex 1 is the CLIP occupied SDS unstable complex 
that is the precursor of a peptide receptive MHC class II 
complex (2). This complex has a short half defaulting to a 
complex that is peptide non-receptive and prone to 
aggregation (5). HLA-DM is believed stabilise complex 
2 and possibly promote its generation from complex 5. 
Optimal peptide may then be loaded to become complex 3 
DM may further act on this peptide loaded complex, 
promoting isomérisation of the peptide occupied complex 
so that it may become a long lived complex (5).
dissociation (Chou and Sadegh-Nasseri, 2000; Denzin and Cressweli, 1995; 
Natarajan et ai., 1999). The concepts and experimental observations of the 
above groups have been tentatively collated into the Figure 1.4.10.2.
As mentioned earlier there is no substantive evidence to suggest that MHC class 
molecules behave in an analogous manner. Recent studies by Hansen and 
colleagues have described an antibody (64-3-7) which recognises non peptide 
occupied complexes (Yu et al., 1999). Their studies have shown that some 
intracellular 64-3-7 complexes in tapasin knock out cell lines fail to load 
exogenous peptide suggesting that at least 2 forms of empty complex may exist 
(Myers et al., 2000). Studies by Springer et al also suggested an early empty 
complex which they termed an encounter complex. This was proposed to form 
an intermediate with peptide which could proceed to a more permanent peptide 
occupied complex following isomérisation (Springer et al., 1998). The concept of 
a suboptimally occupied or low affinity ligand occupied MHC class I complex was 
initially suggested by studies on the MHC class I mutant A2 molecule T134K 
(Lewis and Elliott, 1998). The key observation in this study was that class I 
complexes do become occupied with suboptimal ligands even in the presence of 
a normal peptide supply and that these complexes may egress the ER. It is 
currently presumed that the inability of these mutant complexes to interact with 
the PLC contributes to this phenotype implying that such an interaction normally 
has a qualitative effect upon such low affinity complexes. In a similar manner, 
MHC class II complexes that fail to interact with DM continue to be occupied with 
their low affinity ligand CLIP. With regard to high affinity loaded complexes, no
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counterpart to the MHC class II single peptide occupied complex that becomes 
more stable over time has been definitively identified.
1.4.10.3 Export and secretory pathways
The secretory pathway allows cells to regulate the delivery of proteins, 
carbohydrates and lipids to the plasma membrane and other sites. It consists of 
a series of distinct organelles and tubulovesicular transport proteins that support 
transmembrane cargo flux (Lippincott-Schwartz et al., 2000). Within such 
membranes, posttranslational processing such as proteolysis and glycan 
modification occurs, which can identify and modify the transport routes chosen by 
such proteins. The ER is the starting point of the secretory pathway with the 
cargo packaged for delivery to the plasma membrane, nucleus or other end 
point. For MHC class I molecules that are destined to reach the plasma 
membrane, the pathway involves passage through the golgi stacks prior to post 
golgi trafficking to the cell membrane. The newly synthesised proteins within the 
ER are required to undergo correct folding/unfolding reactions prior to the export 
from the ER. In the case of some glycoproteins this involves sequential 
glycosylation/reglycosylation cycles, mediated through glycoprotein folding 
sensors within the secretory pathway (Zuber et al., 2001). In order to prevent the 
default export of soluble and membrane spanning proteins a series of molecular 
mechanisms are employed to retain and retrieve proteins that are not competent 
for export. Retention relates to the active process of maintaining a protein within
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the ER through immobilisation or extensive interaction with ER resident 
chaperones. Retrieval relates to the ability to selectively return proteins to the 
ER that may have escaped initially the ER but are identified as incompletely 
folded within the early secretory pathway (Vashist et al., 2001). This latter 
mechanism is best understood through the experimental work undertaken on 
cytoplasmic tail motif KDEL of certain proteins. This is recognised as a ligand for 
a KDEL receptor within the secretory pathway which in turn is coupled to a 
retrograde secretory complex that can return KDEL proteins and their cargo back 
to the ER (Aoe et al., 1998; Yamamoto et al., 2001). Within the MHC pathway 
both calreticulin and ERp57 bear such motifs and are resident ER members. 
Another well recognised retrieval motif is a dilysine motif within the cytoplasmic 
tail. Tapasin posses such a tail and it has been postulated that this is both active 
and important in MHC class I assembly.
Following their correct assembly, proteins destined for export from the ER are 
concentrated at ER exit sites. These are organised membrane domains adjacent 
to tubule clusters called pre golgi intermediates (Donaldson and Lippincott- 
Schwartz, 2000). The partitioning into ER exit sites in mediated by the activity of 
a ras related GTPase (Sari) and a cytosolic protein complex known as COPII. 
The COP II complex assembles onto ER exit site membranes following 
GDT>GTP exchange upon Sari. Subsequently Sec23/24 and Sec 13/31 
heterodimers are assembled on to the membrane to form a COPII bud. This is 
then believed to form a vesicle for subsequent tubulovesicular mediated egress 
(Antonny and Schekman, 2001). The egress to pre-golgi intermediate
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compartments allows a further opportunity for sorting and possible recycling 
through retrograde transport back to the ER. This has been most readily seen 
for the lectin like protein ERGIC 53 which constitutively recycles between the ER 
and golgi (Hauri et al., 2000). Its retrograde transport is microtubule dependent 
being inhibited at low temperature (15°G) and in the presence of microtubular 
toxins (i.e. nocodozole). The retrograde transport of proteins is thought to occur 
through the action of another coatmer complex known as COPI. This heptameric 
cytosolic complex assembles on golgi membranes and this is dependent upon 
the presence a GTP binding protein ARF1 and GTP. For K(X)KXX or K(X)KXX- 
proteins this motif binds directly to the COPI coatomer complex (Wieland and 
Harter, 1999). For KDEL tagged proteins a KDEL receptor may engage this 
retrograde pathway. Studies of the non classical molecule HLA-G, which 
possesses a dilysine, have demonstrated COPI associated recycling (Park et al., 
2001). Studies on classical class I molecules have failed to show a retrograde 
transport route apart from an early report in a TAP incompetent cell line (Hsu et 
al., 1991 ). This demonstrated retrograde transport of a mouse allele which was 
not apparent at steady state. Such recycling has also been indirectly suggested 
for other class I molecules that show faster trafficking in calreticulin deficient cells 
(failure of KDEL) (Gao et al., 2002) and for tapasin associated complexes in the 
PLC (KK mutants) (Paulsson et al., 2002).
Upon reaching the trans-golgi, anterograde cargo is packaged into post-Golgi 
carriers that are within large pleomorphic tubular supports. Most studies have 
utilised GFP tagged proteins to follow these latter pathways, with little information
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available for MHC class I specific pathways. Some studies have indicated that 
MHC class I complexes may exit the golgi and not directly traffic to the cell 
surface (Joyce, 1997). Furthermore an absence CD99 has been shown to 
coincide with such a reduced delivery of MHC class I complexes to the cell 
surface despite normal medial golgi passage (Sohn et al., 2001). Further 
research into these areas is needed to clarify these later anterograde pathways
Upon reaching the cell surface the MHC class I complexes can undergo 2 further 
partitions. Preliminary studies suggest that in a similar way to MHC class II 
complexes, MHC class I complexes may cluster within lipid rafts to mediate 
effective signalling (Vogt et al., 2002). The other trafficking opportunity for cell 
surface complexes is cell membrane to endosome transportation (endocytosis). 
This process may be undertaken by clathrin dependent or independent 
mechanisms. Clathrin-dependent internalisation involves the assembly of 
clathrin and its associated adaptor protein (AP-2) on the plasma membrane 
(Takei and Haucke, 2001). The membrane protein them becomes part of the 
budding coated pit of the membrane and internalised. Small GTPases have 
been implicated in the regulation of such recycling. One such GTPase, dynamin 
has been shown to be important for MHC class II internalisation (Wang et al.,
1997). The ADP-ribosylation factor family of proteins (ARF) are another group of 
small GTPases that are thought to regulate this endocytosis. ARF-6 has been 
shown to be important for clathrin-independent MHC class I internalisation 
through studies of expressed dominant mutants of this protein (Radhakrishna
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and Donaldson, 1997). Indeed, the utilisation of this pathway by the HIV protein 
A/ef (elegantly worked out by Blagoveshchenskaya and colleagues) is suggested 
to contribute to the downregulation of MHC class I complexes in early HIV 
infection, contributing to the impairment of T cell control of the virus 
(Blagoveshchenskaya et al., 2002). Lastly a particular tubular protein EHD-1 has 
been shown to be important for clathrin-independent MHC class I internalisation 
and to colocalise with ARF-6 within this recycling network. This protein appears 
to associate with ARF-6 containing tubules allowing MHC class I to normally 
traffic between the cell surface and endosomes (Caplan et al., 2002).
This process of internalisation from the cell surface to the endosome may be 
functionally important. Several studies have shown that this permits an 
exchange of peptides within the acidic endosomes (Kleijmeer et al., 2001 ; 
Schirmbeck and Reimann, 1996) and is one form of TAP independent cross 
presentation of antigen. Other studies have suggested that such a pathway is 
important for the derivation of MHC class I homodimers which may have 
physiological or pathological functions (Bird et al., 2003). Such recycling may 
also refine the peptide repertoire by destabilising certain pH sensitive peptide 
cargos and preventing these from returning to the cell surface (Chefalo and 
Harding, 2001). Lastly it should be mentioned that certain MHC class I may be 
secreted from the cell as a transmembrane lacking soluble protein through exon 
splicing. This has been particularly shown for the non classical allele HLA-G (Lee 
et al., 1995). MHC class I complexes may also be acted upon by cell surface 
trimmases that target dissociated complexes to liberate a 39 kDa heavy
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Soluble MHC class I<
Trimmase
Endosome
Figure 1.4.10.3-Schematlc representation of post
golgi trafficking of MHC class I complexes
After leaving the ER-golgi network the MHC class I complexes arrive 
at the cell surface. They may then enter an endosomal transport 
system that delivers them into endosomal/lysomal vesicles. This may 
promote peptide exchange (2) through the liberation of peptide 
sensitive peptides or lead to HO degradation following PaM 
dissociation (3). Alternatively the complexes may transit between the 
cell surface and endosomal compartments unchanged. MHC class I 
complexes may also end their lifespan through the liberation at the 
cell surface of free heavy chain following the loss of peptide or P2M 
(1).
Chain which may re-associate with extracellular peptide and P2U to form a 37 
kDa complex (Demaria and Bushkin, 2000);(Demaria et al., 1999). The 
physiological significance of these soluble MHC class I complexes is not known 
but they have been implicated in autoimmune diseases and transplantation 
settings ((McDonald and Adamashvili, 1998)(Figure 1.4.10.3).
1.5 INTRODUCTION TO THE PROJECT
My thesis examines the genetic and functional properties of tapasin within the 
context of MHC Class I complex assembly. I set out to define the degree of 
polymorphisms in the tapasin gene and the relevance of this to its role in MHC 
class I peptide assembly. I have developed an in vitro assay to explore the 
function of tapasin in optimising the peptide selection of MHC class I complexes. 
I will present the experimental observations of this work and the integrate the 
findings into a novel working framework for exploring the molecular mechanisms 
of MHC class I peptide selection and assembly
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CHAPTER 2 MATERIALS AND METHODS
2.1. GENERAL TISSUE CULTURE AND CELL LINES
All cells were grown at 37°C within an atmosphere of 5% COaair. All tissue 
culture media was obtained from Gibco BRL, UK. Foetal calf serum (FCS) was 
supplied by M.B. Meldrum Ltd UK. All cells were grown in RPMI 1640 media 
supplemented with 10% FCS, 50 U/ml Penicillin, 50//g/ml Streptomycin and 
2mm L-Glutamine [RIO]. All disposable tissue culture material was supplied by 
Falcon (Becton Dickinson, USA). Cell lines were frozen in 20% DMSO/80% FCS 
for 24 hours within a Nalgene Cryo 1°C freezing container prior to storage in 
liquid nitrogen.
721.220 cell are human EBV transformed B cells that are deficient in tapasin 
function. They are derived from an original EBV transformed B cell line known as 
LCL 721 (DeMars et al., 1985). This cell line has undergone further gamma 
irradiation and anti class I complement mediated selection to provide a range of 
mutant cell lines with interesting MHC class I and II assembly properties.
721.220 is hemizygous across the MHC class I and extended class II region. It 
has retained expression of the MHC class I allele Cwl and the class II DR and 
DQ alleles. It has been shown to carry a point mutation in the acceptor splice 
site of intron 2 (Copeman et al., 1998). This leads to the aberrant splicing out of
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exon 2 which encodes the leader sequence of the protein. The protein is not 
efficiently translated and is non functional.
721.220.8*4402, 721.220.B2705 and 721.220.8*4405 are single allele 
transfectants of the tapasin deficient 721.220 founder cell. The cell lines
721.220.B*4402.Tapasin, 721.220.B*4402.Tapasin, 721.220.B*2705.Tapasin 
and 721.220.B*4405.Tapasin are immunocompetent partner cell lines that 
express a functional tapasin protein. 721.220.B*4402.Tapasin.lCP47,
721.220.B*2705.Tapasin.lCP47 and are cell lines that are incompetent for TAP 
mediated translocation of peptides. 721.220.8*4402.ICP47,
721.220.82705.ICP47 are deficient in tapasin and TAP function. Finaliy,
721.220.B*4402.Sol Tapasin, 721.220.B2705.Soi Tapasin and
721.220.B*4405.Sol Tapasin are cell lines that have been reconstituted with a 
soluble tapasin protein that does not associate with the TAP complex.
2.2. Antibodies
The following antibodies were used for immunoprécipitation, flow cytometry, cell 
selection and western blotting.
W6/32 -  a mouse monoclonai antibody that recognises a conformational epitope 
within a folded ;ff2 M/MHC class I heavy chain complex (Parham et al., 1979). For 
immunoprécipitation studies it was used at a final concentration 10 >L/g/ml and for 
flow cytometry at 1 >i/g/ml.
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116.5.28 -  a mouse monoclonal antibody that recognises the Bw4 epitope on 
B*4402 and B*2705 (Saxon Europe,UK)
RING 4C -a  rabbit polyclonal antibody against human the cytoplasmic tail of 
TAP2 (a gift from P Cresswell, Yaie University school of Medicine, New Haven.). 
Used at 10 //g/mi for immunoprécipitations and 1 //g/ml for western blotting 
HC10- a mouse monoclonal antibody to unfolded MHC class I B and 0  alleles. 
Used at 10 //g/ml for immunoprécipitation and 1 //g/ml for western blotting (Stam 
et al., 1986).
Giles -a  rabbit polyclonal antibody made to a N terminus peptide of human 
tapasin (a gift from B Gao, Institute of Molecular Medicine, Oxford). Used for 
Western blotting at a dilution of 1 in 500.
2.3. Peptides
The peptides used are described in Table 2.3. All peptides were synthesised by 
F-Moc using a Zinnser anaiytical synthesizer and provided as a lysophilised 
powder. Accompanying HPLC profiles showed them to be greater than 95% 
pure. Aliquots were made in 10% DMSO and stored at -20°C
2.4. Primers
Tapasin primers were ordered from Cruachem and made up to a concentration of 
2//g///l. The primers used for Conformation sensitive gel electrophoresis are
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Allele Peptide Source
8*4402 SEIDTVAKY Endogenous 
(DiBrino et al., 1995)
SAIDTVAKY As above
SAIDTVAKA As above
AAASEIDTVAKY As above
AAIAAVAKY As above
ADIAAVAKY As above
AEIAAVAKY As above
B*2705 GRAFVTIGK HIV1 gp120 
(Dedier et al., 2000)
GRDFVTIGK As above
GRAFVTIGS As above
GRAFVTIGG As above
AAAGRAFVTIGK As above
B*4405 SEGATPQDL HIV1 P24 130-39 
(Khanna et al., 1992)
AEDKENYKKF Hsp90a
(Macdonald et al., 2003)
FEDLRVLSF Influenza A nucleoprotein 
(DiBrino et al., 1995)
EENLLDFVRF EBV EBNA3C 281-90 
(Burrows et al., 1990)
EEELLDVFRM Endogenous
(A .Purcell, unpublished data)
Table 2.3 -  BM402, B*2705 and B*4405 binding peptides
detailed in Table 2.4.1. The configuration of the primers used upon human 
tapasin is seen in Figure 2.4.1. The primers for subsequent polymorphic 
anaiyses were designed to have a single mismatch at the polymorphic base 
permitting Sequence Specific Priming (SSP) to be undertaken within a stringent 
PCR cycling design (Table 2.4.2). The configuration of the primers chosen for 
the subsequent exon4-intron4 haplotype analysis is seen in Figure 2.4.2.
The primate primers were as chosen at consensus sites between human and 
murine tapasin sequences (Table 2.4.3). It was assumed that such homology 
would also exist between human and monkey tapasin.
2.5. Vectors
Genomic B*4402 and B*2705 were contained within the pu d  3 vector (Weiss et 
al., 1985). Human tapasin cDNA was cioned into both pMCFR.puro and 
pMCFR.neo vectors (Ortmann et al., 1997). The tapasin contained the vector 
was the *01 (AGA) ailele. The soluble tapasin vector was as previousiy 
described (Lehner et al., 1998). The ICP47 gene was cloned into the 
pMCFR.puro vector. B4402 was mutated to B*4405 using site directed 
mutagensis and cloned into the RSV.5neo vector.
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Tapasin pair Primer sequence Amplified sequence Tapasin region
TAP1F CTTCCCgATAACCCgTgTgT 6669 -7013 5' UT
TAP1R gCCTCCTCTTCCTCCTTTCA
TAP 2F AAAgT gAAAggAgg AAg Agg 6989 -7413 Ex1, ln1,Ex2
TAP 2R gTggAggCaACAgAggTAgg
TAP 3F AgT gTT ggTT CgT gg Agg AT 7256 -7808 In2, Ex3
TAP 3R AggCT gg Ag AggCT g Agg AC
TAP 4F AT ggggCTT ggCT g AT ggTC 7754 - 8031 Ex3, In3 (part)
TAP 4R ggAgCggTAgAgATT gATTC
TAP 5F TAgCCCTCCCCAATAACTgC 15601-16109 Ex 4
TAP 5R TCTgTCCCCCAACTCACTgT
TAP 6F AgT gAgTT gggggACAgAgg 16092 -16438 In4
TAP 6R ggg AAAg Agg ACg AAAT g Ag
TAP 7F gATTTCCCTATgCTCATTTC 16407 -16667 Ex5
TAP 7R T gCCCAgAgAggCT gAGAg A
TAP 8F CT ggAggT ggAgT gggAACT 16549 -17103 Ex5, In5, E6
TAP 8R ggAgTAggTggggAAAgTCC
TAP 9F ggCT gggCT ggTAAgT gT 16944-17193 ln6,Ex7,ln7 (part)
TAP 9R Igggi 1 1 IgAgAIAggAT
TAP 10F TCCTTCTCCCATCATCTgTg 19201 -19680 ln7(part),Ex8, 3' UT
TAP 10R CCCgTCTCTACTAAAAATAC
Table 2.4.1 -  Tapasin primers used for CSGE.
Human Tapasin
Accession Z97184
6601 agtcgtagga gtacaaggtt tttatttttt 
TAP IF 666#
6661 ttacttg gg^fe^sgffaiteaa;® » aesgjtgtg^ 11 
6721 cggagtaatg gttttcgggc aagtggatgt 
6781 gggagggcct ggggttgggg agggctcgaa 
6841 cggtaaggct ggggtgtcct ggtgagaact 
6901 cagtggggaa acaccggtcc cccaggcacc
TAP 2F 698#
GAS
6961 cccctcatgc cqccctttqg 
7040
7021 ctgaggaggt cgcagcgcca tgaagtccct 
7081 gcgaaccccg cgactcatcg cccaagaact 
7141 gagccgatgc cagggtggga gtggggcagg
ttaacagtga ttaaaatatt tattggtcat
gctggggacg cggcacagat agggggaagc 
tggagagcac acacaggagt tggggggcgg 
ctcggggctg ctgggtagtc caggagggcg 5' 
ggagaggatc tacccgggtc cctgcctggc 
ttcacctaac cagagcgggg atttccaccg
UTR
TAP IR 7011
<!§c't’tircc
g a ^ g g  -aggaagagga: gggttcatgg
gtctctgctc ctcgctgtgg ctttgggtga 
agagggaagc ggagggaggt ggccccactg INTRON 1 
tcaccagaca tacaaaccgc tcctcactcg 
TAP 3F 725i>
7201 cgtccctata cgccaggcct ggcgaccgcc gtctcagcag gacccgcggt gatcgagtgt
ïeg.-t g.g-ï-a;g>ga®
72 61 tggttcgtgg aggatgcgag cggaaagggc 
7321 cgccagggac cgggggaacc gccgccccgg
7381 gtacacggtg 
7441 ccctcctctt 
7501 tcactacggg 
7561 ccggcggtga 
7621 caggctgcct 
7681 ttcgtgcctc 
TAP 4 F
7741 ccgcgggccc 
TAP 3R 780#
agtctctagg gactcgccgc 
tagatccggc agtgacctca 
gtagtctgtg catttgaagt 
ctctacagct gcaacttcct
tcaggcggta tccccggggc 
tccccgcctc tgcgaaatgg 
775g> ____________
tggatggggc ttggctgatg
ctggccaaga
ccggacctcg
<^atgga
cccEetacct
ggcctcagct
tccccgaacg
tctctacact
gcccccgcac
gccagcggcc
gacccggtgc actgctgttg 
accctgagct ctatctcagt 
__TAP 2R 74_3jj 
gaca"acggag" gta 
etgtc.fc.atc qagcgaaacc 
tcccctttgt aaagtgagtc INTRON 2 
ctgcccttcc agcccctttc 
cagaccccgc gggcgccctc 
cacactgcga gatgagccgc 
tgacccccgc gcagaactgc
g»tc <|ga g-gag'tcggad
gtcagcatat ccagcccagt cctcagcctc
7801 tccagcctct tgcgaccaca gccagagcct cagcaggagc ctgttctcat caccatggca
7861 acaggtagct ggggagggga ggtggagaag ggtgggtaga ttctaagggt ccagatcagc
7921 cggtggtctc gctttatgga cttgagcaag acatttcgcc aatcggggtt cagtttcctt INTRON 3
TAP 4R 803#
<grtaff.t;taf a#at#@c@a@ f 
7981 tttttgttaa gagaggtggt ttggctagaa tgaatcaatc tctaccgctc cttctagccc
8041 tcacccagtt aaaaaaaaaa aacaaaaaaa aaactgcagc ttggcagggg gtagggggaa
15481 tgctcaccct cagccacact aggtgccacc cagtcgcaga 
15541 gggctaggaa atggtgagta tcagaaaagg tgtcctctga 
TAP 5F 1560i>
gcaaaaggag tttgcaggga 
ggggtgggta aactgcagtt
©.©Qfeeac- ■Gaa fe a a g tj^
15601 tagccctccc caataactgc atttctctat ttttttctcc
15661 cctcccaacc cctcatctcc ctgtcttcct cagtggtact
15721 ctgcccctcg agtgagactg ggacaagatg ctctgctgga
15781 cccccacctc cgaggccgcc tcatctctgg ctccgggtcc
15841 ggcgacgcca gcacctgggt aagggacatc tgctcctggc
15901 gccagatgcc agcagcccaa gaaggggccg tggcatttgc
15961 catggggccc atggaccgga aatgggacct tctggctgcc
16021 agggcaccta tctggccacc atacacctgc catacctgca
TAP 6F 1609i>
ttctttctct
gactgtcctc
cttgagcttt
ccctcccttt
tgcaactcct
tgcttgggat
tacagttcaa
aggacaggtc
ccctcatgcc
acccacaccc
gcctacatgc
gggctagagt
gggctgaatg
gatgatgagc
ccctttcagg
accctggagc
#|@@aca$ag g 
<TAP 5R 1610#
16081 ttgctgtgta cagtgagttg ggggacagag gtctccaggg
16141 tgtggggacc gtaatagggg gagggatgat ggataagagg
16201 agatagaaag aggttcctgg gagttagagg ggtaatggga
16261 tttgaggggc tttgacatgg gtatttctgt gacgcaccaa
16321 tatttcagga gaagaaacct aaccttcttt agttctgagg
gtagagggtg ggcactggat 
gtgcctgggc aagtaagtag 
ggctagaagt ttcctggaaa 
tggagagaca gtgggttccc INTRON 4 
aagccagcag gcaaactgag
 TAP 7 F 1640jf>
bat ttccetatgc tcatttç
<Tap 6R 164;
16381 ggtctcttag ggaggacagt atggactgat ttccctatgc tcatttcgtc ctctttcccc
16441 agaacccccc aaagtgtccc tgatgccagc aacccttgca cgggccgccc caggggaggc
Tap 8F 1654#> ___
é t#:a##tg@W
16501 acccccggaa ttgctctgcc ttgtgtccca cttctaccct tctgggggcc tggaggtgga
16561 gtgggaactc cggggtggcc cagggggccg ctctcagaag gccgaggggc agaggtggct
<TAP 7R 1666#
^  acagtcgigag agacccg%
16621 ctcggccctg cgccaccatt ccgatggctc tgtcagcctc tctgggcact tgcagccgcc
16681 cccagtcacc actgagcagc atggggcacg ctatgcctgt cgaattcacc atcccagcct
16741 gcctgcctcg gggcgcagcg ctgaggtcac cctggaggta gcaggtaaga gctgggagct
16801 ctgcggaatc tgagccagca cccaggaaga caggagctca ctctcacccc ttctgcctgc i n t r o n  5
16861 caggtctttc agggccctcc cttgaggaca gcgtaggcct tttcctgtct gcctttcttc
TAP 9F 1694i>
agcëggg c t'g g ta a g S ^ jg  
16921 tgcttgggct cttcaaggca ctgggctggg ctggtaagtg tcagccctac cctgaccatg
<TAP 8R 1711^
HagacPt-t ccccaebtac toe 
16981 acctgaggtt ggtggacttt ccccacctac tcccaagagc ctgacaccca tccctctgcc INTRON 6
17041 ctccacctct accactccag catcccatcc cttctcaatc tttccccaca gctgtctacc
17101 tgtccacctg caaggattca aagaaggtac agtgctccac ctctctgtat ctttcccttg
<TAP 9R 17191
INTRON 7
|a’t a g a g t 1 g g #
17161 tcactttatc tcctcatcct atctcaaaac ccatggaggg aggctgctgg tgtggtaggc
17221 agaacctagg cttggaattc acactgatct gggttaaaac ctggcactat atcctaactg
19021 attcggacta gccacatatc aaatgctcaa tagcctaatg tgggtggtgg ctgtcatatt
19081 ggacagcgga gcctgagagg acttttagga ggattaagga agacagtgta tctccttaag
TAP lOF 1919i>
Icf
19141 aagatgcagg agatacagca ctcagcagtg tctggagggc agaaaatatt agcctcatcc 
fetctcccatc atctgt^
19201 ttctcccatc atctgtgccc atgatagttt atatgtctct aaactgacca tgtacacctc
19261 aactgccttt taatatcctg aattcctcac caccttcctc tcttccagaa agcagagtga
19321 gggcactcac tgccatcctg tggaagccac catcatctct ggcccaagct tctgtagtag
19381 ctccctaaaa taatacccta tcatctgctc ctaatccctc caatctctct ccactgagtg
19441 gctggaatgc tttttttttt ttctttcact tatataaggg ataatttttc tttttttttt 3'UTR
19501 ttttttgaga cggagtctca ctcttccgcc caggctgcag tgcagtggca tgatcttggc
19561 ttactgcaac ctccgcctcc tgggttcaag caattctgtg gcttcagcct ccggagtagc
<Tap lOR 1968|{| 
jëataaaaatc atctctflccQ
19621 tgggattaca ggcacatgcc accacaccca gtgaattttt gtatttttag tagagacggg
19681 gtttcaccat gttggccagg ctggtcttga attcctgacc tcaggtgatc tgcccacctc
Figure 2.4.1 -  Primer arrangement for CSGE analysis of Tapasin.
The primers were designed upon the human Tapasin sequence (Accession Number Z97184). 
The exon sequences are :Ex 1 7040 -7076, Ex 2 7217 -7387,Ex 3 7604 -7864,Ex 4 15694 - 
16092,Ex 5 16443 -16784,Ex 6  16864 -16953,Ex 7 17092 -17126,Ex 8  19309 -19320. The 
intron sequences are colour coded grey, the exons yellow and the primers green.
The IFN-y activated sites is marked in bold whilst the Interferon stimulated response element 
is in italic
Tapasin region Primer Sequence
Tapasin *01 (16003-g/Ex4) gACCTT CT ggCTgCCTAg
Tapasin *02 (16003-C/Ex4) gACCTTCTggCTgCCTAC
Tapasin In4/16146-g CCCTCCCCCTATTACggTC
Tapasin In4/16232-g AAACTTCTAgCCTCCCATTAC
Tapasin In4/I6317/T T CTT CT CCT gAAATAgggA
Tapasin In4/I6146/T CCCTCCCCCTATTACggTA
Tapasin In4/16232/A gAAACTTCTAgCCTCCCATTAT
Tapasin In4/I6317/A T CTT CT CCT g AAATAgggT
Tapasin In6/I7041/C ACACCCATAAATATgCCC
Tapasin In6/I7041/T gACACCCATAAATATgCCT
Table 2.4.2 -  Tapasin primers used for SSP.
Human Tapasin
Accession Z97184
15601 tagccctccc caataactgc atttctctat ttttttctcc ttctttctct ccctcatgcc
15661 cctcccaacc cctcatctcc ctgtcttcct cagtggtact gactgtcctc acccacaccc
15721 ctgcccctcg agtgagactg ggacaagatg ctctgctgga cttgagcttt gcctacatgc
15781 cccccacctc cgaggccgcc tcatctctgg ctccgggtcc ccctcccttt gggctagagt
15841 ggcgacgcca gcacctgggt aagggacatc tgctcctggc tgcaactcct gggctgaatg EXON 4
15901 gccagatgcc agcagcccaa gaaggggccg tggcatttgc tgcttgggat gatgatgagc
16003-0 gacct tctggctgcc t3i
16003-g> facet tctggctgcc tag
15961 catggggccc atggaccgga aatgggacct tctggctgcc tafagttcaa ccctttcagg
16021 agggcaccta tctggccacc atacacctgc catacctgca aggacaggtc accctggagc
16081 ttgctgtgta cagtgagttg ggggacagag gtctccaggg gtagagggtg ggcactggat
<16146A/16164-|
Bctgg cat^tcccc ct<^
<16146C/16164-q
S|gtg!g~Gattatcccc ctc@gacc gtaatagggg gagggatgat ggataagagg gtgcctgggc aagtaagtag
<1_6232T/16252J 
ISttaccct ccgatcttca aa@
  <162320/16252
iittacsGt cogatcttca aj 
16201 agatagaaag aggttcctgg gagttagagg ggtaatggga ggctagaagt ttcctggaaa
<16317T/16338 -g | p |
<16317A/16338 -g jjfgg
<163090/consensus-^
^tfcgtggtt acctetc"^
16261 tttgaggggc tttgacatgg gtatttctgt gacgcaccaa tggagagaca gtgggtjccc i n t r o n  4 
paaagtcct cttcttt|j 
gtaa_agtect cttc-ttt#
16321 tatttcagga gaagaaacct aaccttcttt agttctgagg aagccagcag gcaaactgag 
16381 ggtctcttag ggaggacagt atggactgat ttccctatgc tcatttcgtc ctctttcccc
Exon 4 -Intron 4 consensus 15986 ( 16003-C/G) -16309 = 323 bp
Exon 4 -Intron 4 15986 (16003-C/G) -16164 = 178 bp
Exon 4 -Intron 4 15986 (16003-C/G) -16252 = 266 bp
Exon 4 -Intron 4 15986 (16003-C/G) -16338 = 352 bp
Figure 2.4.2. -  Configuration of the primers used for Tapasin 
exon 4-intron 4 haplotype analysis.
The primers used for the haplotypes analysis are seen above. The colour coding was as 
follows XXXXXXX -  Intron, XXXXXXX-Exon, Primer similarity,
Polvmorohic base and - Primer mismatch/identitv for SSP.
Primate
Tapasin
primer
pair
Primer Sequence Amplified
region
Tapasin Region
5’UTR CACCT AACCAgAgCgggg 6933-7914 Ex1,ln1,Ex2,ln2,Ex3.
InSR CTggACCCTTAgAATCTACCC
In 3F gCCCTCCCCAATAACTgC 15603-16658 Ex4,ln4,Ex5 (part)
Ex 5R ggCT g ACAgAgCCAT Cgg
Ex5F gCCCCAggggAggCAC 16487-17144 Ex5,ln5,Ex6,ln6,Ex7
In 7R AgAggT ggAgCACT gT
In 7F CCTCACCACCTTCCTCTCTT 19285-19363 Ex8
3’UTR gCCAg Ag AT gAT ggT ggC
Table 2.4.3 -  Tapasin primers used for monkey Tapasin 
sequencing.
2.6. DNA preparation and Conformational Specific Gel 
Electrophoresis (CSGE)
The search for mutations in the tapasin gene was performed using 
conformational specific gel electrophoresis (CSGE). DNA was extracted from 
venous biood sampies using a standard sucrose-lysis procedure. PCR primers 
were designed to amplify 10 regions of the tapasin gene between positions 6669- 
19680 (cosmid F0811 numbering) of tapasin (GenBank accession number 
Z97184) including the 5’ and 3’ untranslated regions, all 8  exons and introns 
1,2,4,5 and 6 . The large introns 3 and 7 were only partially amplified. CSGE 
was performed as previously described (Korkko et al., 1998). All samples with 
bandshifts were sequenced in dupiicate and in forward and reverse orientations 
after re-amplification of the appropriate exon from genomic DNA in the PCR.
PCR products were sequenced using the ABI Ready Reaction Dye Terminator 
Cycle Sequencing Kit and the ABI 377 Prism sequencer.
2.7. Mutational analysis of the tapasin gene
DNA extraction was carried out using a modified salting out procedure. MHC 
class I genotyping was performed using a polymerase chain reaction (PCR) 
sequence-specific method previously described for HLA typing (Bunce et al., 
1995). Primers used were designed with appropriate mismatches to detect the 5
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polymorphisms studied. The control primer used was specific for a constant 
region of HLA DRB1 (796 base product).
PCR was carried out in a final volume of 13 piL in 96-well plates under conditions 
identical to HLA typing. The final concentrations of the reaction components 
were as foliows: 200jaM of each dNTP, 2mM MgCl2 , 67mM Tris base, pH 8 .8 , 
16.6 mM ammonium sulphate, 0.1% (vol/vol) Tween 20 between 0.01 and 0.1 |Lig 
DNA and 0.2 units of Tag polymerase (Advanced Biotechnology, London, UK). 
PCR amplifications were carried out in MJ Research 96 V machines under the 
following cycling conditions: 1 minute at 96°C; 5 cycles of 25 seconds at 96°C, 45 
seconds at 70 °C, 45 seconds at 72 °C ; 21 cycles of 25 seconds at 96 °C , 50 
seconds at 65 °C , and 45 seconds at 72 °C ; 4 cycles of 25 seconds at 96 °C , 60 
seconds at 55 °C , and 120 seconds at 72 °C . An aliquot of the PCR reaction 
plus 6 piL of loading dye was loaded into a 1% agarose gel (containing ethidium 
bromide) in 0.5 -Borate EDTA solution. Gels were electrophoresed for 30 
minutes at 200 V/cm^. Gels were photographed under ultraviolet light (320nm). 
Each gel was scored for the presence or absence of an allele specific band, 
provided that the control amplicon was present.
2.8. Polymorphic analysis of the tapasin gene
The analysis of a linkage between the exon4 and intron 4 polymorphisms was 
undertaken with each sequence specific primer. The configuration of the chosen
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primers is seen in Figure 3.1.2. The PCR conditions were identical to those 
detailed in 2.7.
2.9. Polymorphic analysis and sequence analysis of primate 
tapasin
The primers for primate tapasin were designed using areas of maximal 
human/mouse homology and assuming that such homology wouid be present in 
the evolutionary closer macaque sequences. All primers were chosen to anneal 
at 60°C and the reactions were undertaken in 50//I eppendorf tubes. The 
reactions included 5 //I NH4 reaction buffer (Bioline), 2 //I MgCl2 50mM (Bioline), 2 
jj\ 25mM dNTp mix (Bioiine), 38 //I H2O 1 //moie//y| of forward and reverse 
primers, 0.5 //I of Taq polymerase (Bioline) and 0.5//I of template DNA. The 
PCR amplifications were carried out in an Eppendorf gradient mastercycler under 
the following conditions: 35 cycles of 60 seconds at 94°C; 60 seconds at 58°C 
and 60 seconds at 6 8  °C. PCR products were purified according to the 
manufacturer’s instructions (QUIagen QIAquick PCR purification kit. All 
sequencing was undertaken through the Oxford University Biochemistry 
Department sequencing facility. The sequence analysis was undertaken using 
the internet sequence alignment program CLUSTALW.
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2.10. Statistical methods
Analysis of the relationship between tapasin and MHC class I genotypes was 
made using the Chi-squared test impiemented in the Knowledge Seeker program 
(Knowledge Seeker IV version 4.2.1, Angloss International Limited). All allele 
frequencies were calculated by direct counting. A %2 value of greater than 6.63 
(P<0.01 :DF =1) was considered as a significant association.
2.11. Ceil transfections
721.220 cell lines co-expressing B*4402 or B*2705 were transfected by 
electroporation at 220V and 960//F with the soluble tapasin and ICP47 vectors. 
The cell lines were selected with 0.5mg/ml of G418 or 4 //g/ml of puromycin. All 
experiments were undertaken on bulk populations that were selected using 
magnetic beads (Dynabead) that had been coated with the Bw4 antibody 
(116.5.28).
2.12. Thermostabiiity assays
For thermostability assays, the relevant cell transfectants were starved in 
methionine and cysteine-free medium for 40min and pulsed with [^^S]- 
methionine/cysteine (Promix®, Amersham, U.K.) at 100 |xCi/ml/1 O^cells for 
30min. Celis were collected, washed in coid PBS and lysed in Triton X-100 buffer
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(1% Triton X-100,10mMTris[pH7.4], 150 mM NaCI with PMSF) for 30min at4°C. 
To test for stabilisation of MHC class I complexes by variant peptides, this 
incubation step was carried out in the presence of 5 0 jliM  of the relevant peptide. 
After cell nuclei had been centrifuged, cell lysates were precleared with protein 
A-sepharose beads (Sigma, St. Louis, MO, St. Louis) for 30min. Following this, 
equal aliquots of cell extracts (derived from 2 x 1 0 ® cells) were loaded into thin 
walled eppendorfs and kept at either 4°C or placed across a temperature 
gradient in a thermocycler (Mastercycler Gradient, Eppendorf). The samples 
were heated at required temperatures for 1 2  minutes and then returned 
immediately to 4°C. Thereafter, mAb W6/32 and protein A-sepharose beads were 
added for 1 hour at 4°C with gentle rotation. The beads were washed once in 
450mM NaCI solution containing 0.1% Triton X-100, lOmM Tris buffer (pH7.4) 
and once in lOmM Tris Buffer (pH7.4). The beads were heated at 80°C in 20^1 of 
x2 LDS sample buffer (pH8.5) for 5min and proteins were subsequently 
separated by 10% non-reduced SDS-PAGE gel. The gel was then fixed, soaked 
in Amplify (Amersham, U.K.) and dried. The images were analysed with a Fujifilm 
FLA-2000 phosphorimager. The arbitrary intensity units (AlU) of each heavy 
chain signal was quantified and the relative stability of class I complexes after 
heating is expressed as the AlU after heating in relation to the relevant AlU at 
4°C. For pulse-chase thermostability assays, cells were labelled for 5min with 
[®®S]-methionine/cysteine at 100 pCi/ml/10^ cells and then chased in excess 
methionine (2mM) and cysteine (2mM). At indicated time points, cells were 
harvested and lysed in Triton X-100 buffer. Equal aliquots of cell extracts derived
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from 2x10® cells were kept at either 4°C or heated at indicated temperatures for 
12min. Thereafter, samples were treated as above. Where cell extracts had been 
heated to 50°C, the samples were spun at 21,000g for 10 min to remove any 
heat-induced precipitates prior to immunoprécipitation.
2.13. Pulse chase radiolabelling
Cells were starved in methionine and cysteine-free medium for 40min and pulsed 
with [®®S]-methionine/cysteine (Promix®, Amersham, U.K.) at 100 pCi/ml/1 O^cells 
for 5 minutes. The cells were then chased for 15, 30, 60 and 120 minutes in 
RPMI 1640 media supplemented with 10% PCS and 2mM methionine/cysteine. 
For short pulse chase experiments (6,12 and 18 minutes chase) a 2 minute pulse 
label was used. At each time point, cell aliquots were removed, washed in ice 
cold PBS and lysed in 1% Triton X-100 buffer (pH 7.4). Postnuclear 
supernatants were precleared for 1 hour at 4°C prior to immunoprécipitation with 
W6/32 conjugated Sepharose beads for 1 hour at 4°C. Washed precipitates were 
resuspended in 20uL of 50mM sodium citrate buffer (pH 5.5), containing 0.2% 
SDS, heated to 80°C for 5 minutes, and digested with 5mU endoglycosidase H 
(Roche) overnight at 37°C. Samples were analysed on a 10% SDS-PAGE gel. 
The gel was then fixed, soaked in Amplify (Amersham, U.K.) and dried. The 
images were analysed with a Fujifilm FLA-2000 phosphorimager. The data was 
then plotted as the % of maximal endoglycosidase H resistant material seen at 
each time point.
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2.14. Cell surface lodlniation
Cells (1x10®) were washed once in Dulbecco's PBS (Sigma, St. Louis, MO) and 
radiolabelled with O.SmCi 125-Iodine in 1ml of Dulbecco's PBS within an lodo- 
Gen pre-coated tube (Pierce) for 15min at room temperature with gentle 
agitation. Cells were then washed twice in Dulbecco's PBS containing 5mM Kl, 
lysed in Triton X-100/TBS buffer and subjected to immunoprécipitation as 
described above.
2.15 Flow Cytometry
Cells were stained with mAb 116.5.28 for HLA-B4402 followed by goat anti­
mouse antiserum conjugated to FITC (Sigma, St. Louis, MO). 2x10"  ^cells were 
analysed for each histogram using a FACS analyser (Becton Dickinson, CA). For 
cell surface decay experiments, 5x10® cells were treated with 10pg/ml BFA and 
cultured at 37°C. Equal aliquots of cells were withdrawn at 0, 8,16 and 24hrs, 
stained with mAb and fixed with 1% paraformaldehyde in PBS. Cell surface
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decay of class I complexes was expressed as mean channel fluorescence (MCF) 
at these time points in relation to the MCF at time 0.
2.14 Western blotting
Cells were grown to a density of 3x10®/ml prior to harvesting for immunoblotting. 
The cells were spun at 1300rpm for 3 mins at 4°C. The cells were washed in PBS 
and lysed in ice cold Tris lysis buffer (pH 7.5) (150m NaCI,5mM EDTA, 20mM 
TrisHCI, 2mM PMSF and 5mM iodoacetamide) containing 1% triton X. The cells 
were routinely lysed at a concentration of 10^/ml. Following 30 minutes at 4°C 
the samples were centrifuged at 13000rpm (4°C) for 10 minutes. Samples were 
then mixed with an equal volume of x2 sample buffer (10% SDS, 5% p- 
mercaptoethanol (2-ME), 50mM Tris (pH6 .8 ), 30% glycerol and 0.005% 
bromophenol blue). Following heating for 5 minutes at 95°C the samples were 
loaded onto a 10% SDS-polyacrrylamide gel. A stacking gel (0.125M Tris pH 6 . 8  
,13% Bisacrylamide (30%),0.1% SDS) and 10% resolving gel (0.375M pH8 .6 , 
30% bisacrylamie (30%), 0.1% SDS) were polymerised with 10% ammonium 
persulphate and TEMED and made fresh for each gel. The gels were run at 
200V for 1 hour within a Novex cassette apparatus. Transfer was undertaken for 
90 mins at 26V to nitrocellulose membranes (Hybond C, Amersham). Following 
transfer the gel was stained with Ponceau red. The membrane was then blocked
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in 5% non fat milk in 0.05% PBS tween (blocking buffer) for 1 hour at 4°C. The 
membrane was washed 3 times in 20 ml of 0.05% PBS tween. Primary antibody 
was diluted to the appropriate concentration in blocking buffer and the membrane 
was soaked in this for 90 minutes. The washing procedure was then repeated. 
The secondary species and isotype specifc antibody was then diluted 
appropriately in the blocking buffer and added to the membrane for 1 hour. 
Following 3 further washes the membrane was soaked in a chemiluminescent 
detection reagent (ECL, Amersham) and exposed to a CCD camera for image 
capture (Fuji BAS FLA2000)
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Chapters RESULTS
3.1 INVESTIGATION OF TAPASIN POLYMORPHISMS
3.1.1 DETERMINATION OF TAPASIN POLYMORPHIC FORMS
The investigation of polymorphic variants of tapasin was undertaken by 
conformational sensitive gel electrophoresis in collaboration with Dr R Houlston 
and S Bevan at the Institute of Cancer Research, Sutton. Genomic DMA from 40 
healthy Caucasian U.K. individuals aged less than 55 years of aged was used to 
screen for sequence variation in the tapasin gene. Ten primer pairs were 
designed to amplify all 8  tapasin exons in addition to the 5'UTR, 3’UTR regions 
and introns 1,2,4,5 and 6 . Conformational sensitive gel electrophoresis was 
undertaken to screen for polymorphisms (Korkko et al., 1998). This technique 
depends upon the formation of a mismatched dsDNA which will run differently to 
that of a perfectly matched dsDNA molecule through an acrylamide gel.
Following this approach 43 CSGE band shifts were identified within the 40 
samples (Table 3.1.1). Most of these were located within exon 4 and intron 4.
All samples with a band shift were sequenced in forward and reverse orientations 
following re-amplification of the appropriate PCR product to confirm a true 
positive result by CSGE.
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Primer pair Sample Number
(Total numbers in brackets)
Confirmed by sequencing
TAP 1 None None
TAP 2 1
(1)
None
TAP 3 1
(1)
None
TAP 4 None
TAP 5 3,5,6,7,8,9,13,16,17,18,
20,21,23,24,29,30,32,39
(18)
Confirmed by sequencing
TAP 6 1,3,5,6,7,9,10,11,13,17,
21,22,25,28,29,31,34,37,39
(19)
Confirmed by sequencing
TAP 7 None
TAPS 18,19,34
(3)
None confirmed
TAP 9 16
(1)
Confirmed by sequencing
TAP 10 None
TOTAL 43
Table 3.1.1 -  Potential Tapasin polymorphisms
identified by conformationai sensitive gel 
electrophoresis (CSGE).
A total of 43 CSGE band shifts were identified in a sample 
of 40 DNA samples. The majority of the bandshifts were 
seen with primers that targeted exon 4 and intron 4 of the 
tapasin gene
Direct sequencing did not identify any polymorphisms to account for the 
bandshifts seen with the TAP 2, 3 and 8  primer pairs. It is well recognised that 
the higher sensitivity of CSGE is offset by a higher false positive rate. The 
bandshifts identified with the TAP 5 pair were all secondary to a Cytosine (C) to 
Guanine (G) change at position 16003 within exon 4 (Accession number 
Z97183). This represented a non-conservative codon change of a Threonine 
(ACA) to arginine (AGA) at amino acid position 240. The 16003-G allele was 
subsequently termed Tapasin *01 and the 16003-C, Tapasin *02. The TAP 6  
bandshifts were secondary to one of 3 polymorphisms identified within intron 4. 
These were a Guanine to Thymidine (T) change at 16146, Guanine to Adenosine 
(A) change at 16232 and Thymidine to Adenosine change at 16317 The TAP 9 
bandshift was confirmed as a C>T change at position 17041.
Sequence specific primers were then designed to specifically anneal to the 
identified polymorphic variants. The original 40 samples were again analysed to 
confirm the specificity of the primers and to determine whether any co­
association of polymorphisms existed. The primers were multiplexed to look for 
a linkage between the exonic dimorphism and the three intronic dimorphisms. 
This would allow for the determination of an exonic-intronic 4 haplotype for each 
allele. This configuration is seen in Figure 3.1. Of the original 40 samples used 
for CSGE, 25 were available for typing in this manner. The frequency of the 
dimorphism was 8/25 (0.32) for the 16003-G homozygote, 4/25 (0.16) for the 
16003-C homozygote and 13/25(0.52) as heterozygotes. It became apparent
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that of the many intron 4 sequences that were mathematically feasible, only 4 
sequences were identifiable (Figure 3.1.1). The G/G homozygotes samples 
included 3 TAA, 4 GGT and a single TGA intronic sequence. Within the 4 C/C 
homozygotes all had the GGT wild type intronic sequence. This small initial 
sample suggested that the Tapasin*02 variant may be linked to a fixed intronic 4 
sequence. This initial cohort analysis was investigated further through a review 
of 81 DNA samples obtained from cadaveric renal transplant donors.
3.1.2 ANALYSIS OF THE FREQUENCY OF TAPASIN POLYMORPHIC 
VARIANTS AND THE EXON 4-INTRON 4 LINKAGE.
The frequency of the 5 polymorphisms was determined in a series of 81 genomic 
DNA samples. The PCR typing was set up to determine the tapasin allele 
present and its linkage to the three intronic 4 dimorphisms. The schematic layout 
of the PCR approach and a representative PCR experimental result is seen in 
Figure 3.1.2. All 81 samples were successfully amplified and the results are 
seen in Table 3.1.2a. The Tapasin*01 allele had a frequency of 0.47 and the *02 
allele of 0.53. The genotype frequency was for *01*01 = 0.22, *01*02 = 0.49 and 
*02*02= 0.28. The four intron haplotypes were identified within this population at 
a frequency of GGT = 0.54, TAA = 0.23, TGA = 0.22 and TGT = 0.006. Once 
again all the *02 alleles were associated with the wild type GGT intron 4 
sequence. Only one of the *01 alleles was associated with this sequence. The
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Exon 4
G/C
16003
G/T
16146
G/A
16232
Intron 4
T/A
16317
314 bp
Intron 4 16146 16232 16317
1 G G T
2 T A A
3 T G A
4 T G T
Figure 3.1.1 - Exon 4-lntron 4 haplotype configuration
The exon 4 dimorphism and intron 4 dimorphisms extended 
over less than 350bp of DNA. Of the many permutations 
of intronic sequence that could possibly be identified only 
4 were seen.
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Forward Primer 
16003- G EXON 4
Forward Primer 
16003- C EXON 4
Forward Primer 
16003- G EXON 4
Forward Primer 
16003-C EXON 4
Reverse Primer INTRON 4
G G T T A A G G T T A A G G T T A A G G T T A A
G-TAA C-GGT G-TAA C-GGT
G-TGA C-GGT G-TAA C-GGT
G-GGT G-TAA G-TAA C-GGT
G-TAA C-G*T G-GGT G-TGA
G-GGT G-TAA G-TGT C-GGT
REPEAT G-TGA C-GGT
Figure 3.1.2-Representative multiplex PCR gel of
Tapasin exon 4 and intron 4 polymorphisms
Each DNA sample Is tested with an exon 4 forward primer 
and each of the intronic primers which are specific for 
each dimorphism. An exon-intron 4 haplotype can then 
ascribed to each sample.
most frequent intronic haplotypes associated with the *01 allele were TAA =0.5 
and TGA =0.47
There are only 314 bp between the exon 4 dimorphism and the last of the three 
intronic polymorphisms (Figure 3.1.1 ). The singular linkage between the *02 
allele and the intronic haplotypes GGT is in contrast to the *01 alleles which is 
seen with both the TAA and TGA intronic sequence. A second set of DNA 
samples were then chosen, to assess whether this linkage could be repeatedly 
seen. This second donor set (from the Oxford transplant centre DNA bank of 
cadaveric renal donors) had been previously typed across the MHC region for 
MHC class I and II loci. A similar linkage was seen between the exon 4 
dimorphism and intron 4 sequences within this control set. This data is shown in 
Table 3.1.2b
An analysis was then undertaken to look for a linkage between the tapasin 
polymorphisms and the MHC class I and II genes. The Chi squared 
(X^ )statistical analysis was used to determine whether the frequencies of the 
polymorphisms associated with a particular allele differed significantly from the 
frequencies calculated from the control group
3.2 DETERMINATION OF TAPASIN LINKAGE WITH MHC CLASS I AND II 
ALLELES
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i i  j , -, 1
POLYMORPHISM SAMPLE NUMBER =81 FREQUENCY
16003-G 76/162 0.47
16003-C 86/162 0.53
GG 18/81 0 . 2 2
CC 23/81 0.28
CG 40/81 0.49
GGT 87/162 0.54
TAA 38/162 0.23
TGA 36/162 0.22
TGT 1/162 0.006
C-GGT 8 6 / 8 6 1 . 0
G-TAA 38/76 0.5
G-TGA 36/76 0.47
G-TGT 1/76 0.013
G-GGT 1/76 0.013
Table 3.1.2a - Frequency of the Tapasin dimorphism
and Intron 4 linkage in normal controls
The frequency of the tapasin dimorphism and intron 4 
dimorphisms are seen. The tapasin dimorphisms 
segregate in accordance with the Hardy-Weinburg 
equation whereas the intronic mutations appear to be 
in linkage with particular tapasin exon 4 variants.
Integrated Control results
Polymorphism Controls
1
Control
II
Combined
l&l l
16003-G 76/162 0.47 100/164 0.61 176/326 0.54
16003-C 86/162 0.53 64/164 0.39 150/326 0.46
GG 18/81 0.22 32/82 0.39 50/163 0.31
CC 23/81 0.28 14/82 0.17 37/163 0.23
CG 40/81 0.49 36/82 0.44 76/163 0.47
C-GGT 8 6 / 8 6 1 . 0 63/63 1 . 0 149/149 1 . 0
G-TAA 38/76 0.5 45/99 0.45 83/175 0.47
G-TGA 36/76 0.47 50/99 0.51 86/175 0.49
G-TGT 1/76 0.013 0/99 0 . 0 0 1/175 0.006
G-GGT 1/76 0.013 4/99 0.04 5/175 0.028
G-TAT 0/76 0 . 0 0/99 0 . 0 0 0/175 0 . 0
Table 3.1.2b - Integrated control results for the Tapasin
exon 4/ intron 4 dimorphisms and linkage
Certain MHC class I alleles form extended haplotypes where they are found 
together at a higher frequency than would be predicted by their individual allele 
frequencies (Price et al., 1999). Typical MHC linkage disequilibria include the 
A1B8DR3 and A3B7DR15 associations. It was of note that the former 
haplotypes contained tapasin dependent alleles whilst the latter tapasin 
independent alleles (Greenwood et al., 1994). We undertook a Chi squared 
analysis of the frequency of the tapasin polymorphisms with the single alleles 
and the extended haplotypes. However, no single MHC class I allele or 
haplotype was significantly associated (P<0.01) with any of the tapasin 
polymorphisms (Table 3.2.1).
However, on consideration of the MHC class II alleles some significant 
associations were seen (Table 3.2.2). Of the control samples that were available 
for MHC class II typing, 2 interesting associations were seen. Firstly a positive 
association was seen between DQ6  and Tapasin *02. Of the 30 DQ6  positive 
samples only 1 was identified within the Tapasin *02 allele. The negative 
association of the DQ6  (DQB1*0601-0615) with the G Tapasin allele suggests 
that the DQ6  may exist in cis with the Tapasin *02 allele. DP*0101 also 
appeared to be associated with the Tapasin *02 allele. Of the 7 DP*0101 
samples, 5 were seen within the CC homozygotes. The Tapasin*01 allele 
showed weaker linkages to the DR4 and DP*0402 alleles.
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MHC Class 1 Association
Control
Group
16003-C 16003-G G-TAA G-TGA
Control
Group
81 (100%) 63 (78%) 58 (72%) 31 (38%) 34 (42%)
A1 2 1  (26%) 15(71%) 14 (6 6 %) 10 (48%) 6  (29%)
A3 22 (27%) 7 (77%) 18 (82%) 11 (50%) 9 (41%)
B7 24 (30%) 22 (92%) 19 (79%) 7 (29%) 12 (50%)
B8 16 (2 0 %) 13(81%) 10 (63%) 7 (44%) 4 (25%)
B27 6  (7%) 4 (67%) 4 (67%) 1 (17%) 4 (67%)
B4402 1 0 (1 2 %) 5 (50%) 8  (80%) 7 (70%) 3 (30%)
Cw701 19(235) 16(84%) 11 (58%) 7 (37%) 5 (26%)
Cw702 26 (2 2 %) 24 (92%) 2 1  (81% ) 8  (31%) 13(50%)
A1B8Cw701 13(16%) 10(77%) 8  (62%) 6  (46%) 3 (23%)
A1B8DR3 9 (9%) 6  (6 6 %) 5 (56%) 5 (56%) 1 (1 1 %)
A3B7Cw702 11 (14%) 9 (82%) 10(91%) 6  (55%) 4 (36%)
A3B7DR15 5 (6%) 5 (100%) 4 (80%) 1 (2 0 %) 2 (40%)
Table 3.2.1 -  Association of selected MHC class I
alleles with tapasin polymorphisms
The Chi squared analysis showed no statistical association 
between any MHC class I allele or extended haplotype with either 
of the tapasin polymorphisms.
(i) MHC class II Associations
DQ6 GG Not
GG
Total
+ve 1 29 30
-ve 19 44 63
Total 20 73 93
CHI =8.40 Df=1 P=0.004
MHC class II Associations
DP*0101 CC Not
CC
Total
+ve 5 2 7
-ve 18 65 83
Total 23 67 90
CHI =8.4 Df=1 P=0.003
(ii) MHC class II Associations
DR4 GG Not
GG
Total
+ V 0 11 16 27
-v e 7 56 63
Total 18 72 90
CHI =9.9 Df=1 P=0.001
MHC class II Associations
DP*0402 CC Not
CC
Total
+ve 1 12 13
-ve 17 29 46
Total 18 41 59
CHI =4.8 Df=1 P=0.03
Table 3.2.2 -  Association of selected MHC class II 
alleles with tapasin polymorphisms
(i) The Tapasin *02 allele appeared to be linkage with the DQ6 
alleles. The DP allele, DP*0101, was also associated with 
Tapasin *02.
(ii) Tapasin*01 was associated with DR4 and DP*0402.
Following this initial analysis I undertook an analysis of 2 disease groups. The 
first group were individuals with autoimmune thyroid disease (AITD) and the 
second group, those with psoriasis. These groups were originally chosen 
secondary to the A1B8DR3 association with AITD and the Cw6 association with 
psoriasis. 170 individuals with AITD and 97 individuals with psoriasis were 
analysed. Once again all tapasin *02 alleles were associated with the GGT 
intronic haplotypes and the TGA and TAA intronic haplotypes were the most 
common within these disease groups. Chi squared testing showed no statistical 
association between the tapasin alleles and/or genotypes of these disease 
compared to those of the controls (data not shown).
3.3 INVESTIGATION OF PRIMATE TAPASIN POLYMORPHISMS
The conservation of the exon 4-intronic 4 haplotype across more 150 samples 
prompted its analysis in primates. Rhesus macaque monkey genomic DNA was 
obtained (through Dr Tom Hanke, Institute of Molecular Medicine, Oxford) and 
the tapasin dimorphism investigated. The original exon 4 forward primers were 
chosen as there was human to mouse homology across this region and a 
consensus exon 5 primer designed at a site of homology between mouse and 
human. It was assumed that such conservation would be maintained across the 
human-primate sequences. 67 samples were analysed and all were 
homozygous for the tapasin AGA (arginine -human tapasin*01 ) codon. To 
ascertain which intron 4 sequences were associated with this codon, 4 genomic
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DNA’s where sequenced across this region. These all showed the presence of 
the GGT sequence at positions 16146, 16232 and 16147 respectively. It 
appears that in primate tapasin the exon 4 intron 4 haplotype is of the form G- 
GGT which is the most uncommon haplotypes within the human haplotypes 
identified.
To further analyse these differences between monkey and human tapasin I 
undertook a sequencing project on primate tapasin. Due to the availability of 
only genomic primate DNA, the sequencing consisted of aligning the mouse and 
human introns/exons and designing primers that were directed at conserved 
regions based on the assumption that such regions would also be conserved in 
the primate DNA. This sequencing approach allowed for the determination of all 
the primate tapasin gene apart from that responsible for the first 10 residues of 
exon 4. Despite multiple attempts with different intron 3 primers, this sequence 
could not be successfully amplified and sequenced. A final sequence 
comparison shows a 96% homology between human and primate tapasin (Figure
3.3). Of the 15 amino acid differences between the 2 proteins, most occur within 
exons 2 and 3. Within exon 4 there is a single amino acid change (Proline to 
Alanine) and a threonine seen at the human dimorphic residue. The 
transmembrane and cytosolic regions are almost identical apart from a 
conservative isoleucine to valine change in the exon 6 encoded region. In 
comparison to mouse tapasin where there are over 30 amino acid differences 
compared to human tapasin, monkey tapasin provides a better platform to
75
(i)
+ 1
H - MKSLSLLLAVALGLATAVSAGPAVIECWFVEDASGKGLAKRPGALLLRQG 
M -MKSLSLLLAVALGLATAVSAGPAVIECWFVEDTSGKGLAKRPGALLLRQG
Ex3
H - PGEPPPRPDLDPELYLSVHDPAGALQAAFRRYPRGAPAPHCEMSRFVPLP 
M -QGEPPPRPDLDPELYLNVHDPAGFLQAAFRRYPRDAPAPHCEMSRFVPLP
H - ASAKWASGLTPAQNCPRALDGAWLMVSISSPVLSLSSLLRPQPEPQQEPV 
M -ASANWASGLTPARNCPRALDGAWLMVSMSSPVLSLSSLLRRQPEPQQEPV 
Ex4
H-LITMATWLTVLTHTPAPRVRLGQDALLDLSFAYMPPTSEAASSLAPGPP 
M -LITMAT------------------- -APRVRLGQDALLDLSFAYMPPTSEAASSLAAGPP
H - PFGLEWRRQHLGKGHLLLAATPGLNGQMPAAQEGAVAFAAWDDDEPWGPW 
M - PFGLEWRRQHLGKGHLLLAATPGLNGQMPAAQEGAVAFAAWDDDEPWGPW
Ex5
H - TGNGTFWLPTVQPFQEGTYLATIHLPYLQGQVTLELAVYKPPKVSLMPAT 
M -TGNGTFWLPTVQPFQEGTYLATIHLPYLQGQVTLELAVYKPPKVSLMPAT
H - LARAAPGEAPPELLCLVSHFYPSGGLEVEWELRGGPGGRSQKAEGQRWLS 
M -LAWAAPGEAPPELLCLVSHFYPPGGLEVEWELRGGPGGRSQKAEGQRWLS
H - ALRHHSDGSVSLSGHLQPPPVTTEQHGARYAGRIHHPSLPASGRSAEVTL 
M-ALRHHSDGSVSLSGHLQPPPVPTEQHGARYACRIHHPSLPASGRSAEVTL 
Ex6 Ex7 Ex8(+428)
H - EVAGLSGPSLEDSVGLFLSAFLLLGLFKALGWAAVYLSTCKDSKKKAE 
M - EVAGLSGPSLEDSIGLFLSAFLLLGLFKALGWAAVYLSTCKDSKKKAE
(ii)
1^1 ym
12 57 87 133 114 30 12 3
0 3 6 1 3 1 0 0
Figure 3.3. -  Comparison of human and monkey Tapasin protein 
sequences.
There are 15 differences between human and monkey tapasin and these are highlighted 
in colour (* denotes human polymorphisms), (ii) Most of the polymorphisms are located 
in exons 2 and 3 where approximately 6% of the amino acids are different between the 2 
species.
investigate key regions of the tapasin molecule that may be important for it's 
functions.
Following these observations I focussed on the development of a tapasin 
functional assay that could define the ability of tapasin to improve the peptide 
repertoire of MHC class I complexes.
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CHAPTER 4
4.1 A thermostability assay for the assessment of Tapasin 
function
The nature of the MHC class I peptide cargo has previously been determined 
through peptide elution experiments and mass spectrometry of the peptide 
species (Engelhard et al., 2002; Rammensee et al., 1993). These biochemical 
process performed on lysed cells examined the cell surface and intracellular 
peptide species that survived the MHC class I complex purification procedures. 
Other inferences regarding the peptide cargo had been made through peptide 
addition experiments (‘assembly assay’) where exogenous peptide had been 
added to lysed cells and its ability to stabilise poorly peptide loaded complexes 
analysed by immunoprécipitation experiments (Townsend et al., 1990). Finally 
the effect of temperature on complex stability had been probed. This was initially 
reported through studies of mouse class I alleles from peptide transporter 
incompetent cell lines whose cell surface class I complexes increased upon cell 
culture at 26°C (Schumacher et al., 1990). This was followed by studies upon 
purified empty and peptide filled complexes analysed by circular dichroism 
spectroscopy (Fahnestock et al., 1992). Lastly intracellular complexes from 
pulse labelled cells were assessed for peptide occupancy by heating followed by 
immunoprécipitation with a conformation sensitive antibody (Neefjes et al.,
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1993a; Tan et al., 1997). MHC class I complexes that carried peptides of optimal 
length and anchor residues were thermostable whilst those with suboptimal 
peptide or without peptide were thermolabile and were not recognised by the 
conformation sensitive antibody after incubation at 37°C. This latter methodology 
had been used to probe the early events in HO, yff2 m and peptide binding and 
provided the opportunity of working with cells whose antigen processing 
machinery, namely tapasin, could be manipulated. I decided to develop this 
assay to probe the repertoire of peptides occupied by B*4402, B*2705 and 
B*4405 in the presence and absence of tapasin.
The initial experiment on the cell lines 220, 220.B*4402, 220. B*4402.Tapasin, 
220.B*4402.soluble Tapasin and 220.B*4402.Tapasin.lCP47 is shown in Figure 
4.1.1. The conformational sensitive antibody W6/32 was used to detect HCiyffam 
complexes. Comparison of lanes 1 and 3 shows detection of both the 
transfected B*4402 allele and endogenous C*0102 allele. However the majority 
of the heavy chain detected is that of B*4402. To quantify this proportion an lEF 
gel was run to enable separation of the MHC class I heavy chains. This showed 
that at least 80% of the radiolabelled HC signal detected with the W6/32 
immunoprécipitation was the transfected HC of the B allele within the 220 cell 
line series (Figure 4.1.2). The quantitation of the HC bands in Figure 4.1.1 
showed a spectrum of MHC class I stability. The B*4402 complexes were very 
stable at 37°C when loaded in the presence of tapasin as compared to the 
absence of tapasin (95% stability versus 12% stability). Of additional interest
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Figure 4.1.1 -  Initial thermostability profiles of BM402
Quantitation of HC signal following the heating of cell 
lysates from MHC class I competent and incompetent 
cells.
Lane 1 - 220
Lane 2 - 220.BM402
Lane 3 - 220.B*2705
A-'  ^ Lane 4 - 220.Tapasin
r  ' '' ,,;. Lane 5 - 220.B*4402.Tapasin
i: ' ' ; - ’ Lane 6 - 220.B*2705.Tapasin
"!;4. \sC \
C*0102
B*4402
B*2705
C allele 
(AU)
8  allele 
(AU)
%
8  allele/Total HC
220 4094 0 0
220.8*4402 5193 32812 86
220.8*2705 2255 8248 80
220.Tapasin 1346 0 0
220.8*4402.
Tapasin
485 4478 90
220.8*2705.
Tapasin
767 15407 95
Figure 4.1.2 -  iEF gei of HC intensity in .220 variants
was the observation that the complexes loaded in the presence of soluble 
tapasin were less stable than those seen with full length tapasin (56% versus 95 
%). Finally the introduction of a viral TAP inhibitor in the form of ICP47 reduced 
the stability of the loaded complexes considerably (32% versus 95%). The 
differences in the recovery of thermostable, peptide loaded complexes were 
encouraging for the development of a functional assessment of peptide 
repertoire.
Following this initial analysis of the 220.6*4402 cell line series, a number of 
modifications were made to the assay to ensure that it could be utilised over a 
range of temperatures and cell numbers with reproducible accuracy of 
quantitation. An analysis of cell number is shown in Figure 4.1.3(i) where as few 
as 1.25 xIO® could be successfully used. An analysis of an increased number of 
lower temperature points was initially undertaken to probe the less stable 
complexes. Figure 4.1.3(ii) shows the performance over 7 temperature points 
from 4°C to 37°C. At higher temperature points (>40°C) aggregates were seen 
which made quantitation impossible (Fig 4.1.3(iii)). This was previously identified 
in the work of Tan and colleagues and corrected in a similar manner with the 
introduction of a high spin speed step following thermal dénaturation (Tan et al., 
1997). The upper range of thermal dénaturation was then assessed and due to 
the loss of material above 55°C, a highest temperature of 50°C was chosen for 
further experiments (Fig 4.1.3(iv)). Lastly, the reproducibility of the assay was 
tested. Pulse label thermostability triplicate experiments were set up and 
quantitated with a phosphoimager. Even for the poorly stable complexes that
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220.BM402.Tapasin.lCP47 
Temp op 4 37 4 _  37 4 37
(i) ■mm
Cell No 1.25x10» 2.5x106 5 x106
(ii)
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(iii)
(iv)
4 37 50
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Sol Tapasin
Z^U.b'4402. 
Tapasin
I
24
220.BM402.Sol Tapasin 
29 35 37 45 50 55 60
Figure 4.1.3 -Optimisation of the Thermostability assay
The thermostability assay was assessed across different 
cell numbers and both high and low temperature points.
220.BM402.ICP47 
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Figure 4.1.4 -  Reproducibility of the Thermostability
assay
The thermostability assay was assessed in triplicate in cell 
lines that had exhibited a marked change in the stability of the 
MHC class I complex.
exhibited a large loss of HC signal over the lower temperature ranges, a low 
variation about the mean result was seen (Figure 4.1.4). This optimised 
experimental technique was then used to explore the peptide repertoire of the 
alleles B*4402, B*2705 and B*4405
4.2. VERIFICATION OF THE RELATIONSHIP BETWEEN MHC 
CLASS I COMPLEX THERMOSTABILITY AND ITS PEPTIDE 
CARGO.
Previous studies had correlated the thermostability of a complex with average 
binding affinity of bound peptide cargo to that complex. In order to determine if 
this held true for B*4402 and B*2705 I chose a family of B*4402 and B*2705 
binding peptides which had been previously characterised (Dedier et al., 2000; 
DiBrino et al., 1995). These peptides were added to the lysates of cells prior to 
the thermal dénaturation step and their ability to stabilise the complex, compared 
to a similarly treated lysate in the absence of exogenous peptide. Figure 4.2.1 
shows the first experiment that utilised this approach, assessing stability in cells 
defective in tapasin (.220) or TAP (T2). The B*4402 peptide (SEIDTVAKY) is a 
self peptide isolated by biochemical elution and the A*0201 peptide 
(ILKEPVGHGV) is derived from the POL protein of HIV. Two features are seen 
for both of these alleles. The first is an increased return of W6/32 reactive 
complexes in the presence of peptide at 4°C (32% for B*4402 and 70% for 
A*0201). The second feature is an improved stability of the complexes following
8 0
(i)
220.6*4402 T2
-Pep + 20pM 
Pep
-Pep + 20pM 
Pep
AU % AU % AU % AU %
4 383 100 505 100
(T32)
821 100 1399 100
(Î70)
37 94 25 192 38 282 34 1259 90
(ii)
220.6*4402
- 10|jM 20mM 100pM 500|jM
AU % AU % AU % AU % AU %
4 433 100 582 100
pA
568 100
|31
1496 100
Î345
1397 100
|322
37 48 11 122 21 169 30 951 64 1492 106
50 0 0 104 18 130 23 697 47 1133 81
Figure 4.2.1 -  Peptide optimisation assay
(i) Initial peptide addition experiments (20pM) showed an 
improvement in the thermostabilities of both 6*4402 and A*0201.
(ii) Increasing the peptide concentration led to an improvement in 
the thermostability of 6*4402, as well as the total number of W6/32 
complexes returned.
the addition of peptide (38% for B*4402 and 90% for A*0201 ). Upon increasing 
the concentration of peptide from 10uM to 500uM for B*4402 a similar degree of 
stabilisation could be seen. These initial experiments supported the proposed 
experimental correlation between thermostability and the peptide cargo of the 
complex.
To investigate the extent of this correlation, peptides of different affinity were 
tested. The anchor residues of peptides optimally suited for the BM402 allele 
are a glutamic acid (E) at position 2 and a tyrosine (Y) or phenylalanine (F) at 
position 9. A series of modified peptides were analysed for their hierarchy in 
stabilising BM402 within the thermostability assay. Alanine substitutions were 
introduced at positions P2, P9 as well as an N extended peptide. Figure 4.2.2 
shows that the optimal SEIDTVAKY peptide led to a maximal stability of greater 
than 50% thermostability at 50°C. In comparison the triple alanine N extended 
‘optimal’ peptide had only a 12% return of stable complexes at 50°C. 
Substitutions at P2 of the peptide appeared to have a greater contribution to the 
stability of the complex compared those at the P9 position, with a 12 % and 42% 
stability at 37°C respectively. A second set of B*4402 peptides was analysed 
that had been previously characterised for optimal binding to B*4402 through 
radiolabelled decay experiments.(DiBrino et al., 1995) These peptides were 
P2 and P9 alanine substituted, N extended and included an aspartic acid 
substitution at P2. The thermostability profiles of these peptide loaded 
complexes correlated with the previously determined off rates of yff2 in (Figure
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Figure 4.2.2 -  BM402 modified peptide thermostabiiity 
assay
The anchor residues of the optimal B*4402 peptide (SEIDTVAKY) 
were modified to establish peptides of lowered affinity for B*4402. 
These peptides had different thermostability promoting effects 
upon the B*4402 complexes, with a hierarchy of optimal>N ext>P9 
>P2=no peptide.
4.2.3). The optimal peptide AEIAAVAKY had a thermostability profile of 78% at 
37°C and 62 % at 50°C compared with 54%:6% for ADIAAVAKY and 10%:0% for 
the AAIAAVAKY peptide.
This approach was then performed on the B*2705 allele with a series of peptides 
derived from the HIV-1 gp120 protein. These peptides had been previously 
characterised for optimal B*2705 thermostability through CD spectroscopy. 
B*2705 is more promiscuous in the amino acid anchors it will tolerate at positions 
P2 and P9. The preferred residues are an arginine (R) at position 2 and a lysine 
(K) at position 9. In comparison to B*4402 which only tolerates tyrosine (Y) and 
phenylalanine (F) at P9, B*2705 will accept Y/F/M/L/l and H. Due to the absolute 
requirement of R at position 2, P3 and P9 substituted peptides were used for 
B*2705. Once again the thermal stability of the peptide occupied complexes 
correlated with the previously defined peptide hierarchy (Figure 4.2.4). Lastly, 
this approach was undertaken on the allele B*4405 which differs by one amino 
acid from B*4402, through a aspartic acid to tyrosine change at position 116 
(116D>Y). No previous comparative assays were available on the B*4405 allele, 
so a number of self and viral peptides were chosen for the thermostability assays 
(Figure 4.2.5) (Macdonald et al., 2003). Again stability of the poorly loaded 
complexes isolated from the 220 cell lysates could be markedly improved by 
addition of all peptides including the SEIDTAVAKY peptide initially identified as a 
B*4402 binding peptide.
All three alleles showed an enhanced thermostability following the improvement 
in their peptide cargo through exogenous peptide addition and this improved
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Figure 4.2.3 -  BM402 thermostability assay with previousiy 
characterised modified peptides.
The thermostability assay of B*4402 was undertaken with modified 
peptides which had been previously characterised according to the 
half-time for dissociation of B*4402 complexes (ti/2 ). The hierarchy 
of thermostability follows that of the previously defined ti/2 .
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Figure 4.2.4 -  B*2705 thermostability assay with previousiy 
characterised modified peptides.
The thermostability assay of B*2705 was undertaken with 
modified peptides which had been previously characterised by 
CD spectroscopy. The hierarchy of thermostability was 
comparable to the previously documented thermal dénaturation, 
monitored by CD spectroscopy.
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Figure 4.2.5 -  6*4405 thermostability assay with previously 
characterised modified peptides.
The thermostability assay of B*4405 was undertaken with selected 
peptides ( previously identified by elution). The B*4402 binding 
peptide SEiDTVAKY was also used.
thermostability correlated well with the known affinities of the peptides. The proof 
of principle experiments permitted the subsequent analysis of intracellular bulk 
MHC class I complex thermostability profiles, as a measure of their optimal 
peptide occupancy within different cell lines. Thus, we felt that the 
thermostability of a MHC class I complex was a good indicator of the average 
peptide cargo affinity and this underpins the following experiments.
4.3 STUDIES ON THE TAPASIN DEPENDENCE OF HLA-B*4402 
AND B*2705
4.3.1 8*4402 AND 8*4402.TAP AS IN THERM0STA8ILITY
The following experiments determined the thermostability profiles of newly 
synthesised B*4402 complexes expressed in the presence and absence of 
tapasin. A cohort of newly synthesised complexes, labelled for 30 minutes with 
were analysed for their thermostability characteristics over a range of 
temperatures. Figure 4.3.1.1 shows the poor stability of B*4402 complexes 
expressed in the absence of tapasin with only 45% of complexes surviving at 
25°C and 9% at 37°C. This is consistent with B*4402 molecules having bound a 
spectrum of suboptimal ligands in the absence of tapasin. This suboptimal 
peptide occupancy is mirrored by the poor cell surface expression of B*4402 in 
.220 cell lines. In contrast, B*4402 complexes loaded in the presence of tapasin 
are all thermostable at 37°C, with the majority stable at 50°C. This improvement
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Figure 4.3.1.1 -  Thermostability of B*4402 +/- Tapasin
Triplicate experiments of 8*4402 +/- tapasin were quantified and plotted.
in thermostability indicates that the complexes have bound peptides that have an 
affinity are at least as high as the index peptides characterised in Figure 4.2.3. 
This improvement in thermostability is mirrored by an increase in the cell surface 
appearance of B*4402 complexes.
The poor thermostability of B*4402 complexes suggested that they could either 
be empty complexes or loaded with suboptimal peptide ligands. To test this 
question further I examined the thermostability profile of B*4402 complexes in the 
presence of the viral TAP inhibitor ICP47 (Fig 4.3.1.2 and Fig 4.3.1.3). The 
thermostability experiments were performed 3 times, and showed a further 
deterioration in the thermostability profile of B*4402 complexes loaded in the 
absence of a TAP dependent peptide supply. This was most marked after the 
25°C temperature point with comparable stabilities up until this point. These 
observations are important for 2 reasons. The first is that B*4402 complexes are 
less stable in the presence of ICP47, indicating that in the presence of a peptide 
supply B*4402 complexes are probably not empty. This implies that the B*4402 
complexes in tapasin deficient cells have either bound and lost peptide with a 
consequential improvement in thermostability of the empty complex (but which 
still remains below the ‘quality standard’ to bypass ER quality control ) or are 
occupied with low affinity peptides that cannot be exchanged. The second 
observation is that this quantified change in the thermostability between the 2 
complexes, establishes a minimum thermostability that permits cell surface 
expression.
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Figure 4.3.1.2 -  Thermostability of B*4402 and B*2705 
+/-ICP47.
Triplicate experiments of BM402 and B*2705 +/- ICP47 were quantified and plotted.
(i) Comparison of B*4402 in the presence and absence of a TAP mediated peptide supply
(ii) Comparison of B*2705 in the presence and absence of a TAP mediated peptide supply
(iii) Comparison of the thermostability of BM402 and B*2705 in the absence of a TAP 
mediated peptide supply.
(iv) There is a greater stability of B*2705 compared to B*4402 in the presence of ICP47 
and in the absence of tapasin.
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Figure 4 .3 .1 .3 - FACS of B*4402 ICP47 and B*2705 ICP47+/- 
Tapasin.
Following the introduction of ICP47 into the 220.8*4402 cell line the MPI falls from 89 to 67. 
For the 220.B*4402.Tapasin cell line the MFI falls from 1160 to 54.
In the 220.8*2705 cell line the ICP47 reduces the MFI from 337 to 98 
In the 220.8*2705.Tapasin cell line the MFI falls from 817 to 136
4.3.2 B*2705 AND B*2705.TAPASIN THERMOSTABILITY
B*2705 was originally reported as being tapasin independent, showing 
comparable steady state cell surface expression in the presence or absence of 
tapasin (Peh et al., 1998). Surprisingly the newly synthesised cohort of B*2705 
complexes were very thermolabile in the absence of tapasin (Figure 4.3.2.1). 
Only 18% of complexes survived heating to 37°C, a figure not that different to the 
9% of B*4402 complexes seen at this temperature. In contrast the B2705 
complexes loaded in the presence of tapasin showed excellent thermostability 
with nearly all complexes stable at 37°C. This was a clear indication that this 
allele was dependent on tapasin for the optimal loading of peptides: a result that 
was initially difficult to reconcile with the steady state cell surface data. Upon the 
introduction of ICP47 a further reduction in the thermostability of the complexes 
was seen (Figure 4.3.1.2 and Figure 4.3.1.3). However the thermostability of the 
B*2705 complexes was always greater than that of the B*4402 complexes, even 
in the absence of peptide and tapasin. Although this might be interpreted as 
evidence of a greater stability of the ‘empty’ form of B*2705 compared to B*4402 
consideration should be given to the availability of TAP independent peptides. 
The ability of B*2705 to bind such peptides has been previously demonstrated in 
transfection experiments upon the TAP deficient T2 cell line (Anderson et al., 
1993).
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Figure 4.3.2.1 -  Thermostability of B*2705 +/- Tapasin.
4.4 COMPARISON OF THE THERMOSTABILITY OF CELL 
SURFACE AND INTRACELLULAR 8*2705
The finding that the early cohort of B*2705 complexes assembled in the absence 
of tapasin were less thermostable than those assembled in the presence of 
tapasin appeared to be inconsistent with the cell surface expression of B*2705. I 
compared the thermostability of cell surface radioiodinated B*2705 complexes 
with a labelled intracellular cohort of newly synthesised B*2705 complexes. 
Figure 4.4.1 shows that in the presence of tapasin the early cohort of intracellular 
molecules are as stable as the cell surface molecules. In contrast only the cell 
surface B*2705 complexes were stable in the tapasin negative cell line with the 
intracellular pool having marked thermoinstability. This suggested that B*2705 is 
dependent upon tapasin although this property is less obvious when the steady 
state cell surface pool of molecules is analysed. Furthermore it raised the 
question of how the previously unstable early cohort of B*2705 molecules attain 
eventual stability. One possibility was that such complexes could optimise their 
peptide cargo allowing the eventual cell surface pool to have an enhanced 
thermostability. I tackled this latter possibility by further developing the assay to 
follow complexes over time
8 6
Temp (°C) 4 37
S35
37
Iodine 125
.220.62705 
.220.82705 +Tapasin
Figure 4.4.1 -  Thermostability comparison of cell surface and 
intracellular 8*2705 complexes +/- Tapasin
B*2705 complexes in tapasin deficient cells are stable at the cell surface but are 
less stable in the ER. In the presence of Tapasin the B*2705 complexes are 
equally stable in the ER and at the cell surface.
4.5 TIME DEPENDENT OPTIMISATION OF MHC CLASS I 
ALLELES
4.5.1 A PULSE CHASE THERMOSTABILITY ASSAY FOR AN ASSESSMENT 
OF THE CHANGING PEPTIDE REPERTOIRE OF MHC CLASS I 
ALLELES OVER TIME.
To further examine the discrepancy between the thermostability of an early 
cohort of MHC class I complexes and the steady state cell surface pool, I 
modified the thermostability assay to allow for the characterisation of a cohort of 
MHO class I molecules over time. Figure 4.5.1.1 shows the initial experiment 
upon the allele B*2705 in the absence of tapasin. A five minute pulse label was 
now utilised and the complexes were analysed at 10, 30, 60 and 120 minutes. 
This initial experiment was interesting for a number of reasons. Firstly it showed 
that between 10 and 30 minutes there was on-going assembly of MHC class I 
HC with )^ 2 nn to form W6/32 reactive complexes and that between 30 and 60 
minutes there was a plateau of 4°C stable complexes. Most interestingly the 
amount of 37°C stable material increased between 30 and 60, and 60 to 120 
minutes. There was also a smaller rise in the 50°C stable material over this time. 
As the 4°C material was stable, this figure could be used as the denominator in 
deriving a percentage stability (% stability) at both 37°C and 50°C over time. 
When this pulse chase was extended to 180 minutes no further improvement in 
the number of 37°C or 50°C complexes was seen (Figure 4.5.1.2). However
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Figure 4.5.1.1 -  Pulse chase Thermostability assay of B*2705 (2hrs)
A 2 hour pulse chase of B*2705 was undehaken with thermostability profiles 
determined at 30,60 and 120 minutes.
(i) Quantification of the HC signal at each time and temperature point shows 
an increase in the signal over time.
(ii) A graphical representation of the data illustrates both the change in total 
HC recovered (AU) and the % stability at each temperature and time point .This 
% stability relates to the total material recovered at 4°C.
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Figure 4.5.1.2 -  Puise chase Thermostability assay of B*2705 (3hrs)
A 3 hour pulse chase of B*2705 was undertaken with thermostability profiles 
determined at 30, 60, 120 and 180 minutes.
(i) Quantification of the HC signal at each time and temperature point shows
a decay in the HC signal that is most marked between 2- 3 hours. The loss of material 
is seen in 4°C,37°C and 50°C complexes.
(ii) A graphical representation of the data illustrates both the change in total 
HC recovered (AU) and the % stability at each temperature and time point .This
% stability relates to the total material recovered at 4°C. When there is loss of 4°C 
material a ‘false’ increase in the % stability may be seen.
during the longer pulse chase there was some loss of the 4°C material which 
‘artificially’ increased the proportion of complexes appearing to be 37°C and 
50°C. For this reason the results of these and all further experiments were 
expressed as arbitrary units of HC (AU) and proportion of stable complexes.
A further modification to the assay was the introduction of an endoglycosidse H 
digestion step following the heating and immunoprécipitation steps. This would 
provide an analysis of the newly synthesised cohort of molecules at the pre 
medial golgi and post medial golgi stages of their trafficking. Additionally it would 
provide an assessment of the trafficking characteristics of complexes with 
differing thermostabilities and hence peptide repertoires. Figure 4.5.1.3 shows 
the initial experiment on 220.B*2705 over a 2 hour pulse chase. This 
experimental approach provides a wealth of information. It is possible to 
enumerate:
1) Total time dependent optimisation (figures in italics)
2) Total time dependent optimisation in the endo R cohort (figures in bold/blue)
3) Total time dependent optimisation in the endo S cohort (figures in bold/green)
4) Relationship between the different thermostable cohorts (>4°C<37°C and
>37°C<50°C and >50°C) as they move between the endo S -  to endo R 
fractions
5) Pulse chase assessments on 4°C material (typical pulse chase calculation)
6) Pulse trafficking characteristics of the different thermostable cohorts.
(i) NO
ENDOH
220.6*2705 Endo H +/-
30 mins 60 mins 120 mins
AU % AU % AU %
4 811 100 750 100 672 100
37 401 49 447 60 517 77
50 95 12 182 24 316 47
(ii) ENDO H 220.6*2705 Endo H +/-
30 mins 60 mins 120 mins
AU % AU % AU %
4 Total 822 100 771 100 678 100
Endo R 404 100 476 100 558 100
Endo S 418 100 295 100 120 100
37 Total 366 44 530 69 567 84
Endo R 224 55 417 80 492 88
Endo S 141 33 113 38 75 62
50 Total 129 16 191 25 247 36
Endo R 93 23 150 32 199 37
Endo S 36 9 42 14 48 46
Figure 4.5.1.3 -  Puise chase Thermostability assay of B*2705 
+/- Endo H digestion.
The thermostability assay was undertaken following a true or mock Endoglycosidase 
H digestion. As before, the improving thermostability profile is seen in the absence 
of endo H digestion (i). In the presence of endo H (ii) the addition of the endo S and 
endo R fractions gives a similar result to (i).
Figure 4.5.1.3 shows a similar result to Figure 4.5.1.2 with an increase in the 
37°C and 50°C stable complexes over the two hour time period. In addition, the 
endoglycosidase arm of the experiment shows comparable results when the 
endo sensitive (endo S) and resistant (endo R) fractions are added together. 
Figure 4.5.1.4 illustrates this, showing that B*2705 Endo H +Total experiment is 
similar to the preceeding experiments without digestion. In considering the 
individual cohorts within the pulse chase thermostability analysis of the endo H 
positive experiment, 2 points can be made.
1 ) The first is the clear difference in the 4°C complexes over time, with a 
decrease in the endo S cohort and an increase in the endo R cohort. The 
reduction in the endo S cohort could be secondary to a transfer of such 
complexes out of the ER and through the medial golgi to become endo R 
complexes between time points or a removal of such complexes from the 
ER to a degradative pathway (i.e. ERAD).
2) When the 37°C complexes are considered, a continuing increase in the 
endo R fraction is seen. This is marked for the 50°C stable complexes 
whose number in the endo S pool in very low at all time points but 
continues to increase overtime in the endo R pool.
Figure 4.5.1.5 attempts to further define the origin of the 37°C and 50°C 
complexes. In particular, whether they are all delivered from the endo S pool as 
37°C or 50°C stable complexes or if they are derived from the pre-existing >4°C 
but < 37°C cohort from within the endo R pool. All the AU figures within these 
graphs are tabulated in Figure 4.5.1.3. From the 4°C, 37°C and 50°C figures we
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Figure 4.5.1.4 -  Cohort analysis of the pulse chase Thermostability 
assay of B*2705 +/- Endo H digestion.
The endo H + experiment allows for the representation of 2 cohorts of class I 
molecules. The endo 8 cohort are distinct and may enter the endo R cohort 
(or ERAD) whilst the endo R cohort may undergo further ‘autonomous’ change 
(post ER) and be modified by influx of endo 8 complexes between time points.
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Figure 4.5.1.5 -  Evaluation of the origin of endo R thermostabie 
compiexes within the thermostability assay of 
B*2705 +/- Endo H digestion.
can derive the absolute number of some other thermostable cohorts. For 
example if we consider the 30 minute endo S cohort we can define:
>4°C but <37° cohort (4°C cohort (418) -37°C cohort (141) = 277 (WHITE)
>37°C but <50°C cohort (37°C cohort (141) - 50°C cohort (36) = 105 (RED)
If we then consider the endo R fraction between the 30 to 60 minute time period, 
the >37°C stable material increased from 224 AU to 417 AU, a difference of 193 
AU. The 'loss' from the endo S pool between these times is only 123 AU (418- 
295) suggesting that some of the increase in 37°C stable material may be 
generated within the endo R pool. Interestingly, when the >4°C but <37°C endo 
R material (WHITE) is assessed at these time periods, a fall of 122 AU (180 -  
59AU) (122 AU) is seen. This loss is within a post ER cohort at a time when 
there is little total loss from the experiment (822-771 AU) and so it is tempting to 
speculate that this is due to conversion of this material a 37°C stable pool within 
the endo R fraction. This ‘autonomous change’ would supplement the incoming 
endo S material, in enhancing the overall thermostability characteristics of the 
endo R pool. Between 60 and 120 minutes the endo S >4°C material fell from 
295 to 120 (175 AU) whilst the increase in the endo R pool was only 82 AU (558- 
476). This suggests that during this time period some of the poorly loaded 
complexes in the endo S pool were lost from the experiment. As these 
complexes are not seen in the trafficking populations it is probable that they have 
been degraded. It must be stressed that all these approximations are considered 
in light of this assay being a semi quantitative assay (at best) but they do permit
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a viewpoint upon the qualitative nature of newly synthesised MHC class I 
complexes that has not been previously possible.
Figure 4.5.1.6 shows the comparative pulse chase kinetics of the differing 
thermostability cohorts. The trafficking half life of B*2705 is 30 minutes at 4°C. 
This is similar to that of B*2705 expressed in the presence of tapasin (see later). 
Surprisingly the 37°C and 50°C stable complexes appeared to have a faster 
trafficking rate with 61% of 37°C stable and 72% of 50°C stable material endo R 
at 30 minutes, compared to 49% of the total cohort. It is possible that this 
reflects the faster egress of more stable complexes from the ER compared to the 
bulk 4°C stable pool. Given the improved stability of complexes loaded in the 
presence of tapasin it would be predicted that these complexes would 
demonstrate a faster trafficking rate than those loaded in tapasin deficient cells. 
However, this is not the case for reasons that are not entirely clear.
These initial experiments provided the impetus to analysis the pulse chase 
thermostability profiles of B*4402 and B*2705 in tapasin competent and 
incompetent cell lines.
4.5.2 TAPASIN CATALYSES THE TIME DEPENDENT OPTIMISATION OF 
THE B*4402 PEPTIDE REPERTOIRE.
Figure 4.5.2.1 shows the pulse chase thermostability results for B*4402 
expressed in the presence and absence of tapasin. The first clear difference is
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220.B*2705 30 mins 60 mins 120 mins
4°C AU %
Endo H 
R/S
AU %
Endo H 
R/S
AU %
Endo H 
R/S
Endo R 404 49 476 62 558 82
Endo S 418 51 295 38 120 18
Total 822 771 678
220.B*2705 30 mins 60 mins 120 mins
37°C AU %
Endo H 
R/S
AU %
Endo H 
R/S
AU %
Endo H 
R/S
Endo R 224 61 417 79 492 87
Endo S 141 39 113 21 75 13
Total 366 530 567
220.B*2705 30 mins 60 mins 120 mins
50°C AU %
Endo H 
R/S
AU %
Endo H 
R/S
AU %
Endo H 
R/S
Endo R 93 72 150 79 199 81
Endo 8 36 28 42 21 48 19
Total 129 191 247
Figure 4.5.1.6 -  Pulse chase characteristics of different thermostable 
B*2705 cohorts.
Typical pulse chase calculations enumerate the fraction of total complexes that 
have achieved endo R status at each time point. This is typically undertaken with all 
the complexes kept at 4°C. The first table (i) shows this approach at the 30, 60 and 
120 minute time points. Tables (ii) and (iii) analyse the fractions that have attained 
Endo R status within the more thermostable cohorts.
the loss of 4°C stable material over time in the absence of tapasin. This loss is 
probably due to the dissociation of yff2m following loss of low affinity peptides with 
subsequent loss of the W6/32 epitope. Furthermore the B*4402 complexes 
failed to improve their thermostability over the pulse chase period. In contrast, 
B*4402 complexes loaded in the presence of tapasin became progressively more 
thermostable over time, having undergone tapasin dependent and time 
dependent peptide optimisation. The 4°C stable complexes were all 37°C stable 
at 30 minutes and there was no loss of complexes over the chase period. 
Furthermore the B*4402 complexes continued to optimise their peptide load, 
enabling the entire cohort of complexes to be 50°C stable at 120 minutes. These 
observations are consistent with the idea that MHC class I complexes that are 
unstable at physiological temperatures are prone to degradation and the 
degradation and optimisation are competing processes. This optimisation may 
involve the exchange of suboptimal peptides for those with a higher affinity or 
trimming of peptides of suboptimal length.
The failure of B*4402 to optimise its peptide repertoire may be interpreted as an 
absolute failure to initially load peptides. I think that this is unlikely as Figure
4.3.1.2 has previously shown that the introduction of ICP47 further impairs the 
thermostability, suggesting that the B*4402 complexes in 220 are peptide 
occupied. This inability of B*4402 peptide optimisation in the absence of tapasin 
may illuminate the primary role of tapasin as a facilitator of MHC class I complex 
peptide optimisation or as having an indirect effect upon such processes. One 
such indirect effect would be the stabilisation of TAP and hence improved
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Figure 4.5.2.1 -  Puise chase Thermostabiiity assay of BM402 
+/- Tapasin.
B*4402 complexes were evaluated in the presence an absence of tapasin over a 
2 hour time period. The 4°C stable material diminished over the 2 
hour period in the absence of tapasin whilst in the presence of tapasin an on-going 
improvement in the thermostability of the complexes could be seen.
peptide supply. This is unlikely to be the entire reason as B lymphoblastoid cell 
lines constitutively over-express TAP (Rowe et al., 1995)and soluble tapasin, 
which does not effect TAP levels, restores cell surface BM402 expression (see 
Results 4.6). Furthermore, when 220.B*4402 cells were pre-treated with IFN-k to 
further maximise TAP expression and peptide translocation prior to pulse chase 
thermostability analysis there was no change in the profile of B*4402 (Figure 
4.5.2.2). When exogenous peptide is added to cell cultures to bypass TAP 
delivery there is no improvement in the thermostability of the B*4402 complexes. 
Only when peptide is added at the time of cell lysis is B*4402 able to load peptide 
independent of tapasin (Figure 4.5.2.2). Comparison with the 
220.B*4402.Tapasin.lCP47 cell line shows that there is an improved 
thermostability profile even in the absence of TAP peptides when tapasin is 
present, possibly reflecting the improved usage and optimisation of any existing 
ER or TAP independent peptide sources. Finally, a tapasin mutant with an N 
terminal deletion that permits TAP stabilisation but does not allow a tapasin MHC 
class I complex interaction to form was introduced into 220.BM402. Figure 
4.5.2.S shows that there was no improvement in the peptide repertoire of B*4402 
under these conditions. Therefore tapasin appears to be required for the 
optimisation of the peptide repertoire of BM402. The on-going improvement in 
the thermostability of tapasin even when it has left the ER is intriguing. Perhaps 
this relates to peptide trimming, tapasin independent peptide exchange or further 
conformational changes that make the complex more thermostable.
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(i)
220.6*4402
No IFN-y IFN-y
30 mins 120 mins 30 mins 120 mins
Au % Au % Au % Au %
4 7269 100 5176 100
(i71)
9323 100 5972 100
(i64)
37 1376 19 935 18 1793 19 1190 20
50 173 2 178 3 293 3 219 4
(ii)
220.8*4402 220. B4402.Ta pas i n. 
ICP47
- + Lysis - +
% % % % %
4 100 100 100 100 100
37 17 19 60 44 42
Figure 4.S.2.2 -  Puise chase Thermostability assay of 220. B*4402 
+/- IFNy and following exogenous peptide loading
BM402 complexes show no improvement in thermostability following IFNy usage (i). 
B*4402 does not load exogenously pulsed SEIDTVAKY peptide but does acquire 
peptide following cell lysis (ii). B*4402 is more thermostable in the presence of tapasin 
even when the peptide supply is limiting (220.B*4402.Tapasin.lCP47)
220.B*4402.NDel44Tapasin
30 mins 60 mins 120 mins
Au % Au % Au %
4 1743 100 910 100
(i52)
531 100
(130)
37 295 17 265 29 238 45
50 55 3 61 7 98 18
2100 1
c
D 1800 -
wc
1500 -
Bc 1200 -
(0
900 -
L_
4-»
Z 600 -
< 300 - 
0 -
E l
SOmins
□ 4C 1I37C n s o c
OOmins 120mins
CM
i|
II
^  2
120 -| 
100  -  
80 
60 
40 
20 
0
□ 4C 0  37C 0  5OC
nte-"% j-i
SOmins SOmins 120mins
Figure 4.S.2.3 -  Puise chase Thermostability assay of 220. B*4402. 
NDel44 Tapasin.
Failure to optimise B*4402 in the presence of a N terminal mutant of tapasin which 
restores TAP function but does not permit a PLC to form.
4.5.3 TAPASIN INDEPENDENT TIME DEPENDENT OPTIMISATION OF THE 
B*2705 PEPTIDE REPERTOIRE
Figure 4.5.3.1 shows the comparable data set on the 8*2705 allele. In first 
considering the differences between the presence and absence of tapasin 3 
points can be made. Firstly in the absence of tapasin there is a progressive loss 
of 4°C material over time which is not seen in the presence of tapasin. This is 
similar but less marked to that seen for 8*4402. Secondly the introduction of 
tapasin greatly enhances the thermostability of 8*2705 complexes, with 37°C 
stability occurring early and continued 50°C optimisation seen throughout the 
chase period. Thirdly time dependent optimisation is seen for 8*2705 in the 
absence of tapasin. The 50°C stable complexes increase over the duration of 
the pulse chase as does their ratio compared to the 37°C stable complexes. The 
ratio of 50°C: 37°C stability changes from 0.24 at 30 minutes to 0.61 at 120 
minutes (Table 4.5.3.1). This is a better guide in this cell line as some of the 4°C 
material is lost from the assay, whilst the 37°C material is stable. This ratio 
change is also seen for the tapasin competent cells with ratios of 0.61 at 30 
minutes rising to 0.84 at 120 minutes. Thus the capacity of 8*2705 complexes to 
traffic to the cell surface in the absence of tapasin, despite the fact that the newly 
assembled complexes are unstable, may relate to this property of tapasin 
independent time dependent optimisation. Again it could be argued that these 
complexes are not optimised but are originally empty and then filled with optimal 
peptide. This is unlikely for at least 2 reasons. Firstly, the ratio of 50°C: 37°C
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Figure 4.5.3.1 -  Puise chase Thermostability assay of B*2705 
+/- Tapasin.
B*2705 complexes were evaluated in the presence an absence of tapasin over a 
2 hour time period. The 4°C stable material diminished over the 2 
hour period in the absence of tapasin whilst in the presence of tapasin an on-going 
improvement in the thermostability of the complexes could be seen.
50°C:37°C stab ility  ratio
30 mins (AU) 60 mins (AU) 120 mins (AU)
220.8*2705 0.24
(95:461)
0.41
(182:447)
0.61
(316:517)
220.B*2705.Tapasin 0.61
(696:1145)
0.80
(831:1044)
0.84
(958:1140
Table 4.5.3.1 -  Comparative stability of B*2705 complexes over time 
+/- Tapasin
The 37°C material is stable during the pulse chase period, reflecting the peptide 
cargo bound by the B*2705 complexes. The 50°C stable material continues to 
increase during the pulse chase period. The ratio between the 2 thermostable cohorts 
changes over time with an increased ratio of the 50°C stable cohort to the 37°C cohort. 
This suggests that there is either new recruitment into the 50°C cohort or that the 
37°C cohort is becoming 50°C stable.
stable complexes increase over time suggesting that previously peptide occupied 
complexes are further refining their peptide repertoire as discussed previously for 
B*4402. Secondly when ICP47 is introduced there is a deterioration in the 
stability of B*2705 complexes within pulse label thermostability studies (Figure
4.3.1.2 ) and a blockade of time dependent optimisation within pulse chase 
studies (Figure 4.5.3.2). Furthermore when such experiments are undertaken in 
the presence of BFA, optimisation continues, further supporting the role of ER 
peptides in the time dependent optimisation of B*2705. Therefore B*2705 is 
similar to B*4402 in requiring tapasin for maximal optimisation but differs in that it 
is able to undergo tapasin independent, time dependent optimisation that is 
reliant on a supply of TAP translocated peptides.
4.5.4 A COMPARISON OF THE ROLE OF TAPASIN FOR THE 
OPTIMISATION OF BM402 AND B*2705
Figure 4.5.4.1 compares the pulse chase thermostability profiles of BM402 and 
B*2705 loaded in the presence of tapasin. Both alleles maintain the 4°C material 
throughout the chase period and attain 37°G stability by 30 minutes. For B*2705 
all complexes are stable to 37°C at the 30 minute time point. This is in contrast 
to that achieved for B*2705 in the absence of tapasin at any time point during the 
2 hour chase period. Therefore tapasin appears to offer B*2705 advantages in 
the both the rate and extent of optimal peptide loading. As both alleles are able 
to acquire a 50°C stability it is possible to compare the thermostabilities between
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(i)
220.8*2705 220.8*2705 + BFA
30 mins 120 mins 30 mins 120 mins
AU % AU % AU % AU %
4 2710 100 1799 100
(i66)
2879 100 2080 100
(172)
37 1048 38 1343 75 1161 40 1475 71
(ii)
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220.8*2705 220.B*2705.ICP47
30 mins 120 mins 30 mins 120 mins
AU % AU % AU % AU %
4 3865 100 3074 100
(180)
4227 100 3165 100
(i75)
37 1315 34 1897 62 944 22 1125 36
30 60
+ICP47+BFA Time (mins)
Figure 4.5.3.2 -  Puise chase Thermostability assay of B*2705 
+/- ICP47 and +/- Brefeldin A (BFA)
(i) B*2705 complexes were evaluated in the presence an absence of BFA over a 
2 hour time period. No differences were seen in the optimisation profiles.
(ii) B*2705 complexes were evaluated in the presence and absence of ICP47. The 
presence of ICP47 decreased the time dependent increase in thermostability
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Figure 4.5.4.1 -  Pulse chase Thermostability assay of B*2705 and 
BM402 in the presence of Tapasin.
B*4402 and B*2705 were evaluated in the presence of tapasin. Both alleles showed 
an improved stability of the 4°C material throughout the 2 hour time period. Also the 
attainment of 37°C stability was seen for both alleles at the earliest time point.
different alleles. B*4402 can be seen to achieve maximal 50°C thermostability at 
120 minutes whilst B*2705 only achieved 74%. Therefore the extent of tapasin 
facilitated optimisation is greater for B*4402. To further examine influence of 
tapasin upon the rate of optimisation, a 2 minute label short pulse chase 
thermostability assay was undertaken. Figure 4.5.4.2 shows that at 6 minutes 
80% of the newly synthesised B*4402 MHC class I complexes are 37°C stable. 
As further newly synthesised complexes emerge between 6-12 and 12-18 
minutes their 37°C stability is also maintained. There is also evidence of the 
early stages of further optimisation as the 50°C:37°C ratio begins to improve 
between the 6 and 18 minute time points. Figure 4.5.4.3 shows the results for 
B*2705, again emphasising the speed of optimal peptide acquisition with 74% of 
complexes 37°C stable at 6 minutes rising to 87% at 18 minutes. Therefore 
tapasin can be seen to both enhance the rate of optimisation and the extent of 
peptide loading. A catalyst will normally speed up the rate at which equilibrium is 
attained but will not alter the position of the equilibrium. Tapasin may therefore 
act to enhance the rate of optimisation in an analogous manner to a catalyst but 
it’s effects upon the extent of optimisation is a secondary consequence. This 
may relate to the rate enhancement (i.e. competition of degradation) or another 
function of tapasin (i.e. direct stabilising effect upon MHC class I complexes). 
These possibilities are dealt with further in the discussion. This optimisation of 
the peptide repertoire is a defining property of tapasin that is seen most readily in 
the context of these thermostability assays.
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220.B*4402.Ta pasin
6 mins 12 mins 18 mins
AU % AU % AU %
4 949 100 1515 100 2110 100
37 760 80 1387 92 1733 82
50 418 44 905 60 1200 58
50:37 0.55 0.65 0.69
stability
ratio
(418:760) (905:1387) (1200:1733)
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Figure 4.S.4.2 -  Short puise chase Thermostability assay of B*4402 
in the presence of Tapasin.
B*4402 complexes were followed following a 2 minute label at 6,12 and 18 minutes. 
Early attainment of 37°C stability is seen at each time point.
220.B*2705.Tapasin
6 mins 12 mins 18 mins
AU % AU % AU %
4 1090 100 1634 100 1974 100
37 811 74 1417 87 1719 87
50 627 57 968 59 1370 69
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Figure 4.S.4.3 -  Short puise chase Thermostability assay of B*2705 
in the presence of Tapasin.
B*2705 complexes were followed, after a 2 minute label, at 6,12 and 18 minutes. 
Early attainment of 37°C stability is seen at each time point. The extent of 50°C 
stability is similar to that seen with B*4402 at these early time points.
4.5.5 INVESTIGATION OF THE EFFECT OF TAPASIN ON B*4402
AND B*2705 TIME DEPENDENT OPTIMISATION WITH REGARD 
TO THE ENDOGLYCOSIDASE SENSITIVE AND RESISTANT 
COHORTS
A further analysis of the role of tapasin in optimising the peptide repertoires of 
8*4402 and B*2705 was undertaken through studying the endoglycosidase H 
sensitive and resistant MHC complex cohorts. Table 4.5.5.1 shows the results of 
the pulse chase characteristics of B*4402 in the presence of tapasin. In the 
absence of tapasin no trafficking of B*4402 from the ER could be identified. 
Additional pulse experiments undertaken at 26°C still failed to show an endo R 
cohort of molecules (data not shown). In the presence of tapasin, half maximal 
trafficking is seen at approximately 30 minutes. The trafficking times of the 37°C 
and 50°C cohorts were slightly faster than the total cohort of molecules at each 
time point. Figure 4.5.5.2 examines the thermostabilities of the endo S and R 
fractions at each time point. Notably, all of the endo R complexes are 37°C 
stable, whilst most of the endo S pool was 37°C stable at each time point. 
Furthermore at the end of the chase period 90% of the endo S material is 37°C 
stable with 55% being 50°C stable, compared to 81% and 37% at the 30 minute 
time point. Therefore, as no material is lost in the presence of tapasin, the 
material still within the ER has undergone optimisation over this time period. The 
endo R cohort is all 37°C stable at 120 mins with 83% achieving 50°C stability. It 
therefore appears that even the complexes that do not egress the ER are still
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220.B*4402.Tapasin Endo H +/-
Differential pulse chase kinetics for thermostable complexes.
15 MINS 30 MINS 60 MINS 120 MINS
4°C
ENDO H R 24% 50% 69% 87%
ENDO H S 76% 50% 31% 13%
37°C
ENDO H R 33% 58% 78% 91%
ENDO H S 67% 42% 22% 9%
50°C
ENDO H R 31% 60% 81% 91%
ENDO H S 69% 40% 19% 9%
Figure 4.5.5.1 -  Pulse chase characteristics of different thermostable 
B*4402 cohorts in the presence of tapasin.
Typical pulse chase calculations enumerate the fraction of total complexes that 
have achieved endo R status at each time point. This is typically undertaken with all 
the complexes kept at 4°C. B*4402 does not traffic in the absence of tapasin. In the 
presence of tapasin endo R material is seen as early as 15 minutes with half maximal 
trafficking at 30 minutes. The more thermostable cohorts have slightly faster trafficking 
rates when compared to the total 4°C stable material.
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Figure 4.5.5.2 -  Cohort analysis of the pulse chase Thermostability 
assay of B*4402.Tapasin +/- Endo H digestion.
The endo H + experiment allows for the representation of 2 cohorts of class I 
molecules. The endo 8 cohort are distinct and may enter the endo R cohort 
(or ERAD) whilst the endo R cohort may undergo further ‘autonomous’ change 
(post ER) and be modified by trafficking endo 8 complexes between time points.
able to undertake peptide optimisation whilst those endo R complexes can 
improve their profiles still further. The details of how and where this further 
optimisation occurs and the degree to which the recently exported complexes 
contribute to this observation may now be examined through such an 
experimental design. One such set up will be to 'trap' the endo R cohort of 
B*4402 by culturing cells in deoxymannojirimycin (dMJ) which inhibits ERM I and 
II. This could be timed to act when approximately 50% of the complexes would 
be expected to have become endo H resistant. .The action of dMJ will then 
prevent endo H cleavage of the emerging B*4402 complexes, allowing then to 
transverse the trans-golgi normally but with an endo S phenotype. The B*4402 
complexes that have previously left the ER can then be analysed in the absence 
of a contribution from newly emerging complexes. Figure 4.5.5.S shows the 
detailed thermostability breakdown of the endo S and R complexes. It is 
interesting that the 50°C: 37°C stability ratio increased in the endo R pool in 
excess of that seen in the endo S pool. This may reflect the continuing 
improvement in endo S 37°C complexes which continually enter the endo R pool. 
However these figures are at best semi quantitative and in deriving these figures 
a modification of the endo R figures has been made. This modification was to 
use the 4°C pool as the denominator and assume all of these complexes are 
37°C stable ( as the 37°C complex arbitrary unitage was greater than that of the 
4°C pool). Taking all this into account it would still appear that there is 
disproportionate increase in the 50°C stable pool within the endo R fraction. The 
molecular mechanism of this continual change is not clear but could include
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Figure 4.5.5.3 -  Evaluation of the origin of endo R thermostabie 
B*4402 compiexes in the presence of tapasin
An sub-analysis of three different thermostable cohorts of B*4402 is seen within 
either the endo S material (ER resident) or the endo R material (post medial golgi).
peptide trimming and exchange (as mentioned previously) or possibly change in 
the tertiary structure of the MHC class I complex. Such changes may include 
sialylation, glycan modification or a change in the conformation of the MHC class 
I complex. Such changes have been described for MHC class II peptide 
complexes analysed as recombinant molecules in vitro (Sadegh-Nasseri et al., 
1994). Examining the endo R material in the absence of a continuing influx from 
the endo S pool (i.e. dMJ experiment) would also enable a clearer look at this 
matter. Finally, an examination of a single chain peptide MHC class I complex 
would be fascinating in this regard. Would such a complex that has its peptide 
cargo ‘fixed’ show an improvement over time? Furthermore would complexes 
with a restricted peptide repertoire (i.e. HLA-E) also show an improvement in 
thermostability over time when peptide exchange/trimming might be expected to 
play less of a role during their maturation?
B*2705 can be analysed in an analogous manner, both in the presence and 
absence of tapasin. Figure 4.5.5.4 shows the 4°C pulse chase characteristics of 
B*2705 do not differ markedly in the presence and absence of tapasin, with only 
a slight increase in trafficking seen in the absence of tapasin. B*2705 is seen to 
optimise its peptide cargo within this endo H + thermostability set up (Figure 
4.5.5.5). The loss of 4°C material is again seen between 60 and 120 minutes. 
Whereas there is loss from 4°C material between the 30 and 60 minute time 
points in the endo S fraction, a comparable increase in the endo R material is 
seen. The loss of the 4°C material between 60 and 120 minutes can be further 
scrutinised in Figure 4.5.5.6 where the composite thermostabilities are plotted.
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220.6*2705. Endo H +/-
Differential pulse chase kinetics for thermostable complexes .
15 MINS 30 MINS 60 MINS 120 MINS
4°C
ENDO H R 40% 55% 70% 75%
ENDO H 8 60% 45% 30% 25%
37*0
ENDO H R 54% 69% 78% 88%
ENDO H 8 46% 31% 22% 12%
50°C
ENDO H R 58% 70% 84% 90%
ENDO H 8 42% 30% 16% 10%
220.B*2705.Tapasin Endo H +/-
Differential pulse chase kinetics for thermostable complexes .
15 MINS 30 MINS 60 MINS 120 MINS
4°C
ENDO H R 35% 40% 55% 66%
ENDO H 8 65% 60% 45% 34%
370c
ENDO H R 38% 43% 55% 68%
ENDO H 8 62% 57% 45% 32%
500C
ENDO H R 36% 42% 56% 64%
ENDO H 8 64% 58% 44% 36%
Figure 4.5.S.4 -  Pulse chase characteristics of different thermostable 
B*2705 cohorts in the absence and presence of tapasin.
B*2705 complexes can egress the ER in the absence of tapasin. At the earlier time 
-points the complexes loaded in the presence of tapasin appear to traffic slower than 
those loaded in the absence of tapasin at all thermostabilities.
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Figure 4.5.5.5 -  Cohort analysis of the pulse chase Thermostability 
assay of B*2705 +/- Endo H digestion.
There appears to be a 429 AU loss between 60 and 120 minutes (1787-1358) 
with 232 AU lost from the 4°C stable endo R pool and 197 AU lost from the endo 
S pool. This loss from the 60 minute endo S pool is not accounted for in the 120 
minute endo R pool and has thus probably been degraded. The other losses 
from the endo R pool may represent complexes that have dissociated en route to 
the cell surface or at the cell surface. This loss may represent 4°C stable but 
37°C unstable complexes. Despite this complex loss from the endo R material it 
is clear that the endo R complexes are more thermostable then the endo S 
complexes but neither are ever entirely 37°C stable. In contrast to the B*4402 
data (Figure 4.5.5.3), the endo R material is maximally optimised at 60 minutes 
and only appears to loose ‘>4°C <37°C’ (WHITE) material after this time. When 
B*2705 acquires peptide in the presence of tapasin a different picture is seen. 
Figure 4.5.5.7 shows that both the endo S and R cohorts are comparably stable 
as early as 15 minutes post pulse label. During the chase period there is a 
further improvement in the 50°C stable material. This change is principally seen 
in the endo R material whilst the endo S material remains qualitatively similar. 
Figure 4.5.5.8 details the temperature stability make up of the different cohorts 
and shows a steadily increasing ‘>50°C stable material cohort’ between 30 and 
60 minutes. This ongoing increase in the stability of the endo R material is less 
marked than that of B*4402 and may entirely reflect the increased thermostability 
of the imported endo S material between 60 and 120 minutes. Why peptide 
loaded thermostable B*2705 complexes remain as endo S material within the ER 
is not clear. However, these latter ER complexes are more thermostable than
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Figure 4.5.5.6 -  Evaluation of the origin of endo R thermostable B*2705 
complexes in the absence of tapasin.
An sub-analysis of three different thermostable cohorts of B*2705 is seen within 
either the endo S material or the endo R material.
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Figure 4.5.5.8 -  Evaluation of the origin of endo R thermostable B*2705 
complexes in the presence of tapasin.
An sub-analysis of three different thermostable cohorts of B*2705 is seen within 
either the endo S material or the endo R material.
those seen at 30 minutes and as there is no loss of B*2705 material between 30 
and 120 minutes this would further support the notion of ER mediated 
optimisation of peptide occupied complexes.
4.6 ASSESSMENT OF THE MHC CLASS I COMPLEX-TAP INTERACTION 
FOR PEPTIDE OPTIMISATION.
To further examine the role of tapasin in facilitating peptide optimisation I choose 
to investigate that FLO bridging function of tapasin. It had been previously 
shown that soluble tapasin, lacking its transmembrane and cytoplasmic domains, 
could restore the surface expression and antigen presentation of HLA-B8 , 
despite the failure of soluble tapasin to restore the interaction between HLA-B8  
and TAP (Lehner et al., 1998). I explored this TAP uncoupling’ soluble tapasin 
construct in the context of B*4402 and B*2705 peptide loading. Soluble tapasin 
fully restored the cell surface expression of both B*4402 and B*2705. Figure 
4.6.1 shows the effect of soluble tapasin upon B*4402 in the pulse label 
thermostability assay. Whilst there is an obvious improvement over the 
previously shown 220.8*4402 thermostability plots, consistent with restored cell 
surface expression, there is a clear difference from the loading seen in the 
presence of full length tapasin. As soluble tapasin does not influence the TAP 
levels this improved peptide loading reflects the utilisation of a peptide pool that 
was present in 220.B*4402 cells but could not be utilised in the absence of a 
B*4402 tapasin interaction. The majority of complexes are stable at 37°C but
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Figure 4.6.1 -  Thermostability of B*4402 +/- Soluble Tapasin.
Duplicate experiments of 8*4402 +/- soluble tapasin were quantified and plotted.
they differ markedly from B*4402 loaded in the presence of full length tapasin at 
all higher temperatures. These differences may relate to different pools of 
peptides, poorly trimmed peptides or a combination of such factors.
When B*2705 is examined in an identical manner a similar set of results are 
observed. Figure 4.6.2 illustrates an improved thermostability compared to that 
seen in the absence of tapasin but an inferior profile compared to full length 
tapasin.
The B*4402 and B*2705 complexes were then assessed over a 2 hour pulse 
chase period. Figure 4.6.3 shows the results for B*4402. When compared with 
the optimisation profiles in the presence of full length tapasin (Figure 4.5.2.1) an 
inferior initial and end point optimisation is seen. There is no loss of complexes 
over the pulse chase, suggesting that all complexes are loaded but that this 
repertoire is suboptimal. This is not due to faster trafficking of B*4402 in the 
presence of soluble tapasin as pulse chase analysis shows identical trafficking 
rates (data not shown). At 120 minutes the 37°C stable cohort represents 89% 
and 50°C stable cohort 56% of all 4°C stable material. The ratio of 50°C; 37°C 
material increased over time from 0.45 at 30 minutes to 0.63 at 120 minute. This 
is consistent with soluble tapasin dependent optimisation. It is also notable that 
the profile is similar to full length tapasin with an important improvement in 50°C 
stability occurring between 60 and 120 minutes (31%>56%).
Figure 4.6.4 shows the results for the B*2705 allele. Again the introduction of 
tapasin abrogates the loss of 4°C material but the optimisation profile is 
decreased when compared to full length tapasin (Figure 4.5.3.1). To further
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Figure 4.6.2 -  Thermostability of B*2705 +/- Soluble Tapasin.
Replicate experiments of 8*2705 +/- soluble tapasin were quantified and plotted.
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Figure 4.6.3 -  Puise chase Thermostability assay of B*4402 complexes 
in the presence of soluble tapasin.
B*4402 complexes were evaluated in the presence an absence of soluble tapasin over 
a 2  hour time period.
220.B*2705.Soluble Tapasin
SO mins 60 mins 120 mins
Au % Au % Au %
4 704 1 0 0 810 1 0 0 628 1 0 0
S7 399 57 397 49 375 60
50 289 41 248 31 268 43
900 1
c  
3
• f  600 H
C
0)
2 300
I
<
CMil
!!
S. % 
^  2
100 
80 
60 
40 - 
20  -
B2705 Soluble Tapasin
SOmins
r ?
r
SOmins
M
SOmins SOmins
nSOC
120mins
□  50C
120mins
Figure 4.6.4 -  Puise chase Thermostability assay of B*2705 complexes 
in the presence of soluble tapasin.
B*2705 complexes were evaluated in the presence an absence of soluble tapasin over 
a 2  hour time period.
compare the stability of the complexes I undertook a BFA decay experiment of 
cell surface material across the B*4402 and B*2705 cell lines. Figure 4.6.5 
shows that the differences detected by the thermostability assay are reflected in 
the decay characteristics of the cell surface material. B*4402 and B*2705 are 
both more stable at the cell surface when loaded in the presence of full length 
tapasin. Also, B*4402 is always seen to be more stable that B*2705 when 
compared across full length or soluble tapasin cell lines.
It appears that soluble tapasin can only partially substitute for full length tapasin 
in promoting peptide loading. This may due to a number of direct and indirect 
effects. A failure to fully recruit the complete PLC apparatus to the soluble MHC 
class I complex has been postulated (Tan et al., 2002). Additionally, the failure 
to optimally trim peptides or encounter the maximum number of peptides 
available when the TAP interaction is disrupted, are other possibilities. However 
the restoration of peptide loading for B*4402 indicates that the interaction 
between lumenal tapasin and the MHO class I complex is essential for the 
utilisation of the pre-existing peptide pool. This initial and/or ongoing interaction 
permits a repertoire of peptide selection and time dependent optimisation that is 
sufficient to permit egress of B*4402 complexes to the cell surface.
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Figure 4.6.5 -  Comparative BFA decay of B*4402 and B*2705 in the 
presence of full length or soluble tapasin.
Cell surface complexes were assessed at 18 and 24 hours following the addition of 
BFA to block the egress of newly formed complexes to the cell surface. The MFI of the 
complexes at the cell surface at each time point is presented as a percentage of that 
seen at the start of the experiment.
4.7 A SINGLE B*4402 POINT MUTATION CONVERTS THE 
COMPLEX TO A TAPASIN INDEPENDENT ALLELE (B*4405)
The distinct differences in the behaviour of the B*4402 and 8*2705 were further 
investigated through a comparison of their primary structures and integration of 
the literature on chaperone associations. Although position 116 is not one of the 
20 amino acid differences between B*4402 and B*2705, it’s contribution to both 
peptide selection and PLC interaction prompted us to asses an aspartic acid (D) 
to tyrosine (Y) change at this position in B*4402. This mutated HC is identical to 
the naturally occurring B*4405 allele. Remarkably, this single change was able 
to permit the expression of B*4405 at the cell surface in the absence of tapasin. 
Further more the behaviour of this allele was akin to B*2705 with comparable cell 
surface expression in tapasin competent and incompetent environments (Figure 
4.7.1).
Following this observation we performed pulse label thermostability experiments 
and compared them to those with B*4402 (Figure 4.7.2). The profiles were very 
similar to those seen with B*2705, showing poor stability of 8*4405 complexes in 
the absence of tapasin and enhanced stability in its presence. The stability of 
8*4405 was always greater than that of 8*4402 in the absence of tapasin, whilst 
the opposite was true in the presence of tapasin.
Figure 4.7.3 compares the pulse chase thermostability characteristics of all 4 cell 
lines. The 8*4402 thermostability plots are similar to those previously seen with 
early maximal 37°C stability and ongoing 50°C enhancement. The 8*4405
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Figure 4.7.1 -  FACS profiles of BM402 and BM405 in the presence 
and absence of tapasin
Representative FACS plots of the steady state levels of 8*4402 and 8*4405 in the 
presence and absence of tapasin
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Figure 4.7.2 -  Thermostability of B*4402 and B*4405 +/- Tapasin.
Comparative thermostability experiments were undertaken on the cDNA transfectants 
of B*4402 and B*4405 in the presence and absence of tapasin. B*4405 shows a 
poor thermostability in the absence of tapasin which improves upon tapasin 
transfection. B*4405 is more thermostable than B*4402 at all temperatures.
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Figure 4.7.3 -  Pulse chase Thermostability of B*4402 and BM405 +/- 
Tapasin
Pulse chase thermostability assays wee undertaken on B*4402 and B*4405 complexes 
in the presence and absence of tapasin. B*4405 is seen to have an improved 37°C 
stability at 30 minutes compared to B*4402. In the presence of tapasin an improved 
37°C and 50°C thermostability is seen for B*4405.
thermostability plots show that in the absence of tapasin there is a reduction in 
the number of MHC class I complexes over 2 hours. However, within the 4°C 
stable cohort of molecules, both 37°C and 50°C stable complexes can be 
identified. This contrasts with the B*4402 pool of complexes. However the time 
dependent, tapasin independent optimisation is not as great as that seen with 
B*2705. Upon the introduction of tapasin there is a dramatic change in the 
stability of the B*4405 complexes. For most complexes the 37°C stability is 
achieved by 30 minutes whilst there is ongoing optimisation of the 50°C stable 
cohort. Again when a comparison is made with the B*4402 complexes it can be 
seen that these are superior to the B*4405 complexes at all time points at both 
37°C and 50°C stabilities. Therefore a single point mutation at position 116 is 
able to alter the loading characteristics of the B*4402 molecule so that it behaves 
as a relatively tapasin independent allele. This similarity to B*2705 extends to 
having a dependency upon tapasin for optimal peptide loading, the end product 
of which is always inferior to that of the tapasin dependent allele B*4402. 
However the degree to which B*4405 undergoes tapasin independent 
optimisation is far less marked than that seen for B*2705. Similarly the loss of 
4°C material is more noticeable in the absence of tapasin for B*4405 than for 
B*2705. It is possible that the mechanisms that permit tapasin independent 
presentation differ between B*2705 and B*4405. Both B*4405 and B*2705 show 
an early maximal attainment of 37°C stability but never attain total 37°C or 50°C 
stability. This contrasts sharply with behaviour BM402. Therefore a trade off is 
seen between attaining a degree of tapasin independent peptide selection and
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achieving a final optimal peptide repertoire. An extension of such studies to 
other alleles may help delineate the structural/functional features of the class I 
complexes that influence this behaviour.
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Chapter 5 - Discussion
5.1 Tapasin polymorphisms and their genetic and functional 
relationship
The variable allelic dependency upon tapasin for cell surface expression 
prompted the initial examination for tapasin polymorphisms. All previous MHC 
class I allele transfections had been undertaken into a single cell line (721.220) 
which only expressed endogenous 0*0102 (Greenwood et al., 1994). In 
previous studies of rat MHC class I antigen presentation, a class I modifier (dm) 
locus had been identified following the study of recombinant strains (Livingstone 
et al., 1989; Livingstone et al., 1991). This locus had an antagonistic effect on 
the expression of the rat class I allele RT1-A®. This locus was shown to encode 
for a TAP 2 allele (TAP2B) that was unable to supply favourable peptides for 
RT1-A® assembly (Powis et al., 1992). The TAP2A allele which had previously 
been in strong linkage disequlibria with the RT1-A® allele had been able to 
supply peptides with a favourable carboxyl-terminal arginine residue, whilst the 
TAP2B allele was unable to undertake such peptide transport (Momburg et al., 
1994; Powis et al., 1996). We wondered whether a similar mechanism might 
operate for tapasin and were initially encouraged by the description of a second 
class 1 modifier locus (dm 2) telomeric of TAP (Simmons et al., 1997). 
(Subsequently this report was retracted by the authors (Taurog et al., 1999)).
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Furthermore the existence of certain extended haplotypes (A1- B8-DR3) that 
exhibited an association with viral diseases (Oksenhendler et al., 1992), such as 
HIV, promoted us to examine whether alleles of tapasin were maintained in these 
extended haplotypes. Our initial analysis of the tapasin gene showed a low level 
of exonic polymorphic variation expected for a gene of approximately ISOObp. 
(Zhao et al., 2003). In an analogous manner to HLA-DM we found that tapasin 
showed limited variability in its primary sequence (Sanderson et al., 1994). In 
regard to HLA-DM, this is believed to be secondary to the role of DM as a 
chaperone that may operate upon a number of other MHC Class II alleles. 
Additionally, HLA-DM does not bind peptides and therefore does not require 
binding pocket polymorphisms to accommodate a specific repertoire of peptides. 
We would hypothesize that for similar reasons, tapasin exists as a non- 
polymorphic molecule to maintain its function (or functions) which are applicable 
to all alleles whose intrinsic polymorphic nature dictates whether they require 
tapasin assistance or not.
Four notable observations were made following the analysis of tapasin. The first 
was the corroboration of the coding dimorphism (that had been previously noted 
(Copeman et al., 1998; Furukawa et al., 1998)) and its frequency, the second 
was the absence of other exon polymorphisms and the third a description of 
particular intronic polymorphisms that formed haplotype associations with the 
coding dimorphism. The fourth observation concerned the absence of a linkage 
across the MHC class I region. With regard to the coding dimorphism, it is
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notable that this mediates a change from an amino acid with a basic side chain 
(arginine) to that with a polar uncharged hydroxyl side chain (threonine). This 
charge change may represent an important modifier of function. No functional 
analysis of the different tapasin alleles upon individual MHC class I allele 
expression has been undertaken within this thesis. However work undertaken by 
Momburg and colleagues showed that the tapasin*02 allele was able to restore 
B*4402 expression to an equivalent extent to that seen in my work utilising the 
tapasin*01 allele (Tan et al., 2002). The importance (if any) of this dimorphism is 
not known at present. The genotype frequency of the tapasin alleles within our 
study population was consistent with the Hardy-Weinburg proportions, with 
tapasin *01 at 0.53 and tapasin *02 at 0.47. The tapasin*01/*02 heterozygote 
frequency was 0.49, *01 homozygosity 0.22 and *02 homozygosity 0.28. A study 
of a Canadian, population using PCR restriction fragment length polymorphism of 
exon 4 with a Bfal digest showed comparable results (Copeman et al., 1998). In 
contrast, a Japanese population study (Furukawa et al., 1998) showed an *01 
and *02 gene frequency of 0.37 and 0.63 respectively (Table 5.1.1 ). It is not 
clear if this trend towards a higher frequency of the * 0 2  allele represents a 
selective functional advantage of this within the common MHC class I alleles of 
the Japanese population (i.e. A24,B52,B61) or whether it is a reflection of the 
genetic and racial mix of the island population. All studies so far have been 
performed on genomic DNA and it would be interesting to investigate whether 
both tapasin alleles are co-dominantly expressed when different polymorphic 
variants are present and whether any differences are seen in the ratio of
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Tapasin Williams 
et al 
(N=81)
Copeman 
et al (N=96)
Furukawa 
et al (N=82)
*01 0.47 0.48 0.37
*02 0.53 0.52 0.63
*01/*01 0.22 0.21 0.13
*02/*02 0.28 0.25 0.39
*01/*02
1
0.49
r 1
0.54
r 1
0.48
r
Table 5.1.1 -  Observed frequency of the Tapasin
polymorphic variants
The Tapasin *01 allele is arginine (AGA) and the 
Tapasin *02 is threonine (ACA) alleles.
homozygotes to heterozyogtes in the case of MHC class I associated diseases 
such as ankylosing spondylitis (AS). If the peptide repertoire of alleles such as 
B*2705 is important in predisposing some B27 positive individuals towards the 
development of ankylosing spondylitis (AS), then tapasin may be a candidate 
gene to influence such a polygenic disorder at a mechanisitic level.
Three novel intronic mutations were identified in intron 4. These were 16147 
T, 16232 A and 16317 T-^ A. These did not obviously alter potential 
acceptor/donor splice site regions. The proximity of these polymorphisms to the 
coding dimorphism permitted an analysis of the exon 4-intron 5 haplotype within 
each allele. Each coding dimorphism may have been associated with one of 
eight possible intronic sequences. However, only 3 main haplotypes were 
identified. For the theronine allele (*02) only a C-GGT haplotype was identified. 
For the arginine (*01), 3 major haplotypes were identified; G-TAA, G-TGA and G- 
GGT. Interestingly the GGT intronic sequence was only seen once. This was 
confirmed on the examination of a further 241 control DNA samples (data not 
shown). In considering the evolution of the alleles this latter observation might 
suggest that a G-GGT was originally present and underwent an arginine to 
threonine (aGa -> aCa) point mutation, with subsequent expansion within the 
population. Why the tapasin *02 haplotype has remained stable whilst the other 
shows a diversity across the nearby intronic region is not clear. The genetic 
distance between the polymorphisms is small, varying from 2 0 1  bp to the first 
intronic polymorphism to 351 for the third. Perhaps this tight cis linkage is
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evidence of a recent exon 4 mutation that has increased in prevalence and not 
had time to evolve intronic mutations. This would be supported by the simian 
data where one finds only the arginine codon (AGA) within exon 4. The absence 
of a threonine at this position is one of the 15 changes identified between the 
primate and human tapasin. Furthermore the intron 4 sequence shows only 
GGT, a configuration that is only rarely seen in linkage with the human arginine 
tapasin form (*01) but is seen exclusively with the *02 form. If we consider the 
arginine encoding allele as the ancestral allele for early primates a hypothetical 
ancestral tree can be outlined (Figure 5.1.1).
The failure to detect a linkage association between the tapasin alleles and the 
MHC class I region probably reflects the genetic distance between the two loci 
(2Mb). Although the MHC region shows a lower recombination frequency than 
expected for a 4Mb region (2% cf 4%) (Thomsen et al., 1994) certain hotspots for 
recombination exist (Thomsen et al., 1994). Certain areas of the MHC, such 
those between HLA-B to HLA-C and DQA1 to DRB1, are almost devoid of cross 
over events whilst others show no marked disequilibria i.e. TAPI and TAP2. The 
MHC class II region between DRB1 and DQB1 almost behaves as a single 
evolutionary unit with extreme linkage disequilibria. However these alleles show 
little linkage disequilibrium with TAPI or DPB1, which are located only a short 
genetic distance centromeric of them. This has been identified as being 
secondary to a recombination hotspot that exists between TAPI and TAP2 
(Cullen et al., 1995; Klitz et al., 1995). This recombination hotspot may interfere
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Figure 5.1.1 -  Proposed ancestral tree for primate 
tapasin gene
Consideration of the exon 4 polymorphism and intron 4 
dimorphisms across human and simian tapasin sequences 
permits the construction of an ancestral for primate tapasin

with any cis linkage between MHC class I alleles and tapasin alleles. Within the 
chicken B locus this situation is very different with the tapasin gene seen within 
the class II region and located a small distance away from the class I genes. In 
retrospect the chicken MHC would have been a better genomic target for 
identifying functionally relevant tapasin MHC cis linkages.
The MHC class II linkage that I observed between DQ6 and DP*0101 with 
Tapasin*02 suggests that linkage desequiliria may exist centromeric to TAP1. 
Indeed this region has been termed the extended MHC class II region and shown 
to have a distinct isochore boundary (Stephens et al., 1999) and exhibit linkage 
between DPB1 and the KE4 region which is within 80Kb of the tapasin gene 
(Rajsbaum et al., 2002). The tapasin single nucleotide polymorphisms (SNP’s) 
may permit further linkage studies to be carried out across this extended MHC 
class II region. Previous studies have suggested an association between a TAP 
1 polymorphism (TAP 1.2) and HIV progression and suggested that this 
association was secondary to a linked gene (Kaslow et al., 1996). It would be 
now be interesting to analyse whether any of the tapasin alleles are in linkage 
disequilibrium with TAP 1.2.
The absence of further polymorphisms in the tapasin gene suggested that it may 
have a common function that could be applied to all alleles. To identify critical 
regions of tapasin that may be important for this function I choose to sequence 
primate tapasin from rhesus macaque monkeys. Sequence analysis of 4
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macaque genomic DNA samples identified 15 coding differences from human 
tapasin. This compared with more than 80 differences between human and 
mouse tapasin (Figure 5.1.2). A comparison of the residues that are different 
between primate and human tapasin reveals several that are non conservative 
and 5 which involve a charge change (Table 5.1.2).
Many approaches have been taken towards identifying important functional 
regions within the tapasin protein.
i) Lehner et al originally deleted the C terminus of tapasin to form soluble 
protein that was able to restore MHC class I expression but failed to 
co-localise the MHC class I complex to TAP (Lehner et al., 1998). This 
was subsequently corroborated by Momburg and colleagues who also 
showed that the incorporation of the other chaperones was impeded in 
the absence of the transmembrane region of tapasin (Tan et al., 2002).
ii) Bangia et al showed that the N terminus of the protein was important in 
associating with the MHC class I complex (Bangia et al., 1999).
iii) Dick et al have recently showed that the cysteine at position 95 is 
important in the formation of a mixed disulphide interaction with ERp57 
and that the abrogation of this interaction prevented incorporation of 
ERp57 in to PLC (Dick et al., 2002).
iv) Solheim and colleagues have undertaken site directed mutagenesis on 
murine tapasin and shown that a D337A, S341R or L342T change 
abrogates a tapasin MHC I class I interaction whilst a H334F and
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Mouse
Human
Monkey
Mouse
Human
Monkey
Mouse
Human
Monkey
Mouse
Human
Monkey
Mouse
1 2
MKSLSLLLAVALGLATAVS- - -AGPAVIECWFVEDASGKGLAKRPGALLLRQGPGEPPPR 
MKSLSLLLAVALGLATAVS AGPAVIECWFVEDTSGKGLAKRPGALLLRQGQGEPPPR
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* * ^ * ** .******** ^ ** **★ _********. * .#***.* * * * *
3
p d l d p e l y l s v h dP a g a l q a a f r r y p r g a p a p h c e m s r f v p l p a s a k w a s g l t p a q n c p r 
p d l d p e l y l n v h dP a g f l q a a p r r y p r d a p a p h c e m s r f v p l p a s a n w a s g l t p a r n c p r 
p d l d p k l y f k v d d p a g m l l a a f r r y p a g a s a p h c e m s r f i p f p a s a k w a r s l s p e q n c p r 
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RVRLGQDALLDLSFAYMPPTSEAASSLAPGPPPFGLEWRRQHLGKGHLLLAATPGLNGQM
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PPAQEKATAFAAWDDDEPWGPWTGNGTFWLPAVKPSQEGVYLiATVHLPYLQGQVSLELTV
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Figure 5.1.2 -  Tapasin protein comparison between 
man, monkey and mouse
The monkey tapasin differs from human tapasin at 15 sites, 
compared to over 80 for murine tapasin. The * symbol 
represents amino acid Identity and the : symbol disparity 
between man and mouse/monkey.
Exon Human (side group) Monkey (side group)
2 (l)Alanine 
(Aliphatic and NH)
Threonine 
(HydroxI and PU))
(2)Proline 
(Imino and NH)
Glutamine 
(Amide and PU)
(3)Serine 
(Hydroxyl and PU)
Asparagine 
(Amide and PU)
3 (4)Alanine 
(Aliphatic and NH)
Phenylalanine 
(Aromatic and NH)
(5)Glycine 
(Aliphatic and PU)
Aspartic Acid 
(Acidic)
(6)Lysine
(Basic)
Asparagine 
(Amide and PU)
(7)Glutamlne 
(Amide and PU)
Arginine
(Basic)
(8)lsoleucine 
(Aliphatic and NH)
Methionine 
(Aliphatic and NH)
(9)Prollne 
(Imino and NH)
Arginine
(Basic)
4 (lO)Proline 
(Imino and NH)
Alanine
(Aliphatic and NH)
(11 )Arginine/Threonine 
(Basic/Hydroxyl and PU)
Arginine
(Basic)
5 (12)Arginine
(Basic)
Tyrptophan 
(Aromatic and NH)
(13)Serine 
(Hydroxyl and PU)
Proline
(Imino and NH)
(14)Threonlne 
(HydroxI and PU)
Proline
(Imino and NH)
6 (15)Vallne 
 ^ (Aliphatic and NH) ,
Isoleucine 
 ^ (Aliphatic and NH)
Table 5.1.2 -  A comparison of the amino acid differences
between human and monkey Tapasin
There are 15 differences between human and monkey 
tapasin. Those residues with a charge change are 
highlighted In blue. Abbreviations used are NH- nonploar, 
hydrophobic and PU -  polar, uncharged.
H335Y change retains and reduces the cell surface expression of 
open form complexes (Turnquist et al., 2001).
The changes identified between human and primate tapasin are currently forming 
the targets of a tapasin mutagenesis approach to delineate further key areas of 
the protein that are important in mediating B*4402 expression.
5.2 TAPASIN AND PEPTIDE OPTIMISATION
-DEFINITIONS AND ASSUMPTIONS
The term optimisation is used within my thesis to convey the concept of a MHC 
class I peptide complex that has a peptide cargo that is able to impart an 
improved stability of the ternary complex compared to any preceding peptide 
cargo. Within this framework it is possible to compare the same heavy chain with 
the same yffaM across at a bulk level and relate changes in thermostability to the 
nature of the average peptide cargo. We can then compare similar cell lines that 
differ only in the reconstitution of a single factor that is presumed to be important 
for MHC class I peptide assembly. We must assume that the restored factor only 
influences the peptide availability/loadability and does not directly modify the HC 
oryff2M components of the complex (i.e. facilitated glycosylation/isomerisation).
In comparing one allele with another across the same cell line I have been 
cautious to highlight the sources of error (and of interpretation) in this approach. 
These have been the different inherent stabilities of the HC/ yffaM interactions in
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the peptide vacant state and the possible maximal stabilities for optimally loaded 
complexes. For both B*2705 and B*4402 early peptide binding experiments 
illustrated that both complexes could reach maximal stability (50°C) when loaded 
with optimal peptides. Therefore there was no inherent difference in the maximal 
stability that could be achieved for different complexes in the presence of optimal 
peptide. Similarly for B*4405 optimal peptide loading permitted a thermostability 
of 50°C.
The concept of peptide optimisation is not a new one (Jensen et al., 1999). 
Indeed it is a requisite for MHC Class II assembly and is believed to principally 
involve the mechanism of peptide exchange (Vogt et al., 1999). In regard to 
MHC class I assembly two principal mechanisms may be postulated. The first is 
peptide exchange and the second is ‘intra groove' peptide trimming. The results 
of my thesis suggest that tapasin is a key component in facilitating optimisation 
but the precise mechanism has not been addressed. Indeed my experimental 
work suggests that tapasin may act to improve peptide optimisation both 
kinetically and qualitatively. In the absence of tapasin all three alleles had a poor 
thermostability that improved upon tapasin reconstitution. Importantly the 
impairment of peptide supply, in the absence of tapasin, led to a further 
deterioration in the thermostability of the complexes. For B*4402 and B*2705 the 
thermostabilities converged to within 3°C of each other at T50 (temperature point 
that mediates 50% loss of w6/32 complexes). This suggests that the 
thermostability differences seen in the absence of tapasin but presence of
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peptides represent differential peptide loading of the alleles and not a lowered 
intrinsic thermo-instability in the absence of peptide. Furthermore the results 
imply that in the absence of tapasin, this degree of thermo-instability is not 
reflective of an empty molecule, as it may be further impaired by preventing 
peptide supply. Thus, in the case of BM402 its thermostability profile in the 
absence of tapasin can be seen to reflect either a currently peptide occupied 
state (suboptimal) or a previously peptide occupied state. This latter idea is at 
present only a possibility that is consistent with the data and has not been further 
evaluated. It is possible that in the absence of tapasin, B*4402 is able to load an 
initial peptide and that this complex is transitory but imparts a change in the 
thermostability of the complex. The lowered thermostability of B*4402 in the 
ICP47 transfected cells would then be more likely to represent a truly empty and 
never previously occupied complex. In considering the first option of suboptimal 
peptide occupation, two further considerations must be taken into account. The 
first is that such a peptide occupied complex is excluded from ER export. 
Therefore we have indirect evidence that a MHC class I complex that is occupied 
by peptide may be subject to quality control at a pre cis-golgi level (all endo H 
sensitive). The second point is that if B*4402 has the inherent ability to load with 
peptides why doesn’t it behave like B*4405 and B*2705 which also show a 
similarly low initial thermostability? I suggest that this relates to the abilities of 
the other alleles to optimise their peptide repertoire independently of tapasin.
This property is intrinsic to the alleles and represents (for me) the defining feature 
of tapasin dependent and independent allelism. However for both B*4405 and
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B*2705 their optimisation is kinetically and qualitatively enhanced in the presence 
of tapasin. Therefore I do not believe that they are entirely tapasin independent 
alleles. Instead I would consider them to be independent of tapasin for some 
degree of optimisation but dependent upon tapasin for maximal optimisation. On 
the other hand B*4402 is entirely dependent upon tapasin for any degree of 
optimisation. These initial observations may be furthered by considering the 
following experimental questions. Would B*4402 with a T134K mutation optimise 
in the presence of tapasin (i.e. unable to interact with PLC)? Would a single 
chain dimer (B*4402 HC/ complex optimise in the absence of tapasin (i.e. 
increased peptide receptive complex concentration)? Would a single chain trimer 
(B*4402 H C /^ 2M/optimal. peptide) be independent of tapasin. I am currently 
exploring such approaches to see if peptide acquisition by B*4402 is truly tapasin 
dependent or whether it is optimisation of the peptide repertoire that tapasin is 
required
For B*2705 there was an improvement in thermostability over time in the 
absence of tapasin. This was seen to a lesser degree with BM405. This tapasin 
independent optimisation appears to be a critical factor as it continues to improve 
during the period of the pulse chase examinations and the cell surface stability of 
B*2705 was comparable to that of the B*2705 complexes in tapasin competent 
cells (by radioiodination). This tapasin independent optimisation may also 
operate through peptide exchange or trimming. A third possibility is that the 
changing thermostability reflects a biophysical change in the molecule. This idea
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is borrowed from the MHC class II field where single peptide occupied MHC 
class II complexes can change their stabilities over time (Sadegh-Nasseri et al., 
1994). The molecular mechanisms underlying this are not clear but may relate to 
an intramolecular rearrangement of the complex or reconfiguration of the bound 
peptide into a registry that is more thermostable (Belmares et al., 2003). These 
processes are highly speculative but are not discounted by the presented data. 
Indeed, whilst it has been possible to argue that peptide exchange and trimming 
are the dominant processes driving optimisation within the ER, B2705 continues 
to improve its thermostability profile after it has left the ER. This is certainly 
apparent between 60 minutes and 120 minutes in the absence of tapasin. Whilst 
peptide exchange and/or trimming has been described post ER (Gil-Torregrosa 
et al., 1998), it is intriguing that this appears to further improve upon the 
optimisation undertaken in the ER where most of the quality assurance 
molecules and processes are focused. Trans golgi trimming of peptides by furin 
has been shown by De Val and colleagues to provide peptides for MHC class I 
complexes (Gil-Torregrosa et al., 2000). Similarly MHC class I peptide exchange 
has been described to occur within the endosome for some MHC class I 
complexes (Gromme et al., 1999; Stryhn et al., 1996). The relative contribution 
of peptide optimisation occurring outside the ER is an important area that has as 
yet received little attention. It will be interesting to dissect the contributions of 
these possibilities with experiments on alleles that are prevented from accessing 
endosomal compartments (tail mutants/endocytosis inhibition), trapped in a post
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golgi/pre cell surface environment (CD99 null cells), or following protease 
inhibition (i.e. furin inhibition).
THE' ON AND OFF TAP' FOR PEPTIDE LOADING 
When tapasin function is restored there is a marked improvement in the 
thermostability of all 3 alleles. This is most marked for B*4402 with 50°C stability 
seen for 100% of the loaded complexes. There are 3 important observations to 
consider when comparing the thermostability profiles in the presence and 
absence of tapasin.
i) The degree of thermostability achieved by the individual alleles.
ii) The kinetics of thermostability attainment by individual alleles.
iii) The variation in thermostability seen across the different alleles.
For B*4402, there is maximal 37°C stability at 30 minutes and maximal 50°C 
stability at 120 minutes. This would imply that all complexes have bound a 
peptide of a relatively high affinity during this time period and is in stark contrast 
to that seen in the absence of tapasin at any time point. This improved peptide 
cargo at 30 minutes is also present at 15 minutes when the majority of 
complexes are endo H sensitive and thus proximal to the medial golgi. The 
ability of tapasin to influence this enhanced thermostability may be through a 
number of different direct and indirect effects. As the keystone of the PLC, 
tapasin may simply recruit the peptide receptive (or sub optimally loaded 
complex) to the PLC where ERp57/CRT and enhanced peptide availability 
mediate an improved peptide selection (Momburg and Tan, 2002). The
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individual contribution of tapasin to such a cooperative assembly is difficult to 
dissect. It is possible to return peptide supply to normal without co-localising the 
MHC I class I complex to the PLC (N terminal deletion of tapasin) (Bangia et al., 
1999). Similarly it is possible to remove tapasin from the TAP based PLC (C 
terminal deletion of tapasin) (Lehner et al., 1998; Tan et al., 2002). When the 
former of these was undertaken there was no improvement in optimisation. This 
suggests that the ability to influence TAP level and peptide transport is not 
directly relevant to the optimisation observations made in this human EBV 
transformed B cell model (in contrast to mouse tapasin deficient cells (Grandea 
et al., 2000) (Garbi et al., 2003)). However when soluble tapasin was 
transfected, a significant change in the thermostability profile of B*4402 was 
seen. Although the stability at the end of the chase period was comparable to full 
length tapasin at 37°C, it was reduced at 50°C. Additionally there was no loss of 
4°C material in the presence of soluble despite not all complexes being 37°C 
stable. Thus soluble tapasin was able to permit optimisation for B*4402 but the 
extent of this process was less than that of full length tapasin. This may relate to 
a need to be near the TAP complex from optimal peptide selection, the reduced 
affinity of class I for soluble tapasin, a differential recruitment of chaperones by 
soluble tapasin or even an impaired trimming when MHC class I is not part of the 
PLC complex. However it is important to note that the inability of B*4402 to 
become properly loaded with optimal peptide in the absence of tapasin was 
restored with soluble tapasin without any effect upon peptide supply. This is an 
important observation as it suggests B*4402 peptides are present in the absence
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of a TAP/tapasin complex but cannot be utilised for BM402 (in contrast to 
B*2705) in the absence of tapasin. Therefore tapasin can be considered to have 
at least 2 functions. One is to co-localise MHC class I to the PLC and the other is 
to promote peptide stabilisation and optimisation of the MHC class I complex. 
This optimisation is maximal when both functions are coordinated. Consideration 
of the work of Momburg and colleagues is relevant at this juncture (Tan et al., 
2002). They looked at the expression of B*4402 in the presence of a soluble 
tapasin construct and focused upon the chaperone associations. They were able 
to identify tapasiniMHC class I complexes that were not bound to calreticulin or 
ERp57. They were also able to show that B*4402 was associated with an altered 
peptide repertoire, with a number of different assays, but total cell surface 
expression of B*4402 was normal. Therefore the optimising function of tapasin is 
unlikely to be the ability to facilitate the cooperative assembly of the other 
chaperones on TAP. This action may be a composite of optimal chaperone 
recruitment plus an additional function which has not yet been clearly identified. 
This additional function may relate directly to peptide exchange, peptide trimming 
or an action upon the MHC class I complexes to make it more receptive to the 
above processes.
POST ER OPTIMISATION
The kinetics of optimisation are different between soluble and full length tapasin, 
with soluble tapasin facilitating maximal 37°C stability at 120 mins compared to 
30 mins for full length tapasin. What is interesting is the observation that 50°C
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stability, whilst quantitatively different for both, plateaus between 30 and 60 
minutes and then further improves for both alleles between 60 and 120 minutes. 
This is the time period when the majority of complexes have left the ER. 
Therefore I would suggest that there are 2 phases of optimisation and improved 
thermostability. The first is within the ER and may be entirely tapasin dependent 
for certain alleles. For alleles such as B*4405 and B*2705 tapasin independent 
optimisation may occur. In the presence of tapasin such alleles have the choice 
of utilising or bypassing the tapasin dependent optimisation process. In 
comparing the profiles of B*4402 with those of B*2705 and B*4405 in the 
presence of tapasin, it may be suggested that the poorer profiles of the latter two 
alleles (lower 50°C plateau) is a result of both tapasin independent and 
dependent ER processes being used. The former complexes may be of a poorer 
affinity leading to a reduction in the net thermostability of those alleles. The 
second phase of optimisation would appear to be post cis-golgi and contribute to 
the conversion of 37°C stable to 50°C stable complexes. The nature of this 
process would appear to be operating for all alleles in the presence of tapasin 
(and to a similar relative degree) but only for B*2705 in the absence of tapasin. 
Whilst tapasin-facilitated optimisation (Opt 1) prevents complex loss within the 
ER and promotes the rapid attainment by empty complexes of 37°C stability, later 
optimisation (Opt 2) permits a further improvement in the peptide loaded 
material. This division of optimisation is the starting point for the analysis of what 
would appear to be different processes of MHC class I complex peptide 
optimisation.
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MECHANISMS OF OPTIMISATION
For optimisation 1 tapasin may act in a number of ways.
1 ) Tapasin as a peptide exchange catalyst
Tapasin may act like HLA-DM upon low affinity occupied class I complexes and 
destabalise suboptimally loaded MHC class I complexes. This ‘destructive’ 
approach may be secondary to an interaction with the MHC class I complex that 
is permissible when suboptimal peptide is present but not inhibited when optimal 
peptide is bound. Such a mechanism would appear to require a structural 
difference between the sub-optimally loaded and optimally loaded complex to 
enable tapasin to distinguish between the variants. Such differences have not 
been identified through crystalisation studies on extended peptide MHC class I 
complexes (Khan et al., 2000) or short peptide MHC class I complexes (T Elliott 
.unpublished observations). If there is no structural difference between peptide 
occupied complexes of differing stabilities perhaps tapasin acts upon conserved 
peptide/MHC class I interactions and that this association promotes 
destabalisation of the peptide MHC class I complex. If for example tapasin 
interacted with the MHC class I complex and this interaction destabalised the 
peptide-MHC class I interaction, peptide release may be precipitated. The 
likelihood of peptide release would then relate to the inherent stability of the 
peptide MHC class I interaction and the kinetics of the interaction. Such a 
peptide release mechanism may be dependent upon a tapasin induced 
conformational change in the MHC class I structures which would not be
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identified in crystalisation approaches to MHC class I structures. Such a 
conformational change may be secondary to the destruction of certain key 
peptide main chain/MHC class I groove hydrogen bonds and the establishment 
of a open peptide receptive conformer, as has been suggested for HLA-DM 
(Mosyak et al., 1998). Although this proposed action would form the basis of a 
molecular mechanism to explain an iterative improvement in selected peptides, it 
does not explain why B*4402 is unable to sample its high affinity peptides in the 
absence of tapasin.
2) Tapasin as a peptide trimming facilitator
At present, there is no experimental evidence on the role of tapasin and ER 
aminopeptidase activity. The recent identification of ERAP as an important 
trimmases of MHC class I peptides will now allow such an assessment. It is 
conceivable that tapasin promotes N terminal trimming indirectly through 
recruitment of ERAP to the PLC or directly through a cooperative action with 
ERAP. Again the inability of B*4402 to load with peptides in the absence of 
tapasin within this conceptual framework would suggest that the majority of 
B*4402 peptides are extended or do not have canonical anchors and thus are 
poorly loaded. The change in the thermostability between ICP47+/- cell lines 
may support such a proposal as the difference between the cell lines would 
reflect the loss of extended peptides. It may then be hypothesised that 
220/ICP47 complexes are empty and transport-incompetent 220 complexes 
occupied with suboptimal peptides are transport-incompetent, and 220/tapasin 
complexes being optimal and transport-competent. This supposition will require
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further examination but I think it unlikely for the following reasons. ERAP has 
been shown to be most essential to the mouse allele which has a preference 
for proline at P2. As proline at this position is poorly transported by TAP, 
extended peptides are preferentially transported for this allele. B*4402 has no 
such restriction. Furthermore when ERAP is knocked down in cell lines the 
degree of downregulation is greater than that seen in the absence of tapasin 
(Serwold et al., 2002). A dependence upon tapasin for trimming would predict a 
comparable or worse phenotype in the absence of tapasin. However the 
contribution tapasin makes towards a trimming process may account for the 
improved optimisation profiles seen for B*2705 and B*4405. The N terminal 
extension of a single amino acid can reduce the thermostability of a complex 
considerably and this may have an important impact upon the final stability of the 
MHC Class I peptide complex (Cerundolo et al., 1991; Dedier et al., 2000).
3) Tapasin as a 'doorman' for the MHC class I complex 
Tapasin may act to prepare (hold open the door) the MHC class I complex for 
peptide acquisition. It may also return a complex that has undergone a 
conformational change after binding a suboptimal peptide to a peptide receptive 
form (open the door again). Furthermore it may select which peptides permit 
groove closure by altering the triggering threshold of the open complex such that 
energetically disfavourable suboptimal peptide induced groove closures are 
avoided (offering the revolving door for unwanted visitors). Although 
hypothetical, such a mechanism may account for allelic differences in the 
dependence of tapasin for peptide loading. Alleles such as B*4402 may undergo
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groove closure with suboptimal peptides (low threshold) and require assistance 
to reopen and try again. Alleles such as B*2705 may have a higher threshold 
and only trigger closure with peptides that permit more favourable hydrogen bond 
interactions or have the intrinsic ability to return to a peptide receptive 
conformation in the absence of chaperone assistance. We have previously 
likened this to a Venus fly trap where closure of the plants leaves only occurs 
when sensitive hairs at the base of the trap and at some distance from one 
another are touched two or three times, offering a means of kinetic proofreading 
(Williams et al., 2002). This composite signal for closure, ensures that larger 
insects are caught rather than the smaller insects that would only trigger one or 
two areas of the plant base. This ’quality control’ is important as this process is 
energetically costly, as the plant is unable to return to a functional open form for 
a further 3 days following closure. HLA-DM has also been postulated to have a 
stabilising function on the MHC class II complex, facilitating the maintenance of a 
peptide receptive complex. It is not clear at a molecular level how this operates 
and whether a continued interaction or transient interaction with the MHC class II 
complex is required (Pashine et al., 2003). It is intriguing to speculate that 
convergent evolution may occur and that such processes may be conserved 
across antigen presenting molecules and may even involve comparative systems 
for glycolipids/CD1 associations
4) Tapasin as a ‘conformational catalyst’
One assumption that is made in the interpretation of increasing thermostability 
being representative of an evolving peptide repertoire is that there is no other
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factor that improves the thermal dénaturation characteristics of the MHC class I 
peptide complex. In the presence of tapasin it may be argued that the improved 
thermostability represents a facilitated foldase activity upon a peptide occupied 
complex that improves its cooperative stability (Li et al., 1997). I think this is 
unlikely for a number of reasons. Firstly it has been previously demonstrated that 
peptide alone alters the cooperative stability of the ternary complex within in vitro 
systems (Cerundolo et al., 1991; Elliott et al., 1991; Parker et al., 1992).
Secondly the B*2705 complexes show an improvement in thermostability in the 
absence of a tapasin interaction. Thirdly the alleles can be seen to improve their 
thermostability at a time period when they would not be expected to be in contact 
with tapasin. However, again with reference to HLA-DM, it has been argued that 
DM facilitates the evolving stability of MHC class II complexes through its action 
as a conformational catalyst (Verreck et al., 2001 ; Zarutskie et al., 2001 ). Further 
definitive work in this area requires the preparation of a recombinant tapasin 
which has currently eluded all investigators.
For optimisation 2 ,1 see three possibilities that may operate beyond the ER. The 
first is peptide exchange, probably occurring within an endosomal or cell surface 
location (Schirmbeck et al., 1995; Schirmbeck and Reimann, 1996). What is 
difficult to explain within this context is how B*4402 is able to undertake such an 
exchange independent of tapasin outside of the ER when it was unable to 
achieve this in the absence of tapasin within the ER. Recent studies have 
suggested that a tapasin facilitated loading is necessary for subsequent vacuolar
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presentation to occur (Chefaio et al., 2003). Therefore optimisation 2 may be 
tapasin independent but tapasin is needed to get B*4402 molecules out of the 
ER. The environment of the endosomes may then permit tapasin independent 
peptide exchange. What factors promote or inhibit peptide exchange in the 
endosomes and ER respectively in the absence of tapasin requires further 
investigation. The second possibility is one of ongoing peptide trimming that 
occurs en-route to the cell surface or when the complexes are undertaking their 
cell surface-endocytic cycle. (Gromme and Neefjes, 2002; Schirmbeck and 
Reimann, 2002). Experimental inhibition of these processes may be possible to 
further refine this concept. Finally the same peptide complex may undertake a 
conformational change which imparts an enhanced thermostability profile upon 
the complex. The final stability of the complex will be the product of the initial 
peptide and the enhanced stability conferred upon the ternary complex by such a 
conformation change. Whether such a ‘twist’ exists is currently hypothetical but 
may now be addressed through the examination of trimeric single chain 
constructs that only have a single optimal peptide (Yu et al., 2002). These 
complexes would be expected to have an identical thermostability profile 
throughout their ontogeny as they have a covalently attached optimal peptide. 
Examination of such complexes within cells may provide valuable information of 
the nature of optimisation 2.
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5.3 DM -  COMPARISONS AND CONTRASTS
The work presented in my thesis draws many parallels with previous work 
undertaken on the MHC Class II chaperone HLA-DM (DM). DM is encoded 
within the MHC class II locus and has been shown to be non-polymorphic. Its 
crystal structure has been solved and shown to have a similar fold and domain 
structure to that of classical MHC class II molecules (Fremont et al., 1998; 
Mosyak et al., 1998). Importantly DM contains two novel disulphide bonds in the 
region homologous to the peptide binding site of DR and possesses none of the 
pockets for binding the side chains of peptides. In DM, the a helices 
corresponding to the ‘sides’ of the peptide binding groove of classical class II 
complexes contact each other, precluding peptide binding . The crystal structure 
of tapasin has not been solved and modelling of its structure has shown closest 
phylogeny with that of a MHC class I structure. This modelling has been 
extended by Jan Klein to suggest that tapasin may have a structure of a modified 
MHC class I molecule, once again drawing a comparison with DM (Mayer and 
Klein, 2001). These comparisons at best tentative and we await the crystal 
structure of tapasin with interest.
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Tapasin appears to be multifunctional for MHC class I assembly.
1. It is clearly needed to stabilise TAP (Garbi et al., 2003) and this is 
dependent upon the transmembrane region of the molecule (Lehner et al., 
1998).
2. It is absolutely required to permit assembly of the MHC/ /ffaM 
heterodimer/calreticulin/ERp57 complex at the TAP interface. In the 
absence of tapasin, MHC class I complex binding to calreticulin is 
reduced. Certain alleles (such as HLA-A2) cannot be co- 
immunoprecipitated with calreticulin (Lewis et al., 1998), whilst other 
alleles such as HLA-B27 and can be identified using sensitive 
immunoprécipitation and western blot protocols (Harris et al., 2001 ;
Paquet and Williams, 2002).
In addition to these two functional properties there is much discussion with 
regard to other proposed roles. I would like to suggest from my work that tapasin 
has an important role in optimising the repertoire of peptides bound to MHC class 
I complexes. This property is in addition to that of peptide supply and MHC class 
I co-localisation to the PLC as evidenced by the soluble tapasin experiments.
This peptide optimisation is reminiscent of the role DM plays in MHC class II 
assembly. Before considering the way in which tapasin mediates peptide 
optimization let us consider the experimental data accrued on DM peptide 
optimisation.
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The role of DM in peptide editing was first described in 1995 by Denzin and 
Cressweil (Denzin and Cressweil, 1995). Using imuno-purified DM, DR and a 
specific reagent for suboptimally loaded DR (CerCLIP) they identified 2 key 
features of DM function. The first was that it liberated CLIP from the suboptimally 
loaded DR and that it permitted peptide loading at the appropriate pH of the 
MHO. Furthermore, when compared to a detergent that liberated CLIP and 
permitted peptide exchange it was shown to improve upon the rate and efficiency 
of such loading compared to this detergent. This was furthered in 1996 by the 
experiments of Weber and Jensen (Weber et al., 1996). They showed that DM 
was able to dissociate other peptides from DR and that the enhancement of DM 
mediated dissociation was directly proportional to the intrinsic dissociation rate of 
the peptide. Work by Kropshofer and Hammerling identified an important 
influence of PI anchor mutants of the haemagglutinin (HA) peptide for a DR/DM 
interaction (Kropshofer et al., 1996). They suggested that suboptimal residues at 
the PI anchor position may be a key molecular signature for DM interaction. 
Allelic differences in DM dependence were noted with the mouse allele l-E*^  
showing little dependence upon DM for peptide loading (Wolf et al., 1998). A 
model for DM activity has been proposed whereby DM may selectively disrupt 
hydrogen bonds between the MHC class II molecules and the main chain atoms 
in the bound peptide. Peptides with optimal anchor residues remain relatively 
stable whereas those with suboptimal anchors (such as CLIP) dissociate. 
Publication of the structure of DM in 1998 provided further support for a model in 
which DM acts to break (or compete for) hydrogen bonds between the MHC
131
class II molecule and bound peptide near the peptide N terminus at P1.
Hydrogen bonds between CLIP and DR3 involve important contributions from 
Histidine (H/His) yff81 and Serine (S/Ser) a53 of DR3. These resides are outside 
of the binding groove and were candidates for an interaction with the lateral 
surface of DM. Initially it was postulated that the DMor chain tryptophan (W/Trp) 
a62 of DM might interact with the Phenylalanine (F/Phe) a51 of DR3 and move 
the neighbouring Ser #53, thereby breaking 2 conserved hydrogen bonds at P-2 
and P-1 (Mosyak et al., 1998). A further interaction with His of DR3 may 
distort the third hydrogen bond of PI (Figure 5.3.1). However more recent 
mutagenesis studies have shown that D61R and W62A mutations in DM# do not 
impede the function of DM whereas mutations in a conserved cluster of acidic 
residues in DM f^f severely impaired both CLIP release and peptide binding 
(Pashine et al., 2003). Interestingly, MHC class II structural comparisons have 
shown that l-E^ has a shallow PI pocket and this may relate to its difference 
upon DM dependence (Fremont et al., 1996). These ideas have been extended 
by the groups of Sant, McConnell and Sadegh-Nasseri. Sant and colleagues 
analysed the murine class II molecule l-A^ which bound peptides in the absence 
of strong pocket interactions. A single mutation at His yff81 showed that 
disruption of a single hydrogen bond severely impaired the stability of the peptide 
MHC complex (Arneson et al., 2001 ). The allele l-A*^  was subsequently 
examined as, in contrast to l-A^, it engaged peptides through strong pocket 
interactions. An identical Hisyff81 mutation led to rapid degradation of the 
complex compared to wild type (McFarland et al., 1999). This could be
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5.3.1 -  Speculative molecular mechanism of action 
of HLA-DM on HLA-DR
DM may act upon the residues of the DR groove to 
break important hydrogen bond networks between 
the peptide and a/p chains of the class II 
molecule (-1 ,-2,P1 ). This may then favour liberation 
of the peptide from the binding groove
prevented by stabilisation with high affinity ligand but an association with DM 
could not be identified. Work by Sadegh-Nasseri and McDonnell suggested that 
empty class II complexes could exist in at least 2 conformations (Sadegh-Nasseri 
and McConnell, 1989). The first conformation was peptide receptive and was 
that seen immediately after peptide/CLIP dissociation. In the absence of peptide 
binding it would rapidly convert to a second conformer that was resistant to 
peptide binding. This second isomer slowly converted to the peptide receptive 
form overtime (Sadegh-Nasseri and Germain, 1991; Sadegh-Nasseri et al., 
1994). Work by McConnell suggested that an importation function of DM was to 
maintain the class II complex in the peptide receptive conformation (Rabinowitz 
et al., 1998). Sadegh-Nasseri has further suggested that DM may favour the 
conversion of the peptide non-receptive conformer to the peptide receptive 
conformer. Finally, Stern and colleagues have proposed that DM has an 
important role post peptide acquisition (Zarutskie et al., 2001). They have 
followed up on the work of Sadegh-Nasseri et al who had shown that MHC class 
II single peptide complexes were more stable the longer they were in contact with 
each other and that the initial MHC peptide complex (MHCpep^) may progress 
over time to a more compact and stable complex (MHCpep^). Stern and 
colleagues have proposed that DM acts as a conformational catalyst to promote 
the conversion of MHCpep^ to MHCpep^ Furthermore they showed through UV 
circular dichroism, gel filtration and hydrodynamic radii estimation that conversion 
from an empty to a conformed state may occur with a variety of partial groove 
occupancies. These conformational states show loss of antibody recognition for
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an open form of class II, increased thermostability and different dichroism 
spectra. These same changes may be induced through occupation of only the 
P1 pocket or P5-P9 regions. However, only when all interactions are optimum is 
there maximal dichroism, thermal stability and SDS stability. Such overlapping 
interactions that promote the conversion to a compact form may be analogous to 
those occurring in the transition of an optimally peptide loaded MHCpep^ to 
MHCpep^ complex (Figure 5.3.2).
How similar is tapasin to DM in its functions within MHC class I assembly? 
Notable differences include the belief that MHC class I complexes do not have a 
CLIP equivalent and that peptide vacant complexes are all peptide receptive. 
However suboptimal peptide loading has been proposed as an important initial 
event in MHC class I assembly, perhaps acting in an analogous manner to CLIP 
(Lewis and Elliott, 1998). My work would support the existence of a suboptimally 
loaded MHC class I complex that may precede the loading of optimal peptides. 
The thermostability differences seen between B*4402 and B*2705 +/- ICP47 
would be consistent with suboptimally loaded complexes that may subsequently 
change their peptide cargo. Prior to the start of my experimental work it was 
suggested that tapasin associates with peptide receptive complexes that are 
devoid of peptide and mediates a loading advantage for peptide that had been 
previously available but not utilised. This facilitated loading process appeared to 
occur equally well when MHC class I and tapasin were not bound to TAP and 
therefore not dependent upon a high local concentration of peptide. However as
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5.3.2 - Proposed actions of HLA-DM
1 -  Release of CLIP ; 2 -  Maintenance of class II complex in 
a peptide-receptive confirmation: 3 -  Conversion of empty 
non-receptive class II complex to the peptide-receptive conformer: 
4 -  Loading of peptide and conformational change to a compact 
stable class II complex
shown by my work (and that of others (Tan et al., 2002)) the bridging function to 
TAP does convey a different repertoire of peptides upon that allele. This 
advantage is not simply due to enhanced availability of peptides but due to the 
ability of tapasin to optimally direct peptide loading when associated with the 
PLC. The inability to load previously available peptides is most clearly seen for 
the mouse H2-M3 allele and HLA-G (Chun et al., 2001; Park and Ahn, 2003). In 
these experiments high affinity peptides are not bound by the alleles in the 
absence of tapasin. Such complexes remain in a compartment proximal to the 
medial golgi mannosidase enzymes and do not exit until they are furnished with 
such peptides. Despite their inability to load high affinity peptides that may 
liberate them from the ER, their ER half lifes are much longer than similar 
conformed complexes in peptide transport incompetent cells. This raises the 
intriguing possibility that these complexes are or have been loaded with 
suboptimal ligand and that such an interaction permits an MHC class I extended 
lifespan, allowing for the eventual capture of an optimal peptide. My work 
suggests that B*4402 is not devoid of peptide in 721.220 as its thermostability is 
further reduced in the presence of an ICP47 blockade of peptide transport. This 
is akin to the nonclassical allele associations above, requiring tapasin to permit 
loading of available high affinity peptides. Experiments using an N terminal 
deletion of tapasin that is able to restore maximal TAP transport but is still unable 
to support B*4402 expression, argue against peptide availability as an alternative 
reason for poor loading. How could tapasin be mediating this loading? With 
analogy to DM, tapasin may bind to MHC class I complexes that have a
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suboptimal ligand. Tapasin may then permit liberation of the suboptimal ligand. 
Two new considerations arise from this idea. The first is that previously occupied 
MHC class I molecules may exist in 2 forms, one of which is peptide receptive 
and the other of which is not. Tapasin may influence this ratio and stabilise 
peptide receptive forms in a way proposed for the action of DM in promoting an 
ap* form that can be readily loaded (Rabinowitz et al., 1998). The second 
consideration is that tapasin may ‘fix’ on a structural motif such as exposed 
hydrophobic residues or a signature motif such as a glycosylation signal for a 
molten globule state. With regard to these considerations:
1) There is notable allelic variance in the association of MHC class I
molecules with tapasin. This has been observed with natural variants and 
selected mutants (see Section 5.4) and has focused principally on position 
116. My work with B*4405 is consistent with this pattern where this 
residue determines the tapasin dependence of loading. Thus the 
configuration of the F pocket may be a signature for tapasin binding. It is 
possible that certain alleles have an F pocket configuration which 
promotes a peptide receptive conformation and does not require tapasin 
to stabilise such a conformer. Alternatively, tapasin dependent alleles 
may have a different F pocket configuration which favours a peptide 
induced conformational change even following transient peptide 
occupancy (Fig. 5.4.2). Tapasin dependency may then relate to the 
property of tapasin to target such alleles that are of a peptide non 
receptive conformation and return them to a peptide receptive state. This
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would be analogous to DM promoting an oryff'-» c/yg* conformer for peptide 
loading in class ii assembly. Alternatively such tapasin dependent alleles 
may have a binding groove anatomy that is relatively difficult to induce into 
conformational change with suboptimal peptide. Tapasin dependent 
alleles such B*4402 may undergo a conformational change that is 
dependent upon F pocket interaction/peptide interaction even when other 
pocket/peptide interactions are unfavourable. Experiments with the 
mouse allele D^ and the peptide FAPGYNYPAL lend some support to this 
idea ( Elliott and colleagues, unpublished observations). Truncated 0  and 
N terminus peptides (FAPGY and NYPAL) have differential effects upon 
the conformational changes of D^. Within in vitro assembly assays both 
‘half peptides’ are required to drive a conformational change in D  ^ that 
allows for immunoprécipitation by a conformationally sensitive antibody. 
However the C pocket directed suboptimal NYPAL peptide is able induce 
a full conformational change in D  ^when co-crystalised with D*^ . The 
structure of the suboptimally loaded complex is almost identical to that of 
the optimally loaded D  ^complex apart from the occupation of the N 
terminus pockets with water and glycerol. This may be likened to the 
properties of a Venus fly trap as mentioned earlier where the apex of the 
trap should not be triggered by small prey, requiring multiple signals from 
the ‘groove’ to induce a productive closure. Position 114 contributes to 
the groove residues of the F and E pockets and it will be interesting to see 
whether this alters the configuration of the empty class I structure between
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the 2 molecules. The approach of Sadegh-Nasseri and colleagues with 
the MHC class II DR3 allele is interesting with regard to these pocket 
changes. They engineered a DR3 complex with a shallow P1 pocket 
which is predicted to be a poorer target for DM despite the inability to load 
stabilising peptides (Natarajan et al., 1999). Indeed this DRI^GssY mutant 
has a number of interesting properties that are relevant to the class I 
alleles B*4402/*2705 and B*4405. Firstly the empty complex has an 
improved midpoint of thermal dénaturation compared to wild type ( 72°C 
vs. 65°C) and also showed improved SDS stability, an assay format 
previously considered representative of stably occupied complexes (Sato 
et al., 2000). Further work has suggested that SDS stability reflects the 
degree of exposure to SDS of hydrophobic residues in the PI pocket. It is 
speculated that DM acts through conformational recognition of a ‘floppy’ 
class II configuration and that this is representative of class II that is empty 
or loosely bound to peptide in the PI pocket (Chou and Sadegh-Nasseri, 
2000). In the case of the DRI^GSGv mutant, the PI pocket is made 
artificially ‘rigid’ and therefore, despite a low affinity peptide load, it is not 
seen by DM. Whether an analogous process is occurring within the F 
pocket of MHC class I complexes is intriguing. It would be interesting to 
measure the thermostability of the 114 mutant complexes made in the 
absence and presence of a supply of peptides. My predication would be 
that the B*4402D114H would be more thermostable than B*4402 within an
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ICP47 transfected cell line, maintaining a peptide receptive form and with 
a reduced tendency for conformational change with suboptimal peptides.
2) The second consideration is whether tapasin has specific recognition of a 
signature motif within the MHC class I complex and whether glycosylation 
at position 8 6  in the HC is important for this recognition. Interesting 
studies on murine class I have shown that inhibition of deglucosylation 
(through castanospermine [CAST] treatment) traps MHC class I 
complexes onto tapasin (van Leeuwen and Kearse, 1996). Furthermore 
studies by Sadasivan and colleagues showed that CAST prevented 
human MHC class I association with tapasin but did not impair 
heterodimer formation (Sadasivan et al., 1996). It was initially postulated 
that this may relate to an inability to bind a Glci residue to calreticulin 
which is required prior to tapasin association. An alternative is that tapasin 
requires a Glci signature for association. Recent work has shown that 
tapasin association with TAP and class I is not affected in the absence of 
calreticulin (Gao et al., 2002). Furthermore in the absence of tapasin a 
MHC/ yff2M /calreticulin association is very difficult to see (Harris et al.,
2001 ). It is therefore possible that the Glci motif in the a1 domain of class 
I is a marker of an incompletely folded complex and that tapasin is able to 
register this and initiate binding with subsequent recruitment of calreticulin 
to this N8 6  monoglucosylated conformation. If a peptide binds to the 
complex a conformational change may occur which lowers the affinity of 
calreticulin for the heterodimer. Glucosidase II may then trim the
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monoglucosylated glycan upon the PLC and prevent its re-association 
with calreticulin, permitting the release from tapasin and the PLC. If this is 
not possible, calreticulin may rebind to the PLC and stabilise the peptide 
loaded complex on the PLC. A projection of this concept is that PLC 
associated class I in calreticulin knock out cell lines should be more 
transiently associated with tapasin. The faster trafficking rate of in the 
absence of calreticulin would support this prediction. Tapasin dependent 
alleles that are engineered to lack an N8 6  glycan (B*4402-/-/-) or that are 
trapped in a Glcs state (B*4402 +CAST) may fail to utilise tapasin 
facilitated loading due to inability to associate with the peptide loading 
complex. Studies by Salter and colleagues showed that a B*0702 S8 8 A 
mutant which is non glycosylated fails to interact with calnexin and is 
expressed on the cell surface at 50 % of wild type (Zhang and Salter, 
1998). Targeted experiments that selectively inhibit glucosidase II (butyl- 
deoxynojirimycin) or impair UGGT (RNAi) may offer new approaches to 
these questions.
Finally, does the suggestion that DM may act as a conformational catalyst have 
relevance to the mechanism of action of tapasin? A seminal study by Sadegh- 
Nasseri examined the stability of recombinant DR1 complexed with a 
radiolabelled peptide. The study showed that there existed both a fast on/off and 
slow on/off interaction with the same peptide. Furthermore the conversion to a 
slow on/off rate complex was time dependent, changing from a DR1 :peptide t i /2
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of 10 mins following 10 mins incubation to 140hr after 96 hours incubation. It 
was postulated that peptide bound MHC class II complex could exist in 2 
conformers, one compact and stable and the other flexible and unstable. 
Subsequent work by Stern and colleagues suggested that DM acted to convert 
the peptide bound intermediate (MHO-pep^) to the more compact stable form 
(MHCpep). It was argued that DM acts to stabilise the transition intermediate, 
thereby favouring interconversion. A further complication has been recently 
proposed by McConnell and colleagues who have suggested that DM can 
differentially catalyse a CLIP peptide DR*0404 complex with regard to 2 isomers 
having different peptide registries within the peptide binding groove. A second 
interpretation is that each registry imparts a conformational change which does 
not change the monophasic dissociation of the complex at pH7 but does provide 
a signature for DM mediated biphasic dissociation at pH5. Does this have any 
relevance to the actions of tapasin? The observation that B*4402 can undergo a 
time dependent improvement in its thermostability requires a consideration of this 
phenomena. Although peptide exchange and peptide trimming are the most 
likely explanations for this improvement a tapasin facilitated conformational 
mechanism should be considered. The interconversion of MHC-pep^ to MHCpep 
complex following tapasin assisted loading may account for the improved 
thermostability profile post ER egress. Schmidt and McConnell have reported 
such a peptide class II complex whose conformer shows differential sensitivity to 
DM mediated dissociation at pH5.3 but identical dissociations at pH7 (Schmitt et 
al., 1999). More recently Hammerling and colleagues have identified a DR/CLIP
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complex that shows differential reactivity with an antibody in the presence or 
absence of DM. It was suggested that this conformation was independent of 
peptide but dependent upon a prior interaction with DM (Verreck et al., 2001). 
Previous studies by McCluskey and colleagues on B*2705 and Momburg and 
colleagues on B*4402 have demonstrated differential antibody reactivities 
between tapasin competent and incompetent cells (Purcell et al., 2000; Tan et 
al., 2002). It is probable that these represent different peptide repertoires but it 
will be interesting to look at such cell lines with peptide specific antisera to see if 
there are possible conformational differences in bound complexes in the absence 
or presence of tapasin.
Therefore the role of tapasin in MHC class I assembly is analogous to HLA DM in 
many ways. It is multifunctional, allele dependent, non-polymorphic and 
improves the rate and extent of MHC stability. Whether it can release suboptimal 
ligands, stabilise and favour the formation of peptide receptive isomers and act 
as a conformational catalyst for peptide occupied complexes remains to be 
determined
5.4 TAPASIN AND MHC CLASS I ALLELE 
DEPENDENCE/INDEPENDENCEALLELIC
The original description of the tapasin deficient cell line 721.220 commented 
upon a post translational, allele specific process that was absent in this cell line
142
(Greenwood et al., 1994). Further work subsequently identified tapasin as the 
missing factor and a hierarchy of allele dependence/independence based upon 
cell surface expression levels was described (Li et al., 1997; Ortmann et al.,
1997; Sadasivan et al., 1996). Grandea et al and Braud et al extended these 
allele dependences to include the non-classical complexes of HLA-G and E 
respectively (Braud et al., 1998b; Grandea et al., 1995). Peh and colleagues first 
described the alleles B*4402 and B*2705 as representative of the extremes of 
tapasin dependence and independence respectively (Peh et al., 1998). These 
serial observations have all approached the question of what determines tapasin 
dependence at both a functional and structural level. My initial approach within 
this work was to explore whether B*4402 and B*2705 were significantly different 
as peptide receptive complexes with regard to their stability and peptide 
receptivity. One explanation for tapasin dependence might have been a 
requirement of a chaperone interaction for the stability of a peptide receptive 
complex prior to peptide acquisition. B*4402 may have required such an 
interaction and B*2705 not. However examination of the complexes in the 
presence of ICP47 when they are as “empty” as possible showed very little 
difference in their thermostability profiles, with neither showing expression at the 
cell surface. Therefore an intrinsic difference in the affinity of the HC:yg2 M 
interaction that permits a tapasin independent loading phenotype does not seem 
likely. When one looks at the primary sequence of the tapasin dependent and 
independent alleles many differences are present. In comparing B*4402 with 
B*2705 there are 20 differences, occurring within the ori, a i and as regions
143
1 60
B*27 05 ,GSHSMRYFHTSVSRPGRGEPRFITVGYVDDTLFVRFDSDAaSPREEPRAPWIEQEGPEYW
B*4402 ,GSHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYW
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61 120
B+2705 ,DRETQICK/YKAQTDREDLRTLLRYYNQSEAGSHTLQNMYGCDVGPDGRLLRGYHQDAYDG
B*4402 ,DRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQDAYDG
k k k k k k k k k k k kkk kkkkkkkkkkkk k kkkkkkkkkkkkkkkk k k k k k k
121 180
B*2705 ,KDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQ
B* 4 4 02 ,KDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQDRAYLEGLCVESLRRYLENGKETLQ
kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk kkkkkk kkk kkkkkkkkkkkkk
181 240
B + 2705 , RADPPKTHVTHHPISDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRT
B+4402 ,RADPPKTHVTHHPISDHEVTLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRT
kkkkkkkkkkkkkkkkkk kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk
241 300
B*27 05 ,FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIG
B+4402 ,FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTVPIVGIVAGLAVLAVVVIG
kkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk
301 338
B*2705 ,AVVAAVMCRRKSSGGKGGSYSQAACSDSAQG5DVSLTA 
B+4402 fAVVAAVMCRRKSSGGKGGSYSQAACSDSAQGSDVSLTA
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Figure 5.4.1 -  Comparison of the primary sequences of 
B*4402and B*2705
The 20 differences between B*4402 and B*2705 are seen in red. Identical aspartic acid 
residues (D) at position 116 are highlighted in blue.
(Figure 5.4.1 ). The 20 differences are mostly within the a ,^ a i regions with a 
single change in the as region. The 116 position is identical between the 2 alleles 
and highlighted in blue. When one compares B*4402 and B*4405 there is only a 
single difference at position 116, a negatively charged aspartic acid in B*4402 
(D116) and an aromatic tyrosine (Y) in B*4405. Position 116 is an important 
residue as it, in addition to other residues (Table 5.4.1), forms part of the F 
pocket which accommodates the C terminal peptide residue.
How might a single residue change the dependence upon tapasin for the 
acquisition of peptide? The motif for B*4402 is E at P2 and Y/F at P9. I would 
suggest that the change at 116 crucially affects the function of the F pocket for 
these alleles. Ascribing a function to a pocket of the peptide binding groove 
other than its role in dictating specificity is tentative at present. I would suggest 
that the substitution of a negatively charged residue for an aromatic residue at 
this position, whilst not directly impacting upon the specificity of the F pocket 
could change the propensity of the MHC class I molecule to undergo a peptide 
induced confirmation change. The D>Y change enables B*4405 to bind to 
relatively high affinity peptides in the absence of tapasin help. This may relate to 
a structural change in the hydrogen bonding network that is set up with the 
peptide receptive molecule. It is possible that this change also permits B*4405 to 
remain peptide receptive following low affinity peptide interactions or it may 
increase the threshold level of any peptide induced conformational change. It is 
also possible that the altered F pocket permits an improved transition between
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Pocket Residues Peptide position 
accommodated
A 5,7,59,63,66,99,159,16
3,167,171
1
B 7,9,24,35,34,45,63,66,6
7,70,99
2
C 9,70,73,74,97 6
D 99,113,114,155,156,15
9,160
3
E 97,114,147,152,156,15
9,160
7
F
1
77,80,81,84,95,116,123
,143,146,147
r 1
Carboxy-terminus
r
Table 5.4.1 -  Amino acid composition of the MHC class
peptide binding groove pockets
The 6 peptide binding pockets that are constitute the 
peptide binding groove of MHC class I HC have 
contributions from several amino acids. Each pocket 
accommodates a particular amino acid residue of the 
bound peptide.
Thermal
Energy
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B*4402 +Tapasin
B*2705 (B*4405)
B*4402
Fast on 
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Figure 5.4.2 -  Hypothetical model peptide induced
conformational changes in different MHC 
class I complexes
The conversion of a peptide receptive complex to an occupied 
one will need to overcome an energy barrier for such a 
conformational change to occur. This change may be induced 
through a F pocket peptide interaction. This may be more easily 
triggered with lower affinity ligands for alleles such as B*4402. 
Tapasin may resist such low affinity peptide mediated 
conformational changes.
peptide non-receptive and receptive states (Figure 5.4.2). The importance of 
position 116 had been previously eluded to regarding the ability of alleles to 
interact with the TAP/tapasin PLC complex. Alleles such as B*3501 with a serine 
(small polar) at 116 bound poorly to TAP whilst B*3503 which only differed from 
B*3501 by the substitution of phenylalanine (aromatic) at 116 was able to 
associate with TAP (Neisig et al., 1996). Turnquist and colleagues have studied 
the alleles B*1510 (Y116) and B*1518 (S116) which only differ at a single 
residue. Again the aromatic amino acid at 116 permitted a good interaction with 
TAP whilst the serine did not (Hildebrand et al., 2002). For A*6807 (H116) a 
single change to D116 (A*68012) abolishes a Tap association (Turnquist et al.,
2002). However, in B*0701 the mutagenesis of Y116 to D116 greatly improves 
the TAP association (Turnquist et al., 2000). Again the tapasin dependences of 
these alleles and their mutants would be interesting, with the prediction that 
those showing a TAP association would be more tapasin dependent. Most 
recently, work by Ahn and colleagues has implicated a single amino acid within 
the 0 2  domain (114) as a critical determinant of tapasin dependence (Park et al.,
2003). They identified a number of alleles that were tapasin independent 
(B*2705, B*2702, B*0801 and B*5401) and some that were tapasin dependent 
(B*4402, B*3501, A*3001 and HLA-G) (Table 5.4.2). Those alleles that were 
tapasin independent all had a histidine (basic) at position 114 whilst those 
dependent alleles possessed a negatively charged glutamic acid (E) or aspartic 
acid (D). Remarkably when B*4402 was mutated (D114H) it became tapasin 
independent whilst B*2705 (HI 14D) became tapasin dependent. Furthermore
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Pocket
Contribution
0
B F F F E0 DB
A
E
D F ED P9Peptide
Residue 70 77 81 95 97 99 114 116 156
Dependent
B*4402 N N A 1 R Y D D D Y/F
B*3501 N S L 1 R Y D S L Y/F
A*3001 Q D L 1 1 Y E H L Y/L
G*0101 H N L L W 1 E Y R L
E*0101 T N L L W H E F Q L
K*0101! H y i 1 lû Ë u tà tù
B*2705 H114D K D L L N Y D D Y ?
Weakly
Dependent
B*0801 N S L L S Y N Y D L
B*5401 Q S L W T Y N L L A
BM402 D114N N N A 1 R Y N D Y ?
B*2705 H114N K D L L N Y N D Y ?
Independent
B*2705 K D L L N Y H D L R/K
B*4405 Ü H k 1 fe k Ë k a m
B*2702 K N A L N Y H D L F/Y
A*0201 H D L V R Y H Y L L
A*2401 H N A L M F H Y R F/W
BM402 D114H N N A 1 R Y H D D ?
Table 5.4.2 - Pocket residues of Tapasin dependent and independent 
aiieies
The important amino acid residues of the F pocket are highlighted in yellow. Other amino acid 
residues that are represented in at least 2 other pockets are also shown. The preferred Carboxy 
terminus anchor residues are highlighted in boldface. The alleles highlighted in red (A*0101 & 
B*4405) have position 114 residues that do not conform to the notion of an acidic residue at this 
position conferring tapasin dependence and a basic residue, tapasin independence.
the basic 114 B*4402 complex showed a lowered affinity for tapasin whilst the 
negative 114 B*2705 complex demonstrated a higher affinity for tapasin 
compared to their natural alleles. This approach has since been extended to the 
non classical HLA-G allele (Park and Ahn, 2003). Position 114 is interesting as it 
contributes to the D and E pockets of the peptide binding groove (Table 5.4.1). 
However BM405 has an aspartic acid at position 114 and is independent whilst 
A*0101 has a basic arginine at position 114 and is tapasin dependent 
(Greenwood et al., 1994). In considering all these experimental findings it is 
clear that broad generalisations about single residue alterations and predicted 
functional consequence are likely to be allele specific and relevant within the 
context of the structure of that particular complex. However the attention upon 
the F pocket and possibly the E pocket places an emphasis on the interaction of 
the C terminal and P7 residues of the peptide. Perhaps in the context of B*4402 
and B*2705 the ‘tapasin-independent inducing' mutations alter peptide selection 
so that peptide loading may occur with the similar set of peptides, due to the 
relaxation of certain functional constraints that may have been previously 
present. Similarly for the ‘tapasin-dependent inducing’ mutations a structural 
constraint for a productive F pocket-peptide-interaction may have been invoked, 
thereby limiting assembly with the previously favourable peptide cargo.
I consider that the allele differences in the requirement of tapasin for peptide 
loading will relate to a structurally determined property of each allele that 
facilitates their chaperone independent peptide receptivity. Certain alleles will be
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peptide receptive following early assembly and following a transitory peptide 
induced conformational change. This permits multiple cycles of peptide 
assembly/disassembly without loss of peptide receptivity until a high affinity 
peptide is loaded. For dependent alleles this acquisition of peptide either 
requires tapasin to enable peptide receptivity following early assembly or 
following the conformational change secondary to a low affinity peptide 
interaction. Thus tapasin would both increase the quantity of peptide receptive 
complexes (a quantitative component of tapasin function) and control the quality 
of loaded peptide for such alleles (a qualitative component of action). The 
mutations mentioned probably alter the balance of these chaperone 
requirements for each allele. The characterisation of such molecular alterations 
will probably require crystalisation approaches to the various allele variants, 
analysis of the peptide vacant forms and possibly the assessment of other MHC 
class I mutants that selectively target intra-hydrogen bond networks within the 
peptide binding grooves.
5.5 Summary - integrated pathways of peptide loading, 
optimisation, trafficking and cell surface expression.
The molecular mechanisms and exact differentiation pathways of MHC class I 
assembly still elude us. Two major assumptions may be made concerning the 
assembly and export of MHC class I complexes. The first is that the process of
147
ER assembly and export of this heterotrimeric glycoprotein complex share many 
similarities with other transmembrane multi-subunit glycoproteins. The second 
assumption is there are specific ‘regulations’ placed upon some MHC class I 
complexes that may relate to their subunit assembly, i.e. - peptide 
abundance/suitability, ^ 2^  affinity, HC anomalies or chaperone interactions. The 
work undertaken in this thesis and its relationship to the existing literature has 
been assembled into the following working model.
- THE MHC HEAVY CHAIN GLYCOPROTEIN FOLDING AND OXIDATION
The unfolded HC is glycosylated at an asparagines (Asn) residue (position 86) 
within the a^ domain of all human class I proteins. The growing polypeptide 
chain is post translationally modified on an NXT/s glycosylation sequon as the 
nascent chain is translocated to the luminal side of the ER. A 14-saccharide 
‘glycan unit’ is transferred from the dolichylpyrophosphate carrier to the Asn 
residue via an N-glycosidic bond (Figure 5.5.1). This triglycosylated 
oligosaccharide (Glc3MangGlcNAc2 ) subunit has an important role in the folding 
of nascent glycoproteins and this is of equal importance in MHC class I 
assembly. It has been previously noted with other protein models that the 
glycosylated regions of a protein are not random but coordinate with tertiary 
structures that have important conformational properties (Ellgaard and Helenius,
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Figure 5.5.1 -  The MHC HC -  Glycoprotein folding
The first stage in the assembly of a heterotrimeric MHC class I complex is 
the folding of the glycosylated HC. This is undertaken by the chaperones 
calnexin and calreticulin. P2  m binding to oxidised HC permits release from 
calnexin and suitability for calreticulin binding or GS II cleavage. UGGT 
reg lu cosy I ate the HC for a further cycle of folding.
2003). This is of importance with regard to the a^ region of the class I molecule 
and I will return to this point later. The GIC3Man9GlcNAc2 subunit is immediately 
acted upon by ER resident glycosidases (GS 1 and II). The membrane bound 
GS I removes the terminal glucose and the residual 2 glucoses are removed by 
the soluble GS II. Further glycan processing may proceed within the ER through 
the action of mannosidases I and II to generate a Man/GlcNAca. Besides 
deglucosylation and demannosylation a further glycan modification may occur 
within the ER. This is the re-glucosylation of the previously glycosylated 
mannose by the enzyme UDP-glucose:glycoprotein glucosyltransferase (UGGT). 
Its activity is dependent upon the integrity of the polymannose core with greater 
activity for the Mang > Man8 > Man/ structures (Frigerio and Lord, 2000). This 
appears to be of importance for 3 reasons. Firstly, the UGGT has been shown 
act as a protein folding sensor acting to re-glucosylate proteins that are 
incompletely folded (Caramelo et al., 2003). Secondly, monoglucosylated 
proteins are a substrate for the ER resident chaperones calnexin and calreticulin 
which have an important role in the assembly of MHC class I complexes. Thirdly, 
the glycan side chain and in particular its glucosylated and mannosylated 
structure are important in mediating the removal and degradative pathway of ER 
glycoproteins (ERAD) (Tsai et al., 2002).
The calnexin-calreticulin cycle is an important ‘quality control' step in the 
formation of many glycoproteins. These homologous proteins have been 
extensively investigated in the processes of glycoprotein quality control and
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specifically MHC class I assembly. The principle is that monoglucosylated Man/. 
9GICNAC2 subunits are ligands for both calnexin and calreticulin. Removal of the 
terminal glucose disrupts this interaction leading to dissociation, whereas re- 
glucosylation by UGGT would permit a further cycle of interaction. Calnexin was 
initially described as associating with mouse MHC class I molecules (Degen and 
Williams, 1991). This association was shown to be increased in cells where 
MHC class I assembly was impaired through peptide or 02^  deficiency. The role 
of the glycan in mediating this interaction has been looked at in 3 ways. Firstly, 
HC point mutants have been made which replace asparagines (N8 6 ) residues 
(Zhang et al., 1995), secondly enzyme inhibitors have been used to prevent 
glucose trimming to the monoglucosylated form (Neefjes and Ploegh, 1988) and 
thirdly calnexin deficient cell lines have been generated (Scott and Dawson, 
1995). Zhang and Salter investigated the human A*0201 (A2) allele by 
transplanting an additional glycosylation site at position 176 within the alpha 2  
domain (Zhang and Salter, 1998). Two important points were made. Firstly the 
double glycosylation mutant bound more stably to calnexin compared to wild type 
A2 and secondly the mutant bound to calnexin in both a j52M associated and free 
form. This latter point supported earlier work which had identified a division 
between mouse and human class I assembly where mouse calnexin was able to 
remain associated with 0 2 ^  bound heavy chain whereas human heavy chains 
were unable to do so (mouse class I heavy chains are all glycosylated at position 
8 6  and 176). A model was constructed where human class I associated with 
calnexin during its initial folding utilising position 8 6  and upon correct folding and
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0 2 ^  association, release from calnexin occurred with subsequent availability of 
the monoglucosylated N8 6  to soluble calreticulin but inaccessibility to calnexin 
(Sugita and Brenner, 1994). In comparison, mouse still posses glycans at 
positions 176 (+/- 256) and may simultaneously co-associate with both 
calreticulin and calnexin (Nossner and Parham, 1995). However this association 
may not be strictly dependent upon glycan interactions as Carreno and 
colleagues generated an aglycosylated mouse allele and showed comparable
association with calnexin compared to wild type . However, the cell surface
expression of this allele was reported to be much lower than that of the wild type 
allele with more peptide receptive complexes identified within the ER (Carreno et 
al., 1995). In mannosamine treated cells the glycan chain is prematurely 
terminated as a Glc3Man5-7GlcNAc2 subunit (Bennett and Kearse, 1999). The 
mouse allele was shown to associate poorly with calnexin when this 
termination was induced whilst its association with calreticulin was comparable to 
wild type K .^ In tunicamycin treated human cells, which completely inhibits N- 
linked glycosylation, allele differences were found in the assembly of class I 
alleles. For many B locus alleles there was a failure to associate with 02U and 
an enhanced binding to antibodies that detect unfolded class I molecules 
(Neefjes and Ploegh, 1988). For certain class I alleles (mainly A locus) only 
small differences were seen in the presence or absence of glycosylation. Finally 
MHO class I expression has been assessed within a calnexin deficient human 
cell line. No differences were seen in the trafficking rate, heavy chain turnover or 
cell surface expression of MHC class I molecules between mutant and wild type
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cells. This may be due to the redundancy of function between folding 
chaperones in the ER. Indeed, some groups have shown that the protein BiP 
may be important in HC folding or degradation (Nossner and Parham, 1995; 
Paulsson et al., 2001b). It is not clear whether BiP is involved in targeting 
unfolded heavy chains for degradation or facilitating folding.
These studies demonstrate that early MHC class I assembly is similar to other 
glycoproteins, utilising the glycoprotein modifications of the ER to assist in 
folding, quality control and degradation in the absence of a correct structure. 
These process may show allele and species selectivity in their generalised 
actions upon MHC class I assembly. In what way do the glycoproteins assist in 
these processes at a molecular level?
The calnexin-calreticulin cycle has an important role in the mechanism of UGGT 
based folding but is also thought to be crucial for the recruitment of thiol 
oxidoreductases (High et al., 2000). The oxidising environment of the ER and 
the presence of thiol oxidoreductases permit disulphide bond formation within the 
ER. MHC class I. complexes have a disulphide bond in the alpha 3 domain 
(cys203-cys259) and within the alpha 2 domain (cys101-cys164). One of the thiol 
oxido reductases , ERp57, is particularly interesting in the context of MHC class I 
assembly. ERp57 is a member of the protein disulphide isomerase family (PDI) 
with 2 thioredoxin motifs that constitute its thiol/disulphide oxidoreductase sites.
It is of interest in the assembly of MHC class I complexes as it is recruited to
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glycoproteins to participate in corrective folding by the calnexin-calreticulin cycle. 
This was shown by Oliver et al where blockade of lectin binding prevented 
ERp57 mediated disulphide formation (Oliver et al., 1997). Furthermore, release 
from ERp57 was only permitted upon deglucosylation. For MHC class I 
assembly 3 groups reported an association between ERp57 and class I heavy 
chain (Hughes and Cresswell, 1998; Lindquist et al., 1998; Morrice and Fowls, 
1998). This was identified in rat, mouse and human systems. Important points 
from these papers were that the ERp57 was seen within the peptide loading 
complex, tapasin was required for ERp57 incorporation into the complex, a ‘sub’ 
loading complex could exist in the absence of TAP and inhibition of glucose 
trimming prevented co-association of ERp57 with MHC class I HC. It has proved 
more difficult to identify early complexes of MHC class I HC with 
calnexin/calreticulin outside of the PLC. Previous studies undertaken by Bulleid 
et al required crosslinkers to demonstrate the co-association of the glycoprotein 
with the calnexin/calreticulin/ERp57 complex (Farmery et al., 2000). Lindquist et 
al probed for a mixed disulphide intermediate through the use of a membrane 
permeable alkylating agent to trap mixed disulphides (Lindquist et al., 2001). 
Using an antibody to the free HC (in a detergent that disrupted the PLC) they 
identified a 105kDa protein which was shown to be ERp57 and MHC HC. 
Furthermore, they showed that an antibody to free heavy chain could co- 
immunoprecipitate ERp57 in a calnexin positive cell line but not in calnexin 
negative cell line. As calnexin is not part of the human PLC this implies co­
association in the early assembly of MHC class I HC. Interestingly in the
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calnexin deficient cell line ERp57 was not seen as a mixed disulphide with HC 
but ERp72 was seen instead. Such redundancy of function possibly accounts for 
the normal class I expression in CEM-NKR cells. More recently, recombinant 
ERp57 has been shown to form mixed disulphides with HLA-B*2705 (Antoniou et 
al., 2002). This interaction has preference for partially folded HC and may 
promote further unfolding with subsequent targeting for degradation. This again 
underlies the dual function of the early glycoprotein chaperones in the ‘quality 
sorting’ of MHC molecules.
It appears that the MHC class I HC behaves in a similar manner to other nascent 
glycoproteins, forming mixed disulphide intermediates with ERp57 in the context 
of a calnexin-calreticulin interaction. It is important to distinguish this general 
chaperone interaction from that interaction that is specific to MHC at the PLC.
The role of calnexin in this early folding cascade suggests that redundancy of 
thiol oxidase activity is possible (i.e. ERp72 substituting for ERp57). It is 
probable that calreticulin has less of a role to play in the early folding of MHC 
class I HC and that calnexin is key for ERp57 recruitment and assisted function. 
These early events may now be looked at in a murine calreticulin knock out cell 
line. Finally it would also be of interest to assess the efficiency of 02^  
association and HC oxidative state of in a glycosylation mutant of a human MHC 
class I HC. As discussed previously with the experiments on tunicamycin treated 
cells (Neefjes and Ploegh, 1988) glycoprotein independent pathways for 
disulphide rearrangements may be utilised for certain alleles.
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THE FIRST HETERODIMERIC MHC CLASS I COMPLEX-^ CHECKPOINT 1
Following the assembly of HC and 02^, to form a correctly disulphide bonded 
heterodimer, a number of possibilities for further assembly are available. The 
key omission in the current experimental approach to MHC assembly is a 
reagent that can distinguish peptide occupied from peptide receptive MHC/ 02^  
heterodimers. I have made some attempt to address this issue within my thesis 
with regard to the differing thermostability profiles of such complexes.
Previously, 02^  associated complexes that have been unable to exit the ER have 
been considered as peptide empty complexes. This has been based upon 
original work in the TAP deficient cell lines where the egress of MHC class I 
molecules had been prevented (Baas et al., 1992; Ljunggren et al., 1990; 
Schumacher et al., 1990). This link between a failure of peptide 
supply/occupancy and egress initially supported the idea that these complexes 
were empty. Indeed, culturing such cell lines at 26°C restored MHC class I 
expression and this was initially thought to represent the expression of empty 
molecules. Subsequent studies have isolated peptides from these 26°C (37°C 
unstable) complexes (De Silva et al., 1999), supporting the concept that MHC 
class I complexes may be loaded with a suboptimal/thermo-unstable/low affinity 
ligand cargo (Lewis and Elliott, 1998). There are some key conceptual difficulties 
with the notion of a suboptimally loaded complex that is not exported at 
physiological temperatures but that is exported at reduced temperatures. Is
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export competence governed by a quality control folding sensor ttiat is ‘tricked’ at 
26°C or is such machinery inoperative at this temperature? An alternative 
explanation that such complexes are better identified at reduced temperatures as 
they are less prone to dissociation. A principle that is applicable to most 
secretory glycoproteins is one where incompletely folded molecules are 
distinguished from compact molecules by UGGT and subsequently tagged by 
glucosylation. This ‘glucosylation stamp’ is a signal for further engagement 
within the calnexin/calreticulin cycle. However studies on the mouse allele in 
wild type cells or peptide deficient cells with glycan radiolabelling shows less than 
5% of all retained complexes are monoglucosylated (Hayes et al., 1995). The 
majority are Man 8.9GICNAC2 in the peptide deficient RMA/S cell line whilst in the 
wild type cell they have been acted upon the medial golgi enzyme alpha 
mannosidase II (resistant to endoglycosidase H). In a more recent investigation, 
the HC glycans within the PLC were analysed. This suggested that 50% of the 
V \d 02^  complexes within the PLC were monoglucosylated (Radcliffe et al., 
2002). It was suggested that the deglucosylated 50% is peptide occupied and 
awaiting release. Furthermore the complexes on the PLC show evidence of 
trimming to Man6-8GlcNAc2 forms, consistent with ongoing ER mannosidase 
activity. Therefore a UGGT folding sensor system may operate for complexes on 
the PLC. Indeed the steady state detection of monoglucosylated proteins is in 
equilibrium between glucosidase II mediated deglucosylation and UGGT 
mediated re-glucosylation. The ability of MHC class I complexes to bind to the 
PLC may alter this equilibrium so that the monoglucosylated from is more readily
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identifiable. What about complexes that are retained in the peptide incompetent 
cell lines? In such cell lines MHC HC/ 02^ heterodimers are identified within the 
ER but their half life is faster than in peptide competent cells. This turnover is 
thought to be mediated through a reduced HC/ 02^  stability in the absence of 
peptide which leads to dissociation. Such misfolded HC, following 
reglucosylation, may then be a ligand for further calnexin binding. The process 
of glycoprotein loss through ERAD has been recently enlightened with the 
identification of EDEM (ER degradation enhancing alpha-mannosidase-like 
protein ) (Molinari et al., 2003; Oda et al., 2003). The failure of a MHC class I 
glycoprotein to be re-glucosylated may target it for a degradative pathway which 
prevents its egress from the ER. This has recently been shown for non-MHC 
class I glycoproteins such as alpha 1 antitrypsin (Liu et al., 1999). The key 
change within a glycoprotein that is destined for degradation appears to be its 
conversion to a Mans form (Tsai et al., 2002). This is the signature for 
subsequent ERAD. This latter process appears to involve an ER resident alpha 
-mannosidase homologue that lacks enzyme activity. This protein has been 
termed EDEM (ER degradation enhancing alpha-mannosidase-like protein) and 
is a class II transmembrane protein with specificity for non-glucosylated 
misfolded Mans glycoproteins. Through the pathway of calnexin association, 
glucosidase II mediated calnexin release and ER mannosidase I modification, the 
misfolded glycoprotein is targeted for Sec 61 retrotranslocon transport and 
degradation, rather any than further UGGT mediated folding cycles. Therefore 
HC/ 02U complexes (or free heavy chains) may have an initial quality checkpoint
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Figure 5.5.2 -  The MHC:p2M complex - Checkpoint 1
The first quality checkpoint for MHC class I assembly may utilise 
the CNX/CRT/UGGT pathway with 3 options available to an empty 
MHC class I complex. It may bind peptide (1 ), dissociate to a free 
HC which re-enters the cycle (2) or be acted upon by ERM1 and 
enter a EDEM associated ERAD pathway (3).
1 that operates at the level of HC dissociation from calnexin. This is depicted in 
Figure 5.5.2 where there are 3 options for a HC/yff2 M complex in a peptide 
incompetent cell. The first is the attainment of a degree of stability through an 
interaction with suboptimal peptide that maintains the HO!p2^  association. This 
trimeric complex may not be a substrate for ER mannosidase I and hence 
escape ERAD. It is possible that it is a substrate for PLC binding upon which 
optimisation of the peptide cargo may occur. The second option is of rapid 
dissociation of HC from A2 M, re-glucosylation via UGGT and further calnexin 
binding. A further attempt at cooperative p M  and peptide binding may then be 
made. The third option operates as a competition between EDEM binding or a 
further cycle of;^2 M assembly/disassociation and UGGT mediated glyosylation. 
Binding to EDEM is facilitated by calnexin dependent ERM 1 activity to form a 
Mans HC. This mannose motif is recognised by EDEM and less favoured as a 
re-glycosylation motif by UGGT. This third option would ultimately lead to HC 
removal via ERAD.
Therefore checkpoint 1 is the measure of the cooperative stability of the HC / 
A2 M complex with the competing forces of
(i) Peptide mediated stabilisation of the MHC/ A2M complex prior to 
further exchange/trimming or export
(ii) UGGT mediated reglucosylation of dissociated HC prior to a for a 
further calnexin cycle or
ER mannosidase I mediated Mans modification and calnexin/EDEM 
facilitated removal of the dissociated heavy chain.
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THE FIRST HETEROTRIMERIC MHC CLASS I COMPLEX-» CHECKPOINT 2
Returning to the intermediate stages of MHC class I assembly following release 
from calnexin it is next convenient to consider 2 possibilities. The first possibility 
is that peptide acquisition occurs in the absence of further chaperone assistance 
and this completes the assembly process of the heterotrimeric complex (See 
5.2). This type of complex is exemplified by MHC class I HC mutants with single 
amino acid changes that impair associations within the PLC. Also some naturally 
occurring alleles associate poorly with the PLC. For such alleles it is convenient 
to consider them as peptide receptive and perhaps open to chaperone 
independent sampling of peptides. B*2705 and B*4405 might behave in this 
manner, with the monoglucosylated trimeric complex subsequently acted upon 
by GS II. This compact molecule would no longer be a substrate for UGGT, 
passing quality control checkpoint 1 and able to leave the ER. The second 
possible intermediate stage of MHC class I assembly requires the peptide 
receptive complex to utilise the PLC to facilitate peptide loading. This assistance 
may then furnish the peptide receptive complex with a suitable peptide that 
permits egress from the ER. What happens to PLC dependent A2 M associated 
complexes (i.e. B*4402) in tapasin incompetent cell lines? For classical alleles 
such as B*4402 their inability to egress the ER leads to their eventual 
degradation through ERAD. As peptides are available in such tapasin 
incompetent cell lines and B*4402 molecules are able to load peptides in a
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detergent lysate in the absence of tapasin, why is there a ‘reluctance’ to load in 
the ER? From the observations made within this thesis I have proposed one 
model that might explain this phenomenon. This model is built on 3 experimental 
observations and interpretations.
1) The first relates to the change in thermostability of B*4402 complexes in the 
presence and absence of ICP47.
2) The second is the improved thermostability of B*2705 over B*4402 in the 
absence of peptide and tapasin.
3) The third observation is from the MHC class II literature which relates the 
thermostability, SDS stability and compact conformation of different MHC class II 
molecules with their DM dependence and peptide receptivity.
One model which I have proposed from the observations made within this thesis 
is seen in Figure 5.5.3. The features of this model are: (I) MHC class I 
complexes may exist in an open conformation with or without peptide and a 
closed conformation with and without peptide (ii) different alleles may show 
different intrinsic propensities to adopt one of these conformations. We can 
consider an allele such as B*4402 as easily triggered to undergo a transition to a 
closed conformation following an interaction with suboptimal ligands that have a 
fast off rate and poor complementarity for anchoripocket interactions. B*2705 
may be more compact due to the composition of its binding pockets and be less 
easily triggered into a full rearrangement by poor affinity ligands. This more 
compact open conformation may be a peptide receptive form which upon suitable
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peptide occupation undergoes a full conformational change to a compact, closed 
peptide occupied form. In contrast, B*4402 may more easily move to a closed 
peptide vacant form which is unsuitable for further peptide binding. Such 
conformed but un receptive molecules would eventually dissociate to HC and A2 M 
and be dealt with through ERAD. The role of tapasin may be to disfavour the 
non-productive conformational change from a sub optimal peptide occupied open 
conformer to a peptide dissociated dosed conformation. This may be secondary 
to an affinity for the open conformation which alters the sensitivity for a fuil 
conformational change by a ligand that is suboptimal. This would predict that 
tapasin dependent alleles would acquire peptides of a higher affinity than alleles 
that can acquire peptides equally well in the absence or presence of tapasin. In 
the latter case such alleles would have a mix of affinities, with the introduction of 
tapasin competing with peptide for a productive interaction with open 
conformation compiexes. This is consistent with the results seen in thesis with 
regard to B*4402 and B*2705. An additional function of tapasin for such 
dependent alleles may be to act upon open, peptide empty non receptive 
conformera to return them to a peptide receptive state. Whereas B*4402 
complexes are unable to load peptide in the absence of tapasin inside a cell, 
such complexes can subsequently be loaded with peptide in a detergent lysate. 
This is analogous to the detergent CgGIc in MHC class II assembly. Here the 
detergent is able to liberate CLIP peptide (‘suboptimal ligand') which releases 
peptide receptive MHC Class II molecules which were previously difficult to load 
in the absence of HLA-DM.
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For nonclassical alleles such as HLA-G a different process appears to take 
place. Elegant studies by Ahn and colleagues have shown that HLA-G is poorly 
expressed at the cell surface in tapasin incompetent cell lines and that such 
complexes are probably occupied with suboptimal complexes (Park and Ahn, 
2003). This latter point is based upon the observations that ICP47 blockade 
further reduces the thermostability of HLA-G molecules and that high affinity 
peptides improved export in the presence of tapasin. The unique feature of HLA- 
G is the presence of an RKKSSD motif in its shortened cytoplasmic tail. This 
motif permits association with the coatmer complex C0P1. C0P1 recognition of 
the cytoplasmic tail of HLA-G directs its retrieval of the heterotrimeric complex 
from the ERGIC to the ER. These complexes have not yet attained Endo H 
resistance and are therefore proximal to the medial golgi. It is hypothesised that 
this pathway is dependent upon suboptimal ligand occupation of the MHC class I 
complex since HC/A2 M complexes are more rapidly lost in peptide incompetent 
celis possibly relating to their inability to enter this ER exit and retrieval pathway, 
which in some way protects them from ERAD (even though they are not suitable 
for medial golgi egress). Similar studies were undertaken over 10 years ago in a 
peptide incompetent cell where it was first suggested that MHC class I 
complexes may recycle between the ER and cis-golgi (Hsu et al., 1991). These 
studies were undertaken in a mouse cell line and showed co-localisation of a 
classical mouse MHC class I allele with a marker of recycling vesicles. Such 
studies have not been undertaken for human alleles, at least not in the context of
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a peptide incompetent cell, and may therefore add further to the recycling 
mechanisms that operate for classical molecules under different circumstances 
of peptide availability or ‘loadability’. Another non ciassical mouse allele, H2-M3, 
which binds selected N-formylated peptides has been similarly assessed (Chun 
et al., 2001). Again, the provision of high affinity ligands is necessary but not 
sufficient for cell surface expression requiring tapasin for loading. It is proposed 
that suboptimal ligands are required for protection of HC from degradation. It will 
be interesting to see how this is mediated as H2-M3 does not possess an ER 
retrieval motif in its cytoplasmic tail and is therefore is unlikely to recycle in an 
identical manner to HLA -G . It is possible that it utilises the retrieval motif of 
another chaperone such as calreticuiin (i.e. driven by the KDELR) (Yamamoto et 
al., 2001) or undergoes COPI independent retrievai (Girod et al., 1999; Storrie et 
al., 2000). Alternatively suboptimal peptide may operate differentiy for H2-M3 
and simply extend the HC/A2M interaction thus preventing premature HC 
dissociation and ERAD mediated degradation.
In considering these experiments upon classical and non-classical MHC class I 
complexes a further quality control checkpoint is suggested. Such a check point 
permits HLA-G complexes with high affinity peptide to egress and peptide 
occupied H2-M3 and classical alleles in TAP incompetent cells to be identified 
and retained. A further consideration with regard to this hypothetical checkpoint 
is the behaviour of the MHC class I mutant T134K A*0201 (A2). This aiiele exits 
with a suboptimal peptide cargo, cannot interact with the PLC and traffics faster
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than wild type A2 (Lewis et ai., 1996; Peace-Brewer et al., 1996). However, in 
the presence of a TAP blockade it is retained in the ER suggesting that 
suboptimal ligands are important for bypassing checkpoint 1 and in their absence 
the class I complex is unstable and dissociated HC may interact with the calnexin 
EDEM apparatus for retention and removai (Lewis and Elliott, 1998). Similarly, 
its trafficking and poorer peptide selection compared to wild type in the presence 
of suboptimal ligand suggests that it may selectively bypass checkpoint 2. This 
hypothetical checkpoint is presumably active upon the HLA-G and H2-M3 
complexes mentioned earlier. Would T134K mutations in HLA-G permit 
suboptimal complex egress increase the trafficking rate or conversely slow the 
trafficking rate of HLA-G secondary to an antagonism of tapasin facilitated high 
affinity peptide loading ? Such a checkpoint 2 may also operate upon classical 
MHC class I complexes (Paulsson et al., 2002). It is intriguing that wild type A2 
expressed in tapasin incompetent ceil lines behaves differently to the non tapasin 
binding T134K allele (Lewis et al., 1998). Here the trafficking time is not reduced 
and the complexes that do exit are more stable. This would suggest that the 
ability to associate with tapasin is indirectly involved with checkpoint 2, 
secondary to its effect upon peptide loading, but that the quality controi 
checkpoint of the loaded complex is not tapasin itseif. The molecular nature of 
this secondary checkpoint is not clear although experiments with HLA-G offer 
some interesting perspectives. When the cytoplasmic tail of G is swapped for 
that of A2 the retention of G is no longer seen. As the peptide repertoire is not 
expected to change (assumption at present), it is probable that the previous
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cargo which was being rejected at checkpoint 2 is now able to egress the ER 
when the competing ER retention is removed. Similarly, the reverse is seen with 
a G tail upon A2. Therefore peptide loading may be sufficient for default egress 
unless a specific signal for retrieval is received. Alternatively peptide loading 
may engage an ER export apparatus whose activity is impaired by 
chaperone/COP1 association. Recent studies upon the ER export of potassium 
channels have identified an important role for phosphorylation of a cytoplasmic 
tail sequence. This sequence, when phosphorylated, is able to bind a member of 
the 14-3-3 family of proteins which permits ER release (O'Kelly et al., 2002).
This 14-3-3 binding is shown to block binding COPI to the cytoplasmic tail of the 
potassium channel. Such a conserved phosphorylation sequence is seen for 
MHC class I heavy chains, including HLA-G (Vega and Strominger, 1989). In the 
case of T134K, a gain of function may be introduced with a pro-exit phenotype 
acquired in the absence of ‘correct’ assembly. Another possibility with regard to 
the latter allele is that a different ER exit route is chosen from wild type MHC 
class I complexes. Edidin and colleagues have provided some experimental 
data to support this latter hypothesis through the use of fluorescently tagged 
complexes. Through the analysis of FRET between complexes they suggest that 
T134K complexes do not co-localise with wild type complexes and may leave the 
ER through a different exit site (Pentcheva and Edidin, 2001).
In the case of alleles such as B*4402, peptide loading at the PLC is mandatory 
for competent assembly. For alleles such as B*2705, such an interaction is
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possible and indeed is shown within this thesis to increase the rate and extent of 
peptide loading despite its previous tapasin independent status. This 
redundancy of chaperone requirement may be important for the immune 
response to pathogens that subvert PLC interactions. Such infections would in 
principle, impair the ability of certain alleles to present pathogen peptides to CTL. 
In contrast, certain alleles may require chaperone assistance to load pathogenic 
peptides with the slowest off rate, thus providing a longer cell surface 
appearance and opportunity for recognition and CTL generation. For alleles with 
a restricted peptide display that is distinct for particular receptors (i.e. HLA-E and 
CD94/NKG2A) it may be beneficial to become tapasin dependent so that only a 
particular set of peptides mediates cell surface expression. The molecular 
mechanisms that mediate such peptide loading at the PLC are far from clear. 
Within my thesis I have shown that the thermostability of a complex is greatest 
when loaded with the assistance of tapasin at the PLC interface. This effect may 
relate to the abundance of peptides at the PLC, or perhaps favoured peptide 
trimming at the PLC. Interference with other components of the PLC has also 
been achieved. When calreticulin is absent from the loading complex a greater 
proportion of sub-optimally loaded complexes leave the ER (Gao et al., 2002). 
However, the PLC shows association of tapasin, heavy chain and ERp57 within 
this modified PLC. How the absence of calreticulin leads to impaired 
optimisation is not understood but may relate to:
(1) a stabilisation effect upon the MHC class l/TAP/tapasin complex,
(2) modulation of a calcium dependent ER trimmase.
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(3) chaperone of peptides from TAP,
(4) retrieval of suboptimally loaded complexes via its KDEL motif or
(5) augmentation of the action of tapasin.
It will be interesting to analyse human tapasin dependent and independent 
alleles in the absence of calreticulin and assess whether a correlation exists 
between tapasin and calreticulin dependence. The third important component of 
the loading complex is ERp57. Insightful experiments undertaken by Cresswell 
and colleagues have drawn attention to this role of disulphide isomérisation in 
peptide loading at the PLC. Their first key observation was that of a mixed 
disulphide complex of tapasin and ERp57 within the PLC (Dick et al., 2002). The 
entire PLC associated ERp57 was disulphide linked to tapasin, whereas 
approximately 50 % of PLC associated tapasin was disulphide linked to ERp57. 
When ERp57 was excluded from the complex through the clever generation of a 
tapasin mutant (C95A), B*4402 complexes showed a slightly reduced 
thermostability compared to wild type tapasin. In addition, the HC within the PLC 
was partially reduced in the presence of the C95A mutant of tapasin. If it is 
assumed that the MHC class I HC/ A2M complex is fully oxidised prior to the PLC 
interaction, it is then implied that reduction of one the disulphide bridges in the 
MHC ciass I HC takes place within the PLC. The disulphide bridge in the a2 
domain would seem the obvious candidate for an influence upon peptide loading 
through isomérisation. MHC class I mutants which are mutated at either the Cys 
101 or 164 sites within the a2 domain are poorly peptide receptive (Warburton et 
al., 1994) as might be expected as the disulphide bridge is important in the final
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structure. How this process of heavy chain disuiphide bond isomérisation 
contributes to MHC class I peptide assembly and optimisation is not clear. 
Experiments by Powis and colleagues have shown that peptide unoccupied 
complexes are move susceptible to recombinant ERp57 mediated reduction 
(Antoniou et al., 2002). Perhaps the susceptibility of cys 101-164 reduction is 
related to the conformation of the peptide biding groove and accessibility to the 
reducing agent. This may aiso differ between aileles so that certain alleles are 
more dependent upon a tapasin-ERp57 mediated oxidation event. Such 
oxidation would allow for further peptide sampling and its absence might ‘fix’ the 
dependent allele into a partially reduced non peptide receptive confirmation.
The complexity of chaperone interactions within the PLC and their cooperative 
and unique roles in the assembly of certain MHC class I molecules cannot be 
overstated. The involvement of pathways relating to glycoprotein folding, oxido­
reductase activity and perhaps the unique roles of calreticulin and tapasin stiil 
remain poorly integrated in providing an explanation as to how an optimised 
peptide repertoire following PLC association.
5.6 CONCLUSIONS
At the outset of my research there were 13 published papers concerning the role 
of tapasin in antigen processing (now 158 in 4 years). From this initial 
experimental database the functions of tapasin as a peptide editor/peptide 
trimmase/MHC foldase and ‘PLC cornerstone’ were proposed. My experimental
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objectives were to assess the allele dependencies upon tapasin, initially through 
a genetic approach and then through a functional one. The first of these 
approaches confirmed that tapasin in not polymorphic, perhaps suggesting that 
allelic dependencies/independencies are reflective of MHC variation conserved. 
The functional approach has been constructed around the tapasin dependent 
(B*4402) and independent alleles (B*2705). By developing a time resolved 
assay that is reflective of average peptide repertoire I have been able to further 
dissect the similarities and differences of these alleles within different 
environments. The resulting experimental observations have suggested that 
tapasin dependent non-trafficking alleles may not be peptide empty and that 
tapasin independent alieles are kinetically and quaiitatively disadvantaged when 
they acquire peptide in the absence of tapasin assistance. Aiso a phenomena of 
continued thermostability improvement has been noted which occurs at a time 
when the complexes have left the ER environment. Lastly, I have demonstrated 
that maximal optimisation of the MHC class I cargo is achieved when the MHC 
class I complex abridges to the PLC and that a singie amino acid change in the F 
pocket of a tapasin dependent allele can reverse the previously dependent 
phenotype. These observations have led me to reconsider some of the pre­
existing concepts regarding MHC class I peptide acquisition, intracellular 
trafficking and chaperone functions. These evolving ideas will now form the 
basis of further work to estabiish, at a moiecuiar level, how tapasin influences 
peptide binding by MHC ciass I molecules and which MHC class I structural 
features contribute to this dependence and independence. Finally, the
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mechanisms governing quality control at checkpoint 2 and post ER optimisation 
are undetermined at present. The detaiis of such mechanisms are warranted 
both for an improved understanding of both classical MHC class I presentation 
and possibly, cross presentation. Extending these investigations to dendritic 
cells will be a considerable challenge over the next few years. Such an 
understanding of MHC I antigen presentation pathways within dendritic cells will 
be of crucial importance, as we attempt to influence the priming and generation 
of effector/memory T cell responses against a wide variety of human diseases 
(viral and bacterial infections, solid tumours and viral associated tumours).
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